<SEC-DOCUMENT>0001641172-25-002783.txt : 20250404
<SEC-HEADER>0001641172-25-002783.hdr.sgml : 20250404
<ACCEPTANCE-DATETIME>20250404172908
ACCESSION NUMBER:		0001641172-25-002783
CONFORMED SUBMISSION TYPE:	S-1
PUBLIC DOCUMENT COUNT:		13
FILED AS OF DATE:		20250404
DATE AS OF CHANGE:		20250404

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Imunon, Inc.
		CENTRAL INDEX KEY:			0000749647
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				521256615
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-286403
		FILM NUMBER:		25815876

	BUSINESS ADDRESS:	
		STREET 1:		997 LENOX DRIVE
		STREET 2:		SUITE 100
		CITY:			LAWRENCEVILLE
		STATE:			NJ
		ZIP:			08648
		BUSINESS PHONE:		(609) 896-9100

	MAIL ADDRESS:	
		STREET 1:		997 LENOX DRIVE
		STREET 2:		SUITE 100
		CITY:			LAWRENCEVILLE
		STATE:			NJ
		ZIP:			08648

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Celsion CORP
		DATE OF NAME CHANGE:	20071121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CELSION CORP
		DATE OF NAME CHANGE:	19980515

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHEUNG LABORATORIES INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1
<SEQUENCE>1
<FILENAME>forms-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"> <B>As filed with the Securities
and Exchange Commission on April 4, 2025</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registration
No. 333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>FORM
S-1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OF 1933</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>Imunon,
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2834</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>52-1256615</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction of</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">incorporation
    or organization)</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Primary
    Standard Industrial</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Classification
    Code Number)</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</FONT></P></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>997 Lenox Drive, Suite 100</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lawrenceville, NJ 08648</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(609) 896-9100</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address, including zip code, and telephone number, including area code, of registrant&rsquo;s principal executive offices)</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stacy
Lindborg</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>President
and Chief Executive Officer</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Imunon,
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>997
Lenox Drive, Suite 100</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lawrenceville,
NJ 08648</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(609)
896-9100</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name,
address, including zip code, and telephone number, including area code, of agent for service)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Copies
to:</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 32%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Jurgita
    Ashley</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Thompson
    Hine LLP</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3900
    Key Center</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>127
    Public Square</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cleveland,
    OH 44114</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(216)
    566-5500</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 32%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 32%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ron
    Ben-Bassat, Esq.</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Eric
    Victorson, Esq.</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sullivan
    &amp; Worcester LLP</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>1251 Avenue of the Americas</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>New
    York, NY 10020</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(212)
    660-3000</B></FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Approximate
date of commencement of proposed sale to the public:</B> As soon as practicable after the effective date of this registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act of 1933, check the following box. &#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following
box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.
&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo;
&ldquo;smaller reporting company,&rdquo; and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    accelerated filer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    filer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated
    filer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
    reporting company</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
    growth company</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the
registrant shall file a further amendment that specifically states that this registration statement shall thereafter become effective
in accordance with Section 8(a) of the Securities Act or until the registration statement shall become effective on such date as the
Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>The
information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement
filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities, and it is not
soliciting offers to buy these securities, in any state where the offer or sale of these securities is not permitted.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B><I>SUBJECT
TO COMPLETION, DATED APRIL 4, 2025</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>PRELIMINARY
PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="form_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 14pt"><B>IMUNON,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UP
TO 10,000,000 SHARES OF COMMON STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UP
TO 10,000,000 COMMON WARRANTS TO PURCHASE 10,000,000 SHARES OF COMMON STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UP
TO 10,000,000 PRE-FUNDED WARRANTS TO PURCHASE UP TO 10,000,000 SHARES OF COMMON STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UP
TO 10,000,000 SHARES OF COMMON STOCK UNDERLYING SUCH COMMON WARRANTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UP
TO 10,000,000 SHARES OF COMMON STOCK UNDERLYING SUCH PRE-FUNDED WARRANTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are offering on a reasonable best-efforts basis up to 10,000,000 shares of our common stock, par value $0.01 per share (&ldquo;<U>Common
Stock</U>&rdquo;), together with warrants to purchase up to 10,000,000 shares of our Common Stock based on an assumed public offering
price of $1.00 per share of Common Stock and accompanying warrant, which was the closing price of our Common Stock on the Nasdaq
Stock Market (&ldquo;<U>Nasdaq</U>&rdquo;) on April 3, 2025. Each share of Common Stock, or a pre-funded warrant in lieu thereof,
is being sold together with a common warrant to purchase one share of Common Stock. The shares of Common Stock and common warrants are
immediately separable and will be issued separately in this offering but must be purchased together in this offering. Each common warrant
will have an assumed exercise price per share of $1.00, equal to the assumed combined public offering price per share of Common
Stock and accompanying common warrant, and will be immediately exercisable beginning on the effective date of stockholder approval
of the issuance of the shares upon exercise of the warrants (the &ldquo;<U>Warrant Stockholder Approval</U>&rdquo;); provided however,
if (i) the offering is deemed a public offering or (ii) the Pricing Conditions (as defined below) are met, Warrant Stockholder Approval
will not be required and the common warrant will be exercisable upon issuance (the &ldquo;<U>Initial Exercise Date</U>&rdquo;). As used
herein &ldquo;<U>Pricing Conditions</U>&rdquo; means that the combined public offering price per share of Common Stock and accompanying
common warrants is such that the Warrant Stockholder Approval is not required under the rules of Nasdaq because either (i) the offering
is an at-the-market offering under Nasdaq rules and such price equals or exceeds the sum of (a) the applicable &ldquo;Minimum Price&rdquo;
per share under Nasdaq Rule 5635(d) plus (b) $0.125 per whole share of Common Stock underlying the common warrants or (ii) the offering
is a discounted offering where the pricing and discount (including attributing a value of $0.125 per whole share underlying the common
warrants) meet the pricing requirements under Nasdaq&rsquo;s rules. The common warrants will expire on the five year anniversary of the
Initial Exercise Date or the Warrant Stockholder Approval, as applicable. This prospectus also relates to the shares of Common
Stock issuable upon exercise of the common warrants sold in this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are also offering to certain purchasers whose purchase of shares of Common Stock in this offering would otherwise result in the purchaser,
together with its affiliates and certain related parties, beneficially owning more than 4.99% (or, at the election of the purchaser,
9.99%) of our outstanding Common Stock immediately following the consummation of this offering, the opportunity to purchase, if any such
purchaser so chooses, pre-funded warrants, in lieu of shares of Common Stock that would otherwise result in such purchaser&rsquo;s beneficial
ownership exceeding 4.99% (or, at the election of the purchaser, 9.99%) of our outstanding Common Stock. The public offering price of
each pre-funded warrant and accompanying common warrant will be equal to the price at which one share of Common Stock and accompanying
common warrant is sold to the public in this offering, minus $0.0001, and the exercise price of each pre-funded warrant will be $0.0001
per share. The pre-funded warrants will be immediately exercisable and may be exercised at any time until all of the pre-funded warrants
are exercised in full. The pre-funded warrants and common warrants are immediately separable and will be issued separately in this offering,
but must be purchased together in this offering. For each pre-funded warrant we sell, the number of shares of Common Stock we are offering
will be decreased on a one-for-one basis. This prospectus also relates to the shares of Common Stock issuable upon exercise of the pre-funded
warrants sold in this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have engaged A.G.P./Alliance Global Partners (&ldquo;<U>A.G.P.</U>&rdquo;) and Brookline Capital Markets, a division of Arcadia Securities,
LLC (&ldquo;<U>Brookline</U>&rdquo;), to act as our placement agents (the &ldquo;<U>Placement Agents</U>&rdquo;), whereby A.G.P. is
serving as lead placement agent and Brookline as co-placement agent in connection with this offering, to use their reasonable best
efforts to arrange for the sale of the securities offered by this prospectus. The Placement Agents are not purchasing or selling any
of the securities we are offering, and the Placement Agents are not required to arrange the purchase or sale of any specific number or
dollar amount of securities. We have agreed to pay to the Placement Agents the Placement Agent fees set forth in the table below, which
assumes that we sell all of the securities offered by this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
refer to the Common Stock, common warrants and pre-funded warrants to be sold in this offering collectively as the &ldquo;securities.&rdquo;
The securities will be offered at a fixed price and are expected to be issued in a single closing. The offering will terminate on May
13, 2025, unless (i) the closing occurs prior thereto or (ii) we decide to terminate the offering prior thereto (which we may do
at any time in our discretion), except that the shares of Common Stock underlying the warrants and shares of Common Stock underlying
the pre-funded warrants will be offered on a continuous basis pursuant to Rule 415 under the Securities Act of 1933, as amended (the
&ldquo;<U>Securities Act</U>&rdquo;). Investors purchasing securities offered hereby will have the option to execute a securities purchase
agreement with us. We expect that the closing of the offering will occur one trading day after we price the securities offered hereby.
When we price the securities, we will simultaneously enter into securities purchase agreements relating to the offering with those investors
who so choose. The offering will settle delivery versus payment (&ldquo;<U>DVP</U>&rdquo;)/receipt versus payment (&ldquo;<U>RVP</U>&rdquo;).
That is, on the closing date, we will issue the shares of Common Stock directly to the account(s) at the Placement Agents identified
by each purchaser; upon receipt of such shares, the Placement Agents shall promptly electronically deliver such shares to the applicable
purchaser, and payment therefor shall be made by the Placement Agents (or their clearing firm) by wire transfer to us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
we will deliver the securities to be issued in this offering upon our receipt of investor funds, we and the Placement Agents have not
made any arrangements to place investor funds in an escrow account or trust account. Because this is a best-efforts offering, the Placement
Agents do not have an obligation to purchase any securities, and, as a result, there is a possibility that we may not be able to sell
the securities. There is no minimum offering requirement as a condition of closing of this offering. Because there is no minimum offering
amount required as a condition to closing this offering, we may sell fewer than all of the securities offered hereby, which may significantly
reduce the amount of proceeds received by us, and investors in this offering will not receive a refund in the event that we do not sell
an amount of securities sufficient to pursue our business goals described in this prospectus. In addition, because there is no escrow
account and no minimum offering amount, investors could be in a position where they have invested in our company, but we are unable to
fulfill all of our contemplated objectives due to a lack of interest in this offering. Further, any proceeds from the sale of securities
offered by us will be available for our immediate use, despite uncertainty about whether we would be able to use such funds to effectively
implement our business plan. See the section entitled &ldquo;Risk Factors&rdquo; for more information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Stock is listed on the Nasdaq under the ticker symbol &ldquo;IMNN.&rdquo; On April 3, 2025, the last reported sale price
per share of our Common Stock on Nasdaq was $1.00 per share. The actual public offering price per share of Common Stock and accompanying
common warrant, and per pre-funded warrant and accompanying common warrant, will be determined between us, the Placement Agents and the
investors in this offering at the time of pricing and may be at a discount to the current market price for our Common Stock, and the
recent market price for our Common Stock used throughout this prospectus may not be indicative of the final offering price per share
of Common Stock and accompanying common warrant, and per pre-funded warrant and accompanying common warrant. There is no established
public trading market for the common warrants or the pre-funded warrants, and we do not expect such a market to develop. Without an active
trading market, the liquidity of the pre-funded warrants and the common warrants will be limited. In addition, we do not intend to list
the pre-funded warrants or the common warrants on Nasdaq, any other national securities exchange or any other trading system.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should read this prospectus, together with additional information described under the headings &ldquo;<I>Incorporation of Certain Information
by Reference</I>&rdquo; and &ldquo;<I>Where You Can Find More Information,</I>&rdquo; carefully before you invest in any of our securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investing
in our securities involves a high degree of risk. You should only purchase shares if you can afford the loss of your investment. If we
fail to regain compliance with Nasdaq&rsquo;s continued listing requirements, which requires the closing bid price of our Common Stock
to be $1.00 per share or more for a minimum of ten (10) consecutive business days before May 27, 2025, Nasdaq may delist our Common
Stock. Our independent registered public accountant has issued an audit opinion which includes a statement expressing substantial doubt
as to our ability to continue as a going concern. See &ldquo;<I><A HREF="#Aa_005">Risk Factors</A></I>&rdquo; on page 6 of this prospectus and the section
entitled &ldquo;<I>Risk Factors</I>&rdquo; included in our most recent Annual Report on Form 10-K, as revised or
supplemented by our subsequent Quarterly Reports on Form 10-Q, which are incorporated herein by reference, for a discussion of information
that you should consider before investing in our securities.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neither
the Securities and Exchange Commission (the &ldquo;<U>SEC</U>&rdquo;) nor any state securities commission has approved or disapproved
of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Per
    Share and<BR>
    Accompanying<BR>
    Common<BR>
    Warrant</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Per
    Pre-Funded<BR>
    Warrant and<BR>
    Accompanying<BR>
    Common<BR>
    Warrant</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
    offering price<SUP>(1)</SUP></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Placement
    Agent fees<SUP>(2)</SUP></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="margin: 0"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </P><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="margin: 0"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </P><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="margin: 0"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </P><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds
    to us, before expenses<SUP>(3)</SUP></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="margin: 0"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </P><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    combined public offering price is $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    per share of Common Stock and accompanying common warrant (or $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    per pre-funded warrant and accompanying common warrant). </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    a cash fee equal to seven percent (7.0%) of the aggregate purchase price paid by investors in this offering. We have also agreed
    to reimburse the Placement Agents for their accountable offering-related legal expenses in an amount up to $75,000 and $20,000 for
    non-accountable expenses. See &ldquo;<I>Plan of Distribution</I>&rdquo; for additional disclosure regarding compensation payable
    to the Placement Agents.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
there is no minimum number of securities or amount of proceeds required as a condition to closing this offering, the actual public offering
amount, Placement Agent fees, and proceeds to us, if any, are not presently determinable and may be substantially less than the total
maximum offering amounts set forth above. See &ldquo;<I>Plan of Distribution</I>&rdquo; for more information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Does
    not include proceeds from the exercise of the common warrants and/or pre-funded warrants in cash, if any.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delivery
of the securities is expected to be made on or about &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2025, subject to satisfaction of certain conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Lead
Placement Agent</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>A.G.P.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Co-Placement
Agent</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 14pt"><B>Brookline
Capital Markets</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
division of Arcadia Securities, LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
date of this prospectus is &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TABLE
OF CONTENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Aa_001">CAUTIONARY NOTICE REGARDING FORWARD-LOOKING STATEMENTS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Aa_002">ABOUT THIS PROSPECTUS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Aa_003">PROSPECTUS SUMMARY</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Aa_004">THE OFFERING</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Aa_005">RISK FACTORS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">6</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Aa_006">CAPITALIZATION</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Aa_007">DILUTION</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Aa_008">USE OF PROCEEDS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Aa_009">DESCRIPTION OF CAPITAL STOCK</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Aa_010">DESCRIPTION OF SECURITIES WE ARE OFFERING</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Aa_011">PLAN OF DISTRIBUTION</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Aa_012">MATERIAL UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Aa_013">DIVIDEND POLICY</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Aa_014">LEGAL MATTERS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Aa_015">EXPERTS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Aa_016">WHERE YOU CAN FIND MORE INFORMATION</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Aa_017">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="Aa_001"></A>CAUTIONARY
NOTICE REGARDING FORWARD-LOOKING STATEMENTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
statements contained or incorporated by reference in this prospectus and in any related free writing prospectus may constitute forward-looking
statements within the meaning of the Private Securities Litigation Reform Act of 1995 and releases issued by the SEC and within the meaning
of Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended (the &ldquo;<U>Exchange Act</U>&rdquo;).
Forward-looking statements may relate to such matters as anticipated financial performance, business prospects, technological developments,
product pipelines, clinical trials and research and development activities, the adequacy of capital reserves and anticipated operating
results and cash expenditures, current and potential collaborations, strategic alternatives and other aspects of our present and future
business operations and similar matters. These statements involve known and unknown risks, uncertainties and other factors, many of which
are outside of our control, that may cause our or our industry&rsquo;s actual results, levels of activity, performance or achievements
to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking
statements. Such statements include, without limitation:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    statements regarding future operations, plans, regulatory filings or approvals, including the plans and objectives of management
    for future operations or programs or proposed new products or services;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    statements regarding the performance, or likely performance, or outcomes or economic benefit of any of our research and development
    activities, proposed or potential clinical trials or new drug filing strategies or timelines, including whether any of our clinical
    trials will be completed successfully within any specified time period or at all;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    projections of earnings, cash resources, revenue, expense or other financial terms;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    statements regarding the initiation, timing, progress and results of our research and development programs, preclinical studies,
    any clinical trials and Investigational New Drug application, New Drug Application and other regulatory submissions;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    statements regarding cost and timing of development and testing, capital structure, financial condition, working capital needs and
    other financial items, including our ability to continue as a going concern;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    statements regarding the implementation of our business model and integration of acquired technologies, assets or businesses and
    existing or future collaborations, mergers, acquisitions or other strategic transactions;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    statements regarding approaches to medical treatment, any introduction of new products by others, any possible licenses or acquisitions
    of other technologies, assets or businesses, or possible actions by customers, suppliers, strategic partners, potential strategic
    partners, competitors or regulatory authorities;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    statements regarding development or success of our collaboration arrangements or future payments that may come due to us under these
    arrangements;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    statements regarding compliance with Nasdaq&rsquo;s listing standards; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    statements regarding future economic conditions or performance and any statement of assumptions underlying any of the foregoing.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
some cases, you can identify forward-looking statements by terminology such as &ldquo;expect,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;estimate,&rdquo;
&ldquo;continue,&rdquo; &ldquo;plan,&rdquo; &ldquo;believe,&rdquo; &ldquo;could,&rdquo; &ldquo;intend,&rdquo; &ldquo;predict,&rdquo;
&ldquo;project,&rdquo; &ldquo;may,&rdquo; &ldquo;should,&rdquo; &ldquo;will,&rdquo; &ldquo;would&rdquo; and words of similar import regarding
our expectations. Forward-looking statements are only predictions. Actual events or results may differ materially. Although we believe
that our expectations are based on reasonable assumptions within the bounds of our knowledge of our industry, business and operations,
we cannot guarantee that actual results will not differ materially from our expectations. In evaluating such forward-looking statements,
you should specifically consider various factors, including, but not limited to, the inherent uncertainty in the drug development process,
our ability to raise additional capital to fund our planned future operations and continue as a going concern, our ability to obtain
or maintain U.S. Food and Drug Administration and foreign regulatory approvals for our drug candidates, potential impact of the Russian
invasion of Ukraine and the unrest in the Middle East on our business, our ability to enroll patients in our clinical trials, risks relating
to third parties&rsquo; conduct of our clinical trials, risks relating to government, private health insurers and other third-party payers
coverage or reimbursement, risks relating to commercial potential of a drug candidate in development, changes in technologies for the
treatment of cancer, impact of development of competitive drug candidates by others, risks relating to intellectual property, volatility
in the market price of our Common Stock, potential inability to maintain compliance with Nasdaq listing rules and the impact of adverse
capital and credit market conditions. These and other risks and assumptions are outlined under &ldquo;<I>Risk Factors</I>&rdquo; contained
in this prospectus and any related free writing prospectus, and in our most recent Annual Report on Form 10-K, as revised or supplemented
by our subsequent Quarterly Reports on Form 10-Q, incorporated by reference into this prospectus, as well as any amendments thereto reflected
in subsequent filings with the SEC. The discussion of risks and uncertainties set forth in this prospectus or referenced in those filings
is not necessarily a complete or exhaustive list of all risks facing us at any particular point in time. We operate in a highly competitive,
highly regulated and rapidly changing environment, and our business is in a state of evolution. Therefore, it is likely that new risks
will emerge, and the nature and elements of existing risks will change. It is not possible for management to predict all such risk factors
or changes therein or to assess either the impact of all such risk factors on our business or the extent to which any individual risk
factor, combination of factors or new or altered factors may cause results to differ materially from those contained in any forward-looking
statement. Forward-looking statements represent our estimates and assumptions only as of the date such forward-looking statements are
made. You should carefully read this prospectus and any related free writing prospectus, together with the information incorporated herein
or therein by reference as described under the section titled &ldquo;<I>Incorporation of Certain Information by Reference,</I>&rdquo;
and with the understanding that our actual future results may materially differ from what we expect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-looking
statements speak only as of the date they are made, and we assume no obligation to update any forward-looking statements publicly, or
to update the reasons why actual results could differ materially from those anticipated in any forward-looking statements, even if new
information becomes available, except as required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="Aa_002"></A>ABOUT
THIS PROSPECTUS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
used in this prospectus, unless the context otherwise requires or indicates, references to &ldquo;the Company,&rdquo; &ldquo;we,&rdquo;
&ldquo;our,&rdquo; &ldquo;ourselves,&rdquo; and &ldquo;us&rdquo; refer to Imunon, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should rely only on the information contained in this prospectus and any free writing prospectus prepared by us or on our behalf that
we have referred you to. Neither we nor the Placement Agents have authorized anyone to provide you with additional or different information.
If anyone provides you with additional, different, or inconsistent information, you should not rely on it. We and the Placement Agents
take no responsibility for, and can provide no assurance as to, the reliability of any other information that others may give you. This
prospectus is an offer to sell only the securities offered hereby and only under circumstances and in jurisdictions where it is lawful
to do so. We and the Placement Agents are not making an offer of these securities in any state, country, or other jurisdiction where
the offer is not permitted. You should not assume that the information in this prospectus or any free writing prospectus is accurate
as of any date other than the date of the applicable document regardless of its time of delivery or the time of any sales of our securities.
Our business, financial condition, results of operations and cash flows may have changed since the date of the applicable document.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus describes the specific details regarding this offering and the terms and conditions of our securities being offered hereby
and the risks of investing in our securities. For additional information, please see the section entitled &ldquo;<I>Where You Can Find
More Information.</I>&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should not interpret the contents of this prospectus or any free writing prospectus to be legal, tax, business, or financial advice.
You should consult with your own advisors for that type of advice and consult with them about the legal, tax, business, financial, and
other issues that you should consider before investing in our securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated, information contained in this prospectus concerning our industry and the markets in which we operate, including
our general expectations and market position, and market opportunity, is based on information from our own management estimates and research,
as well as from industry and general publications and research, surveys and studies conducted by third parties. Management estimates
are derived from publicly available information, our knowledge of our industry and assumptions based on such information and knowledge,
which we believe to be reasonable. Our management estimates have not been verified by any independent source, and we have not independently
verified any third-party information. In addition, assumptions and estimates of our and our industry&rsquo;s future performance are necessarily
subject to a high degree of uncertainty and risk due to a variety of factors, including those described in &ldquo;<I>Risk Factors</I>.&rdquo;
These and other factors could cause our future performance to differ materially from our assumptions and estimates. See &ldquo;<I>Cautionary
Notice Regarding Forward-Looking Statements</I>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
further note that the representations, warranties and covenants made by us in any agreement that is filed as an exhibit to the registration
statement of which this prospectus is a part were made solely for the benefit of the parties to such agreement, including, in some cases,
for the purpose of allocating risk among the parties to such agreements, and should not be deemed to be a representation, warranty or
covenant to you. Moreover, such representations, warranties or covenants were accurate only as of the date when made. Accordingly, such
representations, warranties and covenants should not be relied on as accurately representing the current state of our affairs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s brand and product names contained in this prospectus are trademarks, registered trademarks, or service marks of Imunon,
Inc. or its subsidiary in the United States (&ldquo;<U>U.S.</U>&rdquo;) and certain other countries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
other trademarks, trade names and service marks appearing in this prospectus or the documents incorporated by reference herein are the
property of their respective owners. Use or display by us of other parties&rsquo; trademarks, trade dress or products is not intended
to and does not imply a relationship with, or endorsements or sponsorship of, us by the trademark or trade dress owner. Solely for convenience,
trademarks, tradenames and service marks referred to in this prospectus appear without the &reg; and &trade; symbols, but those references
are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or that the
applicable owner will not assert its rights, to these trademarks and trade names.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="Aa_003"></A>PROSPECTUS
SUMMARY</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>This
summary highlights certain information about us, this offering and selected information contained elsewhere in this prospectus. Because
this is only a summary, it does not contain all of the information that may be important to you or that you should consider before investing
in our securities. You should read the entire prospectus carefully, especially the information under &ldquo;Risk Factors&rdquo; set forth
in this prospectus and the information in the documents incorporated by reference into this prospectus. This prospectus contains forward-looking
statements, based on current expectations and related to future events and our future financial performance, that involve risks and uncertainties.
Our actual results may vary materially from those discussed in the forward-looking statements as a result of various factors, including,
without limitation, those set forth under &ldquo;Risk Factors&rdquo; in this prospectus and under similar captions in the documents incorporated
by reference into this prospectus. See &ldquo;Cautionary Notice Regarding Forward-Looking Statements.&rdquo;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Business
Overview</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Imunon
is a clinical-stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body&rsquo;s natural
mechanisms with the aim to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating
approach from conventional therapies. Imunon is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas&reg;,
is developed for the coding of proteins and cytokines in the treatment of solid tumors where an immunological approach is deemed promising.
The second modality, PlaCCine&reg;, is developed for the coding of viral antigens that can elicit a strong immunological response. This
technology may represent a promising platform for the development of vaccines in infectious diseases.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s lead clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer
that has completed Phase II development studies. IMNN-001 works by instructing the body to produce safe and durable levels of powerful
cancer-fighting molecules, such as interleukin-12 and interferon gamma, at the tumor site. Additionally, the Company has entered into
a first-in-human study of its COVID-19 booster vaccine (IMNN-101). We will continue to leverage these modalities and to advance the technological
frontier of plasmid DNA to better serve patients with difficult-to-treat conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> <B>Recent Developments</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"> On March 24,
2025, we issued a press release announcing finalization of our Phase 3 study design for IMNN-001, a treatment for women with newly
diagnosed advanced ovarian cancer, and that the U.S. Food and Drug Administration is aligned with the protocol for the Phase 3 pivotal trial, called OVATION 3, of our lead candidate IMNN-001. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Corporate
Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
were founded in 1982 and are a Delaware corporation. Our principal executive offices are located at 997 Lenox Drive, Suite 100, Lawrenceville,
NJ 08648. Our telephone number is (609) 896-9100. Our website is <I>www.imunon.com</I>. The information contained on or that can be accessed
through our website is not incorporated by reference into this prospectus, and you should not consider information on our website to
be part of this prospectus or in deciding to purchase our Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a &ldquo;smaller reporting company,&rdquo; meaning that the market value of our stock held by non-affiliates is less than $700 million
and our annual revenue was less than $100 million during our most recently completed fiscal year. We may continue to be a smaller reporting
company if either (i) the market value of our stock held by non-affiliates is less than $250 million or (ii) our annual revenue was less
than $100 million during the most recently completed fiscal year and the market value of our stock held by non-affiliates is less than
$700 million. For so long as we remain a smaller reporting company, we are permitted and intend to rely on exemptions from certain disclosure
and other requirements that are applicable to other public companies that are not smaller reporting companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="Aa_004"></A>THE
OFFERING</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
    Stock and common warrants offered by us</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Up
    to 10,000,000 shares of Common Stock and common warrants to purchase up to 10,000,000 shares of Common Stock (or pre-funded
    warrants to purchase shares of Common Stock and common warrants to purchase shares of Common Stock) on a &ldquo;reasonable best-efforts&rdquo;
    basis at an assumed offering price of $<FONT STYLE="background-color: white">1.00</FONT> per share of Common Stock and accompanying common warrant (which was the closing
    price of our Common Stock on Nasdaq on April 3, 2025) (or $<FONT STYLE="background-color: white">1.00</FONT> per pre-funded warrant and accompanying common warrant).
    The shares of Common Stock or pre-funded warrants, respectively, and common warrants are immediately separable and will be issued
    separately in this offering, but must initially be purchased together in this offering. The common warrants are exercisable beginning
    on the effective date of the Warrant Stockholder Approval, provided however, if the Pricing Conditions are met, the Warrant Stockholder
    Approval will not be required and the&nbsp;common warrants will be exercisable&nbsp;on the Initial Exercise Date, have an assumed
    exercise price equal to $1.00 (equal to the assumed combined public offering price per share of Common Stock and accompanying
    common warrant), and will expire five years from the Initial Exercise Date or the Warrant Stockholder Approval, as applicable.
    This prospectus also relates to the offering of the shares of Common Stock issuable upon exercise of the common warrants and pre-funded
    warrants. For more information regarding the common warrants and pre-funded warrants, you should carefully read the section titled
    &ldquo;<I>Description of Securities We Are Offering</I>&rdquo; in this prospectus.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pre-funded
    warrants offered by us in this offering</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are also offering to each purchaser whose purchase of shares in this offering would otherwise result in the purchaser, together with
its affiliates and certain related parties, beneficially owning more than 4.99% (or, at the election of the purchaser, 9.99%) of our
outstanding Common Stock immediately following the consummation of this offering, the opportunity to purchase, if the purchaser so chooses,
pre-funded warrants (each pre-funded warrant to purchase one share of our Common Stock) in lieu of shares that would otherwise result
in the purchaser&rsquo;s beneficial ownership exceeding 4.99% of our outstanding Common Stock (or, at the election of the purchaser,
9.99%). The purchase price of each pre-funded warrant and accompanying common warrant will equal the price at which one share of Common
Stock and accompanying warrant are being sold to the public in this offering, minus $0.0001, and the exercise price of each pre-funded
warrant will be $0.0001 per share. The pre-funded warrants will be exercisable immediately and may be exercised at any time until all
of the pre-funded warrants are exercised in full. For each pre-funded warrant we sell, the number of shares of Common Stock we are offering
will be decreased on a one-for-one basis.</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Reasonable
    best-efforts offering</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have agreed to issue and sell the securities offered hereby to the purchasers through the Placement Agents. The Placement Agents
    are not required to buy or sell any specific number or dollar amount of the securities offered hereby, but will use their reasonable
    best efforts to solicit offers to purchase the securities offered by this prospectus. See &ldquo;<I>Plan of Distribution</I>&rdquo;
    beginning on page 21 of this prospectus.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
    Stock to be outstanding after the offering</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,620,732
    </FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares (assuming all of the securities we are
    offering under this prospectus are sold, and assuming no sale of pre-funded warrants, which, if sold, would reduce the number of
    shares of Common Stock that we are offering on a one-for-one basis, and no exercise of the common warrants issued in this offering).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Use
of proceeds</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    expect to use the net proceeds from this offering for general corporate purposes, including the clinical development of our lead
    product candidate (IMNN-001), capital expenditures and working capital. See &ldquo;<I>Use of Proceeds</I>.&rdquo;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lock-Up
    Agreements </B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify; width: 64%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    directors and officers have agreed with the Placement Agents, subject to certain exceptions, not to sell, transfer or dispose of,
    directly or indirectly, any of our Common Stock or securities convertible into or exercisable or exchangeable for our Common Stock
    for a period of 45 days after the completion of this offering. See &ldquo;<I>Plan of Distribution</I>&rdquo; for more information.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nasdaq
    Symbol</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    Common Stock is listed on Nasdaq under the symbol &ldquo;IMNN.&rdquo;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risk
    Factors</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investing
    in our securities involves a high degree of risk. You should carefully review and consider the &ldquo;<I>Risk Factors</I>&rdquo;
    section of this prospectus and in the documents incorporated by reference in this prospectus for a discussion of factors to consider
    before deciding to invest in our securities.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of shares of our Common Stock outstanding is based on an aggregate of <FONT STYLE="background-color: white">14,620,732</FONT>
shares of our Common Stock outstanding as of March 31, 2025 and excludes:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,942,351
    shares of Common Stock issuable upon the exercise of outstanding stock options as of March <FONT STYLE="background-color: white">31</FONT>, 2025, having a weighted average
    exercise price of $1.79 per share;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39,700
    shares of Common Stock issuable upon the vesting of Common Stock awards as of March <FONT STYLE="background-color: white">31</FONT>, 2025, having a weighted average grant
    date fair value of $0.99 per share;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,155,060
    shares of Common Stock issuable upon the exercise of outstanding warrants as of March <FONT STYLE="background-color: white">31</FONT>, 2025, having a weighted average
    exercise price of $2.51 per share; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">223,522</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
    shares of Common Stock reserved for future issuance pursuant to our existing stock incentive plan.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise noted, the above information reflects and assumes no sale of pre-funded warrants in this offering, which, if sold, would
reduce the number of shares of Common Stock that we are offering on a one-for-one basis, no exercise of any common warrants issued in
this offering, and no exercise of outstanding stock options or warrants after March 31, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="Aa_005"></A>RISK
FACTORS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>In
evaluating the Company, its business and any investment in the Company, you should carefully consider the following information about
risks, together with the other information described in or incorporated by reference in this prospectus, before making an investment
in our securities, including the additional risk factors incorporated by reference from Item 1A of the Company&rsquo;s Annual Report
on Form 10-K for the fiscal year ended December 31, 2024, as filed with the SEC on February 27, 2025, any subsequent Quarterly Reports
on Form 10-Q or Current Reports on Form 8-K, and all other documents incorporated by reference into this prospectus (see &ldquo;Incorporation
of Certain Information by Reference&rdquo;). If any of the circumstances or events described below actually arises or occurs, our business,
results of operations, cash flows and financial condition could be harmed. In any such case, the market price of our Common Stock could
decline, and you may lose all or part of your investment.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to this Offering and Our Securities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Future
sales and issuances of our Common Stock or other securities might result in significant dilution and could cause the price of our Common
Stock to decline.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
raise capital, we may sell Common Stock, convertible securities or other equity securities in one or more transactions, at prices and
in a manner we determine from time to time. The price per share at which we sell additional shares of our Common Stock, or securities
convertible or exchangeable into Common Stock, in future transactions may be higher or lower than the price per share paid by investors
in this offering, and investors purchasing shares or other securities in the future could have rights superior to existing stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot predict what effect, if any, sales of shares of our Common Stock in the public market or the availability of shares for sale will
have on the market price of our Common Stock. However, future sales of substantial amounts of our Common Stock in the public market,
including shares issued upon exercise of outstanding options or warrants, or the perception that such sales may occur, could adversely
affect the market price of our Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
you purchase shares of our Common Stock in this offering, you will incur immediate and substantial dilution in the book value of your
shares.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investors
purchasing shares of our securities in this offering will pay a price per share that substantially exceeds the net tangible book value
per share. As a result, investors purchasing shares of our Common Stock in this offering will incur immediate dilution of $0.46
per share, representing the difference between the assumed public offering price per share of Common Stock and accompanying common
warrant and our net tangible book value per share as of December 31, 2024. To the extent outstanding options or warrants to purchase
our Common Stock are exercised, new investors may incur further dilution. For more information on the dilution you may experience as
a result of investing in this offering, see the section of this prospectus entitled &ldquo;<I>Dilution</I>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Management
will have broad discretion as to the use of the proceeds from the offering and uses may not improve our financial condition or market
value.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
we have not designated the amount of net proceeds from the offering to be used for any particular purpose, our management will have broad
discretion as to the application of such net proceeds and could use them for purposes other than those contemplated hereby. Our management
may use the net proceeds for corporate purposes that may not improve our financial condition or market value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>There
is no public market for the common warrants or pre-funded warrants being offered in this offering.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no established public trading market for the common warrants or pre-funded warrants being offered in this offering, and we do not
expect a market to develop. In addition, we do not intend to apply to list the common warrants or pre-funded warrants on any securities
exchange or nationally recognized trading system, including Nasdaq. Without an active market, the liquidity of the common warrants and
pre-funded warrants will be limited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Holders
of common warrants or pre-funded warrants purchased in this offering will have no rights as Common Stockholders until such holders exercise
their warrants or pre-funded warrants and acquire our Common Stock.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Until
holders of common warrants or pre-funded warrants acquire shares of our Common Stock upon exercise thereof, holders of such warrants
will have no rights with respect to the shares of our Common Stock underlying such warrants. Upon exercise of the common warrants or
pre-funded warrants, the holders will be entitled to exercise the rights of a Common Stockholder only as to matters for which the record
date occurs after the exercise date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we do not maintain a current and effective prospectus relating to the Common Stock issuable upon exercise of the common warrants and
pre-funded warrants, public holders will only be able to exercise such common warrants and pre-funded warrants on a &ldquo;cashless basis.&rdquo;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we do not maintain a current and effective prospectus relating to the shares of Common Stock issuable upon exercise of the common warrants
and pre-funded warrants at the time that holders wish to exercise such warrants, they will only be able to exercise them on a &ldquo;cashless
basis,&rdquo; and under no circumstances would we be required to make any cash payments or net cash settle such warrants to the holders.
As a result, the number of shares of Common Stock that holders will receive upon exercise of the common warrants and pre-funded warrants
will be fewer than it would have been had such holders exercised their common warrants or pre-funded warrants for cash. We will use our
best efforts to maintain a current and effective prospectus relating to the shares of Common Stock issuable upon exercise of such warrants
until the expiration of such warrants. However, we cannot assure you that we will be able to do so. If we are unable to do so, the potential
&ldquo;upside&rdquo; of the holder&rsquo;s investment in our Company may be reduced.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
common warrants and pre-funded warrants are speculative in nature.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
common warrants and pre-funded warrants offered hereby do not confer any rights of Common Stock ownership on their holders, such as voting
rights, but rather merely represent the right to acquire shares of our Common Stock at a fixed price. Specifically, commencing on the
Initial Exercise Date or the effective date of Warrant Stockholder Approval, as applicable, holders of the common warrants and
pre-funded warrants may exercise their right to acquire the shares of our Common Stock upon the payment of an exercise price, which
we assume here to be $1.00 per share, equal to the assumed combined public offering price per share of Common Stock and accompanying
common warrant (the closing price of our Common Stock on Nasdaq on April 3, 2025), in the case of common warrants and an exercise
price of $0.0001 per share in the case of pre-funded warrants. Moreover, following this offering, the market value of the common warrants
and pre-funded warrants is uncertain and there can be no assurance that the market value of the common warrants or pre-funded warrants
will equal or exceed their imputed public offering prices. Furthermore, each common warrant will expire five years from the Initial
Exercise Date or the Warrant Stockholder Approval, as applicable, and each pre-funded warrant will not expire until it has been exercised
in full. In the event the price of our Common Stock does not exceed the exercise price of the common warrants during the period when
such common warrants are exercisable, the common warrants may not have any value. There is no established public trading market for common
warrants and pre-funded warrants being offered in this offering, and we do not expect a market to develop. In addition, we do not intend
to apply to list the common warrants or pre-funded warrants on any securities exchange or nationally recognized trading system, including
Nasdaq. Without an active market, the liquidity of the common warrants and pre-funded warrants will be limited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>This
is a reasonable best-efforts offering, with no minimum amount of securities required to be sold, and we may sell fewer than all of the
securities offered hereby.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Placement Agents have agreed to use their reasonable best efforts to solicit offers to purchase the securities in this offering. The
Placement Agents have no obligation to buy any of the securities from us or to arrange for the purchase or sale of any specific number
or dollar amount of the securities. There is no required minimum number of securities that must be sold as a condition to completion
of this offering, and there can be no assurance that the offering contemplated hereby will ultimately be consummated. Even if we sell
securities offered hereby, because there is no minimum offering amount required as a condition to closing of this offering, the actual
offering amount is not presently determinable and may be substantially less than the maximum amount set forth on the cover page of this
prospectus. We may sell fewer than all of the securities offered hereby, which may significantly reduce the amount of proceeds received
by us. Thus, we may not raise the amount of capital we believe is required for our operations in the short-term and may need to raise
additional funds, which may not be available or available on terms acceptable to us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Because
there is no minimum required for the offering to close, investors in this offering will not receive a refund in the event that we do
not sell an amount of securities sufficient to pursue the business goals outlined in this prospectus.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not specified a minimum offering amount nor have or will we establish an escrow account in connection with this offering. Because
there is no escrow account and no minimum offering amount, investors could be in a position where they have invested in our Company,
but we are unable to fulfill our objectives due to a lack of interest in this offering. Further, because there is no escrow account in
operation and no minimum investment amount, any proceeds from the sale of securities offered by us will be available for our immediate
use, despite uncertainty about whether we would be able to use such funds to effectively implement our business plan. Investor funds
will not be returned under any circumstances whether during or after the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>This
offering may cause the trading price of our Common Stock to decrease.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
price per share, together with the number of shares of Common Stock we issue if this offering is completed, may result in an immediate
decrease in the market price of our Common Stock. This decrease may continue after the completion of this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
Common Stock may be delisted from Nasdaq if we fail to comply with continued listing standards.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Stock is currently traded on Nasdaq under the symbol &ldquo;IMNN.&rdquo; If we fail to comply with Nasdaq&rsquo;s continued listing
standards, we may be delisted and our Common Stock will trade, if at all, only on the over-the-counter market, such as the OTC Bulletin
Board or OTCQX market, and then only if one or more registered broker-dealer market makers comply with quotation requirements. In addition,
delisting of our Common Stock could depress our stock price, substantially limit liquidity of our Common Stock and materially adversely
affect our ability to raise capital on terms acceptable to us, or at all. Further, delisting of our Common Stock would likely result
in our Common Stock becoming a &ldquo;penny stock&rdquo; under the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 26, 2024, we received a notice from Nasdaq staff (the &ldquo;Staff&rdquo;) notifying us that, based upon the closing bid price
of our Common Stock, for the 30 consecutive business days prior to the notice, we no longer met the requirement to maintain a minimum
closing bid price of $1.00 per share, as set forth in Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(A),
we were granted 180 calendar days, or until May 27, 2025, to regain compliance with the minimum bid price rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
regain compliance, the closing bid price of our Common Stock must be $1.00 per share or more for a minimum of 10 consecutive business
days at any time before May 27, 2025. If we do not regain compliance with Rule 5550(a)(2) by May 27, 2025, we may be eligible for an
additional 180 calendar day compliance period. To qualify, we will be required to meet the continued listing requirement for market value
of publicly held shares and all other Nasdaq initial listing standards, except the bid price requirement, and would need to provide written
notice to Nasdaq of our intention to cure the deficiency during the second compliance period. If it appears to the Staff that we will
not be able to cure the deficiency, or if we are otherwise not eligible, Nasdaq would notify us that our securities will be subject to
delisting. In the event of such notification, we may appeal the Staff&rsquo;s determination to delist our securities, but there can be
no assurance the Staff would grant our request for continued listing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our Common Stock were to be delisted by Nasdaq, it may be eligible for quotation on an over-the-counter quotation system or on the pink
sheets. Upon any such delisting, our Common Stock would become subject to the regulations of the SEC relating to the market for penny
stocks. A penny stock is any equity security not traded on a national securities exchange that has a market price of less than $5.00
per share. The regulations applicable to penny stocks may severely affect the market liquidity for our Common Stock and could limit the
ability of stockholders to sell securities in the secondary market. In such a case, an investor may find it more difficult to dispose
of or obtain accurate quotations as to the market value of our Common Stock, and there can be no assurance that our Common Stock will
be eligible for trading or quotation on any alternative exchanges or markets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delisting
from Nasdaq could adversely affect our ability to raise additional financing through public or private sales of equity securities, would
significantly affect the ability of investors to trade our securities and would negatively affect the value and liquidity of our Common
Stock. Delisting could also have other negative results, including the potential loss of confidence by employees, the loss of institutional
investor interest and fewer business development opportunities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
will need to raise additional capital to fund our planned future operations, and we may be unable to secure such capital without significant
dilutive financing transactions. If we are not able to raise additional capital, we may not be able to complete the development, testing
and commercialization of our drug candidates and may not be able to continue as a going concern.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not generated significant revenue and have incurred significant net losses in each year since our inception. For the year ended
December 31, 2024, we incurred a net loss of $18.6 million. We have incurred approximately $407 million of cumulative net losses. As
of December 31, 2024, we had cash and cash equivalents of $5.9 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have substantial future capital requirements to continue our research and development activities and advance our drug candidates through
various development stages, including the Phase 3 registrational trial of IMNN-001 in advanced ovarian cancer. We are unable to estimate
the duration and completion costs of our research and development projects or when, if ever, and to what extent we will receive cash
inflows from the commercialization and sale of a product. Our inability to complete any of our research and development activities, preclinical
studies or clinical trials in a timely manner or our failure to enter into collaborative agreements when appropriate could significantly
increase our capital requirements and could adversely impact our liquidity. While our estimated future capital requirements are uncertain
and could increase or decrease as a result of many factors, including the extent to which we choose to advance our research, development
activities, preclinical studies and clinical trials, or if we are in a position to pursue manufacturing or commercialization activities,
we will need significant additional capital to develop our drug candidates through development and clinical trials, obtain regulatory
approvals and manufacture and commercialize approved products, if any. We do not know whether we will be able to access additional capital
when needed or on terms favorable to us or our stockholders. Our inability to raise additional capital, or to do so on terms reasonably
acceptable to us, would jeopardize the future success of our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, our audited financial statements for the year ended December 31, 2024 were prepared under the assumption that we would continue
as a going concern. However, we have concluded that there is substantial doubt about our ability to continue as a going concern, therefore
our independent registered public accounting firm included a &ldquo;going concern&rdquo; explanatory paragraph in its report on our financial
statements for the year ended December 31, 2024 included in our Annual Report on Form 10-K for the year ended December 31, 2024, indicating
that, without additional sources of funding, our cash at December 31, 2024 is not sufficient for us to operate as a going concern for
a period of at least one year from the date that the financial statements included in the Annual Report on Form 10-K for the
year ended December 31, 2024 were issued. Management&rsquo;s plans concerning these matters, including our need to raise additional
capital, are described in the Annual Report on Form 10-K for the year ended December 31, 2024, however, management cannot assure you
that its plans will be successful. If we cannot continue as a viable entity, our stockholders would likely lose most or all of their
investment in us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Purchasers
who purchase our securities in this offering pursuant to a securities purchase agreement may have rights not available to purchasers
that purchase without the benefit of a securities purchase agreement.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to rights and remedies available to all purchasers in this offering under federal securities and state law, the purchasers that
enter into a securities purchase agreement will also be able to bring claims of breach of contract against us. The ability to pursue
a claim for breach of contract provides those investors with the means to enforce the covenants uniquely available to them under the
securities purchase agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
have never paid dividends on our capital stock, and we do not anticipate paying dividends in the foreseeable future.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never paid dividends on any of our capital stock and currently intend to retain any future earnings to fund the growth of our business.
We may also enter into credit agreements or other borrowing arrangements in the future that will restrict our ability to declare or pay
cash dividends on our Common Stock. Any determination to pay dividends in the future will be at the discretion of our board of directors
and will depend on our financial condition, operating results, capital requirements, general business conditions and other factors that
our board of directors may deem relevant. As a result, capital appreciation, if any, of the securities will be the sole source of gain,
if any, for the foreseeable future.<BR STYLE="clear: both"></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="Aa_006"></A>CAPITALIZATION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth our consolidated cash and cash equivalents and capitalization as of December 31, 2024:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
    an actual basis; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
    an as adjusted basis to give effect to the sale of 10,000,000 shares of Common Stock and accompanying common warrants in the
    offering at an assumed public offering price of $1.00 per share of Common Stock and accompanying warrant (which was the closing
    price of our Common Stock on Nasdaq on April 3, 2025), after deducting Placement Agents fees and estimated offering expenses
    payable by us, and assuming no sale of any pre-funded warrants in this offering and no exercise of the common warrants issued in
    connection with this offering.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should read the following table in conjunction with the sections entitled &ldquo;<I>Use of Proceeds</I>&rdquo; included elsewhere
in this prospectus and &ldquo;<I>Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations</I>&rdquo;
and our audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended December
31, 2024, incorporated herein by reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Actual</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Adjusted</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="6">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents</TD><TD STYLE="width: 2%; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; width: 16%; text-align: right">5,872,767</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; width: 16%; text-align: right"> 14,922,705 </TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Stockholders&rsquo; equity:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt">Preferred stock, par value $0.01 per share; 100,000 shares authorized; 0 shares issued and outstanding</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><P STYLE="margin: 0"> &mdash; </P></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt"><P STYLE="border-bottom: white 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
                                    stock, par value $0.01 per share; 112,500,000 shares authorized, 14,500,685 shares issued and outstanding,
                                    actual, 24,500,685 shares issued and outstanding, as adjusted<SUP>(1)</SUP></FONT></P></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right">145,007</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right"><P STYLE="margin: 0"> 245,007 </P></TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">410,987,523</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><P STYLE="margin: 0"> 419,937,461 </P></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Accumulated deficit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(406,803,044</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><P STYLE="margin: 0"> (406,803,044 </P></TD><TD STYLE="text-align: left"> ) </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Accumulated other comprehensive income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><P STYLE="margin: 0"> &mdash; </P></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Treasury stock</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(85,188</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><P STYLE="margin: 0"> (85,188 </P></TD><TD STYLE="padding-bottom: 1pt; text-align: left"> ) </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total stockholders&rsquo; equity</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,244,298</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><P STYLE="margin: 0"> 13,294,236 </P></TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Total capitalization</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,244,298</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><P STYLE="margin: 0"> 13,294,236 </P></TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
$0.10 increase (decrease) in the assumed combined public offering price per share of Common Stock and common warrants of $1.00
would increase (decrease) the as adjusted amount of additional paid-in capital, total stockholders&rsquo; equity and total capitalization
by approximately $0.9 million ($0.9 million), assuming that the number of shares of Common Stock offered by us, as set forth on
the cover page of this prospectus, remains the same and after deducting estimated Placement Agent fees and estimated offering expenses
payable by us and assuming no exercise of common warrants or sale of pre-funded warrants. An increase (decrease) of 1,000,000 in the
number of shares of Common Stock and accompanying common warrants offered by us would increase (decrease) the as adjusted amount of additional
paid-in capital, total stockholders&rsquo; equity and total capitalization by approximately $0.9 million ($0.9 million),
assuming no change in the public offering price per share of Common Stock and accompanying common warrant, and after deducting estimated
Placement Agent fees and estimated offering expenses payable by us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
As adjusted reflects the number of shares of our Common Stock that will be outstanding immediately after this offering and is based on
14,500,685 shares outstanding as of December 31, 2024 and excludes the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,645,873
    shares of Common Stock issuable upon the exercise of outstanding stock options as of December 31, 2024, having a weighted average
    exercise price of $1.95 per share;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39,700
    shares of Common Stock issuable upon the vesting of Common Stock awards as of December 31, 2024, having a weighted average grant
    date fair value of $0.99 per share;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,155,060
    shares of Common Stock issuable upon the exercise of outstanding warrants as of December 31, 2024, having a weighted average exercise
    price of $2.51 per share; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">420,000
    shares of Common Stock reserved for future issuance pursuant to our existing stock incentive plan.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information discussed above is illustrative only and will adjust based on the actual public offering price and other terms of this offering
determined at pricing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="Aa_007"></A>DILUTION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you purchase securities in this offering, assuming no sale of any pre-funded warrants and no exercise of the common warrants issued in
connection with this offering, your ownership interest will be immediately diluted to the extent of the difference between the combined
public offering price per share of our Common Stock and accompanying warrant in this offering and the as adjusted net tangible book value
per share of our Common Stock immediately after giving effect to this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
net tangible book value as of December 31, 2024 was approximately $4.2 million, or approximately $0.29 per share of our Common Stock.
Our net tangible book value is the amount of our total tangible assets minus total liabilities. Net tangible book value per share as
of December 31, 2024 is our net tangible book value divided by the number of shares of Common Stock outstanding as of December 31, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
giving effect to the sale of the maximum number of securities offered hereby, or 10,000,000 shares of Common Stock (assuming no
sale of any pre-funded warrants and no exercise of the common warrants) in this offering at an assumed combined public offering
price of $1.00 per share of Common Stock and accompanying common warrant (the last reported sale price of our Common Stock on
Nasdaq on April 3, 2025), and after deducting estimated Placement Agent fees and estimated offering expenses payable by us, our
as adjusted net tangible book value as of December 31, 2024 would have been approximately $13.3 million, or approximately $0.54
per share of Common Stock. This amount represents an immediate increase in as adjusted net tangible book value of $0.25 per
share of Common Stock to our existing stockholders and an immediate dilution of $0.46 per share of Common Stock to investors participating
in this offering. We determine dilution per share of Common Stock to investors participating in this offering by subtracting as adjusted
net tangible book value per share of Common Stock after giving effect to this offering from the combined public offering price per share
of Common Stock and accompanying common warrant paid by investors participating in this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 93%; border-collapse: collapse; margin-left: 0.5in">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Combined
    public offering price per share of Common Stock and accompanying common warrant</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; width: 16%"><P STYLE="margin: 0"> 1.00 </P><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historical
    net tangible book value per share as of December 31, 2024</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.29</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase
    in net tangible book value per share attributable to this offering</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="margin: 0"> 0.25 </P><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    adjusted tangible book value per share, after giving effect to this offering</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"> 0.54 </TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dilution
    per share to investors in this offering</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font: 10pt Times New Roman, Times, Serif"> 0.46 </TD>
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
$0.10 increase (decrease) in the assumed combined public offering price per share of Common Stock and common warrants of $1.00
would increase (decrease) the as adjusted net tangible book value by approximately $0.29 ($0.21) per share and the dilution to
new investors by $0.52 ($0.40) per share, assuming that the number of shares of Common Stock offered by us, as set forth on the
cover page of this prospectus, remains the same and after deducting estimated Placement Agent fees and estimated offering expenses payable
by us and assuming no exercise of common warrants or sale of pre-funded warrants. An increase (decrease) of 1,000,000 in the number of
shares of Common Stock and accompanying common warrants offered by us would increase (decrease) the as adjusted net tangible book value
by approximately $0.27 ($0.19) per share and the dilution to new investors by $0.44 ($0.52) per share, assuming
no change in the combined public offering price per share of Common Stock and accompanying common warrant, and after deducting estimated
Placement Agent fees and estimated offering expenses payable by us and assuming no exercise of common warrants or sale of pre-funded
warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of shares of our Common Stock outstanding is based on an aggregate of 14,500,685 shares of our Common Stock outstanding as of
December 31, 2024 and excludes:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,645,873
    shares of Common Stock issuable upon the exercise of outstanding stock options as of December 31, 2024, having a weighted average
    exercise price of $1.95 per share;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39,700
    shares of Common Stock issuable upon the vesting of Common Stock awards as of December 31, 2024, having a weighted average grant
    date fair value of $0.99 per share;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,155,060
    shares of Common Stock issuable upon the exercise of outstanding warrants as of December 31, 2024, having a weighted average exercise
    price of $2.51 per share; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">420,000
    shares of Common Stock reserved for future issuance pursuant to our existing stock incentive plan.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent that any outstanding stock options or warrants are exercised, new stock options are issued under our stock incentive plans,
or we otherwise issue additional shares of Common Stock or securities convertible into or exercisable for Common Stock in the future,
at a price less than the public offering price, there will be further dilution to new investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information discussed above is illustrative only and will adjust based on the actual public offering price and other terms of this offering
determined at pricing. Except as indicated otherwise, the discussion and table above assume no exercise of common warrants offered hereby
and no sale of pre-funded warrants, which, if sold, would reduce the number of shares of Common Stock that we are offering on a one-for-one
basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="Aa_008"></A>USE
OF PROCEEDS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
estimate that we will receive net proceeds from this offering of approximately $9.0 million (assuming the sale of the maximum
number of securities offered hereby), based upon an assumed public offering price of $1.00 per share of Common Stock and accompanying
common warrant (which is the last reported sale price of our Common Stock on Nasdaq on April 3, 2025), after deducting the estimated
Placement Agent fees and estimated offering expenses payable by us and assuming no issuance of any pre-funded warrants and no exercise
of the common warrants. However, because this is a reasonable best-efforts offering with no minimum number of securities or amount of
proceeds as a condition to closing, the actual offering amount, Placement Agent fees, and net proceeds to us are not presently determinable
and may be substantially less than the maximum amounts set forth on the cover page of this prospectus, and we may not sell all or any
of the securities we are offering. As a result, we may receive significantly less in net proceeds. Based on the assumed offering price
set forth above, we estimate that our net proceeds from the sale of 75%, 50%, and 25% of the securities offered in this offering
would be approximately $6.7 million, $4.4 million, and $2.1 million, respectively, after deducting the estimated Placement Agent
fees and estimated offering expenses payable by us, and assuming no issuance of any pre-funded warrants and assuming no exercise of the
common warrants. We will only receive additional proceeds from the exercise of the common warrants we are selling in this offering if
the common warrants are exercised for cash. We cannot predict when or if these common warrants will be exercised. It is possible that
these common warrants may expire and may never be exercised.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
$0.10 increase (decrease) in the assumed public offering price of $1.00 per share of Common Stock and accompanying common warrant
would increase (decrease) our net proceeds from this offering by approximately $0.9 million ($0.9 million), assuming that the
number of shares of Common Stock offered by us remains the same, and after deducting estimated Placement Agent fees and estimated offering
expenses payable by us. An increase (decrease) of 1,000,000 in the number of shares of Common Stock and accompanying common warrants
offered by us would increase (decrease) our net proceeds from this offering by approximately $0.9 million ($0.9 million),
assuming no change in the public offering price per share of Common Stock and accompanying common warrant, and after deducting estimated
Placement Agent fees and estimated offering expenses payable by us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
estimates exclude the proceeds, if any, from the exercise of common warrants offered hereby. If all of the common warrants offered hereby
were to be exercised in cash at the assumed exercise price of $1.00 per share (the assumed combined offering price per
share of Common Stock and accompanying common warrant), we would receive additional proceeds of approximately $10.0 million.
We cannot predict when or if these common warrants will be exercised. It is possible that these common warrants may expire and may never
be exercised. Additionally, these common warrants contain a cashless exercise provision that permit exercise of such warrants on a cashless
basis at any time when there is no effective registration statement under the Securities Act covering the issuance of the underlying
shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to use the net proceeds of this offering for general corporate purposes, including the clinical development of our lead product
candidate (IMNN-001), capital expenditures and working capital.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
expected use of net proceeds from the offering represents our current intentions based upon our present plans and business condition.
Investors are cautioned, however, that expenditures may vary substantially from these uses. Investors will be relying on the judgment
of our management, who will have broad discretion regarding the application of the proceeds of this offering. The amounts and timing
of our actual expenditures will depend upon numerous factors, including the amount of cash necessary to run our operations, the amount
of competition and other operational factors. Pending the uses described above, we may invest the net proceeds from this offering in
short-and intermediate-term, interest-bearing obligations, investment-grade instruments, demand deposits, certificates of deposit or
direct or guaranteed obligations of the U.S. government.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="Aa_009"></A>DESCRIPTION
OF CAPITAL STOCK</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summary of the general terms and provisions of our capital stock does not purport to be complete and is subject to, and qualified
in its entirety by, reference to our Amended and Restated Certificate of Incorporation (&ldquo;<U>Certificate of Incorporation</U>&rdquo;)
and our Amended and Restated Bylaws (&ldquo;<U>Bylaws</U>&rdquo;), each of which is incorporated by reference as an exhibit to our most
recent Annual Report filed with the SEC, and applicable provisions of the Delaware General Corporation Law (the &ldquo;<U>DGCL</U>&rdquo;).
The summaries below do not purport to be complete statements of the relevant provisions of the Certificate of Incorporation, the Bylaws
or the DGCL.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Authorized
Capital Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
authorized capital stock consists of 112,500,000 shares of Common Stock, par value $0.01 per share and 100,000 shares of preferred stock,
par value $0.01 per share, all of which preferred stock is undesignated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of Common Stock are entitled to one vote for each share held of record on all matters submitted to a vote of stockholders and do not
have cumulative voting rights. Subject to any preferential rights of any outstanding preferred stock, holders of Common Stock are entitled
to receive ratably such dividends, if any, as may be declared from time to time by our board of directors out of funds legally available
therefor. In the event of a dissolution, liquidation or winding-up of the Company, holders of Common Stock are entitled to share ratably
in all assets remaining after payment of liabilities and any preferential rights of any outstanding preferred stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of Common Stock have no preemptive or conversion rights or other subscription rights. There are no redemption or sinking fund provisions
applicable to our Common Stock. All outstanding shares of Common Stock are fully paid and non-assessable. The rights, preferences and
privileges of the holders of Common Stock are subject to, and may be adversely affected by, the rights of the holders of shares of any
series of preferred stock which may be designated and issued in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Stock is listed on Nasdaq under the symbol &ldquo;IMNN.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transfer
Agent and Registrar</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transfer agent and registrar for our Common Stock is Equiniti Trust Company, LLC. Equiniti Trust Company, LLC is located at 6201 15<SUP>th
</SUP>Avenue, Brooklyn, NY 11219. Their telephone number is (888) 999-0032.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Preferred
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Undesignated
Preferred Stock</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to our Certificate of Incorporation, our board of directors has the authority, without further action by the stockholders (unless such
stockholder action is required by applicable law or Nasdaq rules), to designate and issue shares of preferred stock in one or more series,
to establish from time to time the number of shares to be included in each such series, to fix the designations, powers (including voting),
privileges, preferences and relative participating, optional or other rights, if any, of the shares of each such series and the qualifications,
limitations or restrictions thereof and to increase or decrease the number of shares of any such series, but not below the number of
shares of such series then outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will fix the designations, powers (including voting), privileges, preferences and relative participating, optional or other rights, if
any, of the preferred stock of each series, as well as the qualifications, limitations or restrictions thereof, in the certificate of
designation relating to that series. The certificate of designation will describe the terms of the series of preferred stock. This description
will include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    title and stated value;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of shares we are offering;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    liquidation preference per share;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    purchase price;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    dividend rate, period and payment date and method of calculation for dividends;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
    dividends will be cumulative or non-cumulative and, if cumulative, the date from which dividends will accumulate;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    procedures for any auction or remarketing, if any;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    provisions for a sinking fund, if any;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    provisions for redemption or repurchase, if applicable, and any restrictions on our ability to exercise those redemption and repurchase
    rights;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    listing of the preferred stock on any securities exchange or market;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
    the preferred stock will be convertible into or exchangeable for other securities and, if applicable, the conversion price, or how
    it will be calculated, and the conversion period;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">voting
    rights, if any, of the preferred stock;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">preemptive
    rights, if any;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">restrictions
    on transfer, sale or other assignment, if any;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">liability
    as to further calls or to assessment by the Company, if any;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    discussion of any material U.S. federal income tax considerations applicable to the preferred stock;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    relative ranking and preferences of the preferred stock as to dividend rights and rights if we liquidate, dissolve or wind up our
    affairs;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    limitations on the issuance of any class or series of preferred stock ranking senior to or on a parity with the series of preferred
    stock as to dividend rights and rights if we liquidate, dissolve or wind up our affairs; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    other specific terms, preferences, rights or limitations of, or restrictions on, the preferred stock.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
DGCL provides that the holders of preferred stock will have the right to vote separately as a class or, in some cases, as a series on
an amendment to our Certificate of Incorporation if the amendment would change the par value or, unless our Certificate of Incorporation
provides otherwise, the number of authorized shares of the class or the powers, preferences or special rights of the class or series
so as to adversely affect the class or series, as the case may be. This right is in addition to any voting rights that may be provided
in the applicable certificate of designation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting
power or other rights of the holders of our Common Stock or other securities. Preferred stock could be issued quickly with terms designed
to delay or prevent a change in control of our Company or make removal of management more difficult. Additionally, the issuance of preferred
stock may have the effect of decreasing the market price of our Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Anti-Takeover
Considerations and Special Provisions of Our Certificate of Incorporation, Our Bylaws and the Delaware General Corporation Law</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Certificate
of Incorporation and Bylaws</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
number of provisions of our Certificate of Incorporation and Bylaws concern matters of corporate governance and the rights of our stockholders.
Provisions that grant our board of directors the ability to issue shares of preferred stock and to set the voting rights, preferences
and other terms thereof may discourage takeover attempts that are not first approved by our board of directors, including takeovers that
may be considered by some stockholders to be in their best interests, such as those attempts that might result in a premium over the
market price for the shares held by stockholders. Certain provisions could delay or impede the removal of incumbent directors even if
such removal would be beneficial to our stockholders, such as the classification of our board of directors and the lack of cumulative
voting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
our board of directors has the power to retain and discharge our officers, these provisions could also make it more difficult for existing
stockholders or another party to effect a change in management.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
provisions may have the effect of deterring hostile takeovers or delaying changes in our control or in our management. These provisions
are intended to enhance the likelihood of continued stability in the composition of our board of directors and in the policies they implement
and to discourage certain types of transactions that may involve an actual or threatened change of our control. These provisions are
designed to reduce our vulnerability to an unsolicited acquisition proposal. The provisions also are intended to discourage certain tactics
that may be used in proxy fights. However, such provisions could have the effect of discouraging others from making tender offers for
our shares and, as a consequence, they also may inhibit fluctuations in the market price of our shares that could result from actual
or rumored takeover attempts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
provisions also could discourage or make more difficult a merger, tender offer or proxy contest, even if they could be favorable to the
interests of stockholders and could potentially depress the market price of our Common Stock. Our board of directors believes that these
provisions are appropriate to protect our interests and the interests of our stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Classification
of Board; No Cumulative Voting</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Certificate of Incorporation and Bylaws provide for our board of directors to be divided into three classes, with staggered three-year
terms. Only one class of directors is elected at each annual meeting of our stockholders, with the other classes continuing for the remainder
of their respective three-year terms. Because our stockholders do not have cumulative voting rights, our stockholders representing a
majority of the shares of Common Stock outstanding will be able to elect all of our directors due to be elected at each annual meeting
of our stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Meetings
of and Actions by Stockholders</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Bylaws provide that annual meetings of our stockholders may take place at the time and place designated by our board of directors. A
special meeting of our stockholders may be called at any time by our board of directors, the chairman of our board of directors or the
president. Our Bylaws provide that (i) our board of directors can fix separate record dates for determining stockholders entitled to
receive notice of a stockholder meeting and for determining stockholders entitled to vote at the meeting; (ii) we may hold a stockholder
meeting by means of remote communications; (iii) any stockholder seeking to have the stockholders authorize or take corporate action
by written consent shall, by written notice to the secretary of the Company, request that the board of directors fix a record date, and
that the board of directors shall adopt a resolution fixing the record date in all events within ten calendar days after a request is
received; and (iv) a written consent of stockholders shall not be effective unless a written consent signed by a sufficient number of
stockholders to take such action is received by us within 60 calendar days of the earliest dated written consent received.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Advance
Notice Requirements for Stockholder Proposals and Director Nominations</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Bylaws provide that stockholders seeking to bring business before an annual meeting of stockholders or to nominate candidates for election
as directors at an annual meeting of stockholders must provide timely notice in writing. To be timely, a stockholder&rsquo;s notice must
be delivered to, or mailed and received by, the secretary of the Company at our principal executive offices not later than the close
of business on the 90th calendar day, nor earlier than the close of business on the 120th calendar day in advance of the date specified
in the Company&rsquo;s proxy statement released to stockholders in connection with the previous year&rsquo;s annual meeting of stockholders.
If the date of the annual meeting is more than 30 calendar days before or after such anniversary date, notice by the stockholder to be
timely must be so not earlier than the close of business on the 120th calendar day in advance of such date of annual meeting and not
later than the close of business on the later of the 90th calendar day in advance of such date of annual meeting or the tenth calendar
day following the date on which public announcement of the date of the meeting is made. In no event shall the public announcement of
an adjournment or postponement of an annual meeting commence a new time period (or extend any time period) for the giving of an advance
notice by any stockholder. Any stockholder that proposes director nominations or other business must be a stockholder of record at the
time the advance notice is delivered by such stockholder to us and entitled to vote at the meeting. Our Bylaws also specify requirements
as to the form and content of a stockholder&rsquo;s notice. These provisions may preclude stockholders from bringing matters before an
annual meeting of stockholders or from making nominations for the election of directors at an annual meeting of stockholders. Unless
otherwise required by law, any director nomination or other business shall not be made or transacted if the stockholder (or a qualified
representative of the stockholder) does not appear at the meeting to present the director nominee or other proposed business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Filling
of Board Vacancies</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Certificate of Incorporation and Bylaws provide that the authorized size of our board of directors shall be determined by the board of
directors by board resolution from time to time and that our board of directors has the exclusive power to fill any vacancies and newly
created directorships resulting from any increase in the authorized number of directors and the stockholders do not have the power to
fill such vacancies. Vacancies in our board of directors and newly created directorships resulting from any increase in the authorized
number of directors on our board of directors may be filled by a majority of the directors remaining in office, even though that number
may be less than a quorum of our board of directors, or by a sole remaining director. A director so elected to fill a vacancy shall serve
for the remaining term of the predecessor he or she replaced and until his or her successor is elected and has qualified, or until his
or her earlier resignation, removal or death.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Amendment
of the Certificate of Incorporation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Certificate of Incorporation may be amended, altered, changed or repealed at a meeting of our stockholders entitled to vote thereon by
the affirmative vote of a majority of the outstanding stock entitled to vote thereon and a majority of the outstanding stock of each
class entitled to vote thereon as a class, in the manner prescribed by the DGCL.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Amendment
of the Bylaws</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Bylaws may be amended or repealed, or new Bylaws may be adopted, by either our board of directors or the affirmative vote of at least
66 2/3 percent of the voting power of our outstanding shares of capital stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Section
203 of the Delaware General Corporation Law</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to Section 203 of the DGCL, which prohibits a Delaware corporation from engaging in any business combination with any interested
stockholder for a period of three years after the date that such stockholder became an interested stockholder, with the following exceptions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">before
    such date, the board of directors of the corporation approved either the business combination or the transaction that resulted in
    the stockholder becoming an interested stockholder;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
    completion of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned
    at least 85 percent of the voting stock of the corporation outstanding at the time the transaction began, excluding for purposes
    of determining the voting stock outstanding (but not the outstanding voting stock owned by the interested stockholder) those shares
    owned (i) by persons who are directors and also officers and (ii) pursuant to employee stock plans in which employee participants
    do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange
    offer; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
    or after such date, the business combination is approved by the board of directors and authorized at an annual or special meeting
    of the stockholders, and not by written consent, by the affirmative vote of at least 66 2/3 percent of the outstanding voting stock
    that is not owned by the interested stockholder.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, Section 203 defines a business combination to include the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    merger or consolidation involving the corporation and the interested stockholder;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    sale, lease, transfer, pledge or other disposition of ten percent or more of the assets of the corporation to or with the interested
    stockholder;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">subject
    to certain exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation
    to the interested stockholder;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    transaction involving the corporation that has the effect of increasing the proportionate share of the stock or any class or series
    of the corporation beneficially owned by the interested stockholder; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    receipt by the interested stockholder of the benefit of any loss, advances, guarantees, pledges or other financial benefits by or
    through the corporation.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, Section 203 of the DGCL defines an &ldquo;interested stockholder&rdquo; as an entity or person who, together with the entity&rsquo;s
or person&rsquo;s affiliates and associates, beneficially owns, or is an affiliate of the corporation and within three years prior to
the time of determination of interested stockholder status did own, 15 percent or more of the outstanding voting stock of the corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
Delaware corporation may &ldquo;opt out&rdquo; of these provisions with an express provision in its Certificate of Incorporation. We
have not opted out of these provisions, which may as a result, discourage or prevent mergers or other takeover or change of control attempts
of us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="Aa_010"></A>DESCRIPTION
OF SECURITIES WE ARE OFFERING</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are offering up to 10,000,000 shares of our Common Stock or pre-funded warrants in lieu of shares of Common Stock along with common
warrants to purchase up to 10,000,000 shares of Common Stock. For each pre-funded warrant we sell, the number of shares of Common
Stock we are offering will be decreased on a one-for-one basis. Each share of Common Stock or pre-funded warrant is being sold together
with a common warrant to purchase one share of Common Stock. The shares of Common Stock or pre-funded warrants and accompanying common
warrants will be issued separately. We are also registering the shares of Common Stock issuable from time to time upon exercise of the
pre-funded warrants and common warrants offered hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Common
Stock</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
the description above under &ldquo;<I>Description of Capital Stock&mdash;Common Stock</I>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Pre-Funded
Warrants</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summary of certain terms and provisions of pre-funded warrants that are being offered hereby is not complete and is subject
to, and qualified in its entirety by, the provisions of the pre-funded warrant, the form of which is filed as an exhibit to the registration
statement of which this prospectus forms a part. Prospective investors should carefully review the terms and provisions of the form of
pre-funded warrant for a complete description of the terms and conditions of the pre-funded warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Duration
and Exercise Price</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term &ldquo;pre-funded&rdquo; refers to the fact that the purchase price of each pre-funded warrant, at closing, will equal the price
per share at which shares of our Common Stock and accompanying common warrants are being sold to the public in this offering, minus $0.0001,
and the initial exercise price of each pre-funded warrant offered hereby will equal $0.0001 per share of Common Stock. The pre-funded
warrants will be immediately exercisable and may be exercised at any time until the pre-funded warrants are exercised in full. The exercise
price and number of shares of Common Stock issuable upon exercise is subject to appropriate adjustment in the event of stock dividends,
stock splits, reorganizations or similar events affecting our shares of Common Stock and the exercise price. Subject to the rules and
regulations of the applicable trading market, we may at any time during the term of the pre-funded warrant, subject to the prior written
consent of the holders of a majority of the shares issuable upon exercise of the pre-funded warrants, reduce the then current
exercise price to any amount and for any period of time deemed appropriate by our board of directors. The pre-funded warrants will be
issued separately from the common warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Exercisability</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
pre-funded warrants will be exercisable, at the option of each holder, in whole or in part, by delivering to us a duly executed exercise
notice accompanied by payment in full for the number of shares of our Common Stock purchased upon such exercise (except in the case of
a cashless exercise as discussed below). A holder (together with its affiliates) may not exercise any portion of the pre-funded warrant
to the extent that the holder would own more than 4.99% (or, at the election of the holder, 9.99%) of the outstanding Common Stock
immediately after exercise (the &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;), except that upon at least 61 days&rsquo; prior
notice from the holder to us, the holder may increase the Beneficial Ownership Limitation to a percentage not to exceed 9.99%. No fractional
shares of Common Stock will be issued in connection with the exercise of a pre-funded warrant. In lieu of fractional shares, we will
either pay the holder an amount in cash equal to the fractional amount multiplied by the exercise price or round up to the
next whole share of Common Stock. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Cashless
Exercise</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
at the time a holder exercises its pre-funded warrants, a registration statement registering the issuance of the shares of Common Stock
underlying the pre-funded warrants under the Securities Act is not then effective or available for the issuance of such shares, then
in lieu of making the cash payment otherwise contemplated to be made to us upon such exercise in payment of the aggregate exercise price,
the holder may elect instead to receive upon such exercise (either in whole or in part) the net number of shares of Common Stock determined
according to a formula set forth in the pre-funded warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Fundamental
Transaction</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of a fundamental transaction, as described in the pre-funded warrants and generally including any merger or consolidation of
the Company or the sale of all or substantially all of the Company&rsquo;s capital stock or assets, the holders of the pre-funded warrants
will be entitled to receive upon exercise of the pre-funded warrants the kind and amount of securities, cash or other property that the
holders would have received had they exercised the pre-funded warrants immediately prior to such fundamental transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Transferability</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to applicable laws, a pre-funded warrant may be transferred at the option of the holder upon surrender of the pre-funded warrant to us
together with the appropriate instruments of transfer and funds sufficient to pay any transfer taxes payable upon such transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Trading
Market</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no trading market available for the pre-funded warrants on any securities exchange or nationally recognized trading system, and we
do not expect a trading market to develop. We do not intend to list the pre-funded warrants on any securities exchange or nationally
recognized trading market. Without a trading market, the liquidity of pre-funded warrants will be extremely limited. The shares of Common
Stock issuable upon exercise of the pre-funded warrants are currently traded on Nasdaq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Exchange
Listing</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not intend to list the pre-funded warrants on any securities exchange or nationally recognized trading system.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Rights
as a Stockholder</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise provided in the pre-funded warrants or by virtue of such holder&rsquo;s ownership of shares of our Common Stock, the holders
of the pre-funded warrants do not have the rights or privileges of holders of our Common Stock, including any voting rights, until they
exercise their pre-funded warrants. The pre-funded warrants will provide that holders have the right to participate in distributions
or dividends paid on Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Common
Warrants</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summary of certain terms and provisions of the common warrants that are being offered hereby is not complete and is subject
to, and qualified in its entirety by, the provisions of the common warrants, the form of which is filed as an exhibit to the registration
statement of which this prospectus forms a part. Prospective investors should carefully review the terms and provisions of the form of
common warrant for a complete description of the terms and conditions of the common warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Duration
and Exercise Price</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
common warrant offered hereby will have an initial exercise price per share equal to the combined public offering price per share
of Common Stock and accompanying common warrant, which is assumed here to be $<FONT STYLE="background-color: white">1.00</FONT> per share (the closing price of our Common Stock on
Nasdaq on <FONT STYLE="background-color: white">April 3</FONT>, 2025). The common warrants will be exercisable beginning on the effective date of the Warrant Stockholder
Approval, provided however, if the Pricing Conditions are met, the Warrant Stockholder Approval will not be required and the common warrants
will be exercisable on the Initial Exercise Date. The common warrants will expire on the <FONT STYLE="background-color: white">five
year</FONT> anniversary of the Initial Exercise Date or the Warrant Stockholder Approval, as applicable. The exercise price
and number of shares of Common Stock issuable upon exercise is subject to appropriate adjustment in the event of stock dividends, stock
splits, reorganizations or similar events affecting our Common Stock and the exercise price. Subject to the rules and regulations of
the applicable trading market, we may at any time during the term of the common warrant, subject to the prior written consent of the
holders of a majority of the shares issuable upon exercise of the common warrants, reduce the then current exercise price to any
amount and for any period of time deemed appropriate by our board of directors. The common warrants will be issued separately from the
Common Stock and pre-funded warrants, and may be transferred separately immediately thereafter. A common warrant to purchase one share
of our Common Stock will be issued for every one share of Common Stock (or pre-funded warrants, as applicable) purchased in this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Exercisability</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
common warrants will be exercisable beginning on the effective date of the Warrant Stockholder Approval, provided however, if the Pricing
Conditions are met, the Warrant Stockholder Approval will not be required and the common warrants will be exercisable on the Initial
Exercise Date, at the option of each holder, in whole or in part, by delivering a duly executed exercise notice accompanied by payment
in full for the number of shares of our Common Stock purchased upon such exercise. Except as agreed with individual holders of warrants,
a holder (together with its affiliates) may not exercise any portion of the common warrant to the extent that the holder would own more
than 4.99% (or, at the election of the holder, 9.99%<FONT STYLE="background-color: white">)</FONT> of the outstanding Common Stock
immediately after exercise, except that upon at least 61 days&rsquo; prior notice from the holder to us, the holder may increase the
Beneficial Ownership Limitation to a percentage not to exceed 9.99%. No fractional shares of Common Stock will be issued in connection
with the exercise of a common warrant. In lieu of fractional shares, we will <FONT STYLE="background-color: white">either</FONT>
pay the holder an amount in cash equal to the fractional amount multiplied by the exercise price or round up to the next whole share
of Common Stock. </FONT>The common warrants will expire five years from the Initial Exercise Date or the Warrant Stockholder Approval,
as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"> <I>Cashless Exercise
</I> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"> If, at the time
a holder exercises its common warrants, a registration statement registering the issuance of the shares of Common Stock underlying the
common warrants under the Securities Act is not then effective or available for the issuance of such shares, then in lieu of making the
cash payment otherwise contemplated to be made to us upon such exercise in payment of the aggregate exercise price, the holder may elect
instead to receive upon such exercise (either in whole or in part) the net number of shares of Common Stock determined according to a
formula set forth in the common warrants. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Fundamental
Transaction</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of a fundamental transaction, as described in the common warrants and generally including merger or consolidation of the
Company or the sale of all or substantially all of the Company&rsquo;s capital stock or assets, the holders of the common warrants
will be entitled to receive upon exercise of the common warrants the kind and amount of securities, cash or other property that the
holders would have received had they exercised the common warrants immediately prior to such fundamental transaction. Notwithstanding
the foregoing, in the event of a fundamental transaction, the holders of common warrants have the right to require the Company or a
successor entity to purchase the common warrants from the holder for an amount of consideration equal to the Black Scholes Value (as
defined in the common warrants) of the remaining unexercised portion of the common warrants concurrently with or within 30 days
following the consummation of a fundamental transaction. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"> However, <FONT>in
the event of a fundamental transaction which is not in the Company&rsquo;s control, including a fundamental transaction not approved
by the Company&rsquo;s board of directors, the holders of the common warrants will only be entitled to receive from the Company or its
successor entity, as of the date of consummation of such fundamental transaction, the same type or form of consideration (and in the
same proportion), at the Black Scholes Value of the unexercised portion of the common warrants, that is being offered and paid to the
holders of the Company&rsquo;s Common Stock in connection with the fundamental transaction, whether that consideration is in the form
of cash, stock or any combination of cash and stock, or whether the holders of the Company&rsquo;s Common Stock are given the choice
to receive alternative forms of consideration in connection with the fundamental transaction. If holders of the Company&rsquo;s Common
Stock are not offered or paid any consideration in a fundamental transaction, such holders of the Company&rsquo;s Common Stock will be
deemed to have received shares of the successor entity in such fundamental transaction, and holders of the common warrants will receive
shares of the successor entity in the amount of the Black Scholes Value.</FONT> </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Transferability</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to applicable laws, a common warrant may be transferred at the option of the holder upon surrender of the common warrant together with
the appropriate instruments of transfer and funds sufficient to pay any transfer taxes payable upon such transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Trading
Market</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no trading market available for the common warrants on any securities exchange or nationally recognized trading system, and we do
not expect a trading market to develop. We do not intend to list the common warrants on any securities exchange or nationally recognized
trading market. Without a trading market, the liquidity of the common warrants will be extremely limited. The shares of Common Stock
issuable upon exercise of the common warrants are currently traded on Nasdaq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Exchange
Listing</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not intend to list the common warrants on any securities exchange or nationally recognized trading system.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Right
as a Stockholder</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise provided in the common warrants or by virtue of such holder&rsquo;s ownership of shares of our Common Stock, the holders
of the common warrants do not have the rights or privileges of holders of our Common Stock, including any voting rights, until they exercise
their common warrants. The common warrants will provide that holders have the right to participate in distributions or dividends paid
on Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="Aa_011"></A>PLAN
OF DISTRIBUTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.G.P.
and Brookline have agreed to act as our Placement Agents in connection with this offering subject to the terms and conditions of the
placement agency agreement dated &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2025. The placement agency agreement provides that the Placement Agent obligations are subject to conditions contained in the placement
agency agreement. The Placement Agents are not purchasing or selling any such securities, nor are they required to arrange for the purchase
and sale of any specific number or dollar amount of such securities, other than to use their &ldquo;reasonable best efforts&rdquo; to
arrange for the sale of such securities by us. Therefore, we may not sell all of the shares of Common Stock, pre-funded warrants and
common warrants being offered. The terms of this offering are subject to market conditions and negotiations between us, the Placement
Agents and prospective investors. The securities will be offered at a fixed price and are expected to be issued in a single closing.
The offering will terminate on May 13, 2025, unless (i) the closing occurs prior thereto or (ii) we decide to terminate the offering
prior thereto (which we may do at any time in our discretion), except that the shares of Common Stock underlying the warrants and shares
of Common Stock underlying the pre-funded warrants will be offered on a continuous basis pursuant to Rule 415 under the Securities Act.
We will enter into a securities purchase agreement directly with certain investors, at the investor&rsquo;s option, who purchase our
securities in this offering. Investors who do not enter into a securities purchase agreement shall rely solely on this prospectus in
connection with the purchase of our securities in this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
is a best-efforts offering, and there is no minimum offering amount required as a condition to the closing of this offering. The actual
amount of gross proceeds, if any, in this offering could vary substantially from the gross proceeds from the sale of the maximum amount
of securities being offered in this prospectus. The Placement Agents may retain sub-agents and selected dealers in connection with this
offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 74.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will deliver the securities being issued to the investors upon receipt of investor funds for the purchase of the securities offered pursuant
to this prospectus. We expect to deliver the securities being offered pursuant to this prospectus DVP/RVP on or about one trading day
after we price the securities being offered hereby. When we price the securities, we will simultaneously enter into securities purchase
agreements relating to the offering with those investors who so choose. Since we will deliver the securities to be issued in this offering
upon our receipt of investor funds, we and the Placement Agents have not made any arrangements to place investor funds in an escrow account
or trust account.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed to indemnify the Placement Agents against specified liabilities, including liabilities under the Securities Act, and to contribute
to payments the Placement Agents may be required to make in respect thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Determination
of Offering Price and Warrant Exercise Price</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
actual offering price of the securities we are offering, and the exercise price of the common warrants and pre-funded warrants that we
are offering, were negotiated between us, the Placement Agents and the investors in the offering based on the trading of our shares of
Common Stock prior to the offering, among other things. Other factors considered in determining the public offering price of the securities
we are offering, as well as the exercise price of the common warrants that we are offering, include our history and prospects, the stage
of development of our business, our business plans for the future and the extent to which they have been implemented, an assessment of
our management, the general conditions of the securities markets at the time of the offering and such other factors as were deemed relevant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fees
and Expenses</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed to pay the Placement Agents an aggregate fee equal to 7.0% of the purchase price paid by all purchasers in the offering.
In addition, we have agreed to reimburse the Placement Agents in an amount up to $75,000 for their accountable offering-related legal
expenses and for non-accountable expenses of up to $20,000. We estimate the total expenses of this offering paid or payable by us, exclusive
of the Placement Agent fee, will be approximately $0.3 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the per share price and total cash fees to be paid to the Placement Agents in connection with the sale of the Common
Stock and shares of Common Stock underlying the pre-funded warrants pursuant to this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Per Share of</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common Stock</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>and
                                            Common </B></FONT><B>Warrant</B></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Per Pre-Funded</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Warrant and</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common Warrant</B></FONT></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Total</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 38%">Offering price (1)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Placement Agent fees (2)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Proceeds, before expenses, to us (3)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    combined public offering price is $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per
    share of Common Stock and accompanying common warrant (or $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;     per pre-funded warrant and accompanying common warrant).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    a cash fee equal to seven percent (7.0%) of the aggregate purchase price paid by investors in this offering. We have also agreed
    to reimburse the Placement Agents for their accountable offering-related legal expenses in an amount up to $75,000 and for non-accountable
    expenses of up to $20,000.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Does
    not include proceeds from the exercise of the common warrants and/or pre-funded warrants in cash, if any.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Indemnification</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed to indemnify the Placement Agents and other specified persons against certain liabilities, including liabilities under the
Securities Act and liabilities arising from breaches of representations and warranties contained in the underwriting agreement, or to
contribute to payments that the Placement Agents may be required to make in respect of those liabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lock-up
Agreements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
directors and executive officers have entered into lock-up agreements. Under these agreements, these individuals have agreed, subject
to specified exceptions, not to sell or transfer any shares of Common Stock or securities convertible into, or exchangeable or exercisable
for, our shares of Common Stock during a period ending 45 days after the date of this prospectus, without first obtaining the
written consent of the Placement Agents. Specifically, these individuals have agreed, in part, not to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">offer,
    pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option,
    right or warrant to purchase, lend, or otherwise transfer or dispose of (or enter into any transaction or device that is designed
    to, or could be expected to, result in the transfer or disposition by any person at any time in the future of), any shares of capital
    stock of the Company or any securities convertible into or exercisable or exchangeable for shares of capital stock of the Company;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">make
    any demand for or exercise any right or cause to be filed a registration statement, including any amendments thereto, with respect
    to the registration of any of our securities; or </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">enter
    into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership
    of capital stock of the Company.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.45in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
these limitations, these shares of Common Stock may be transferred under limited circumstances, including, without limitation, by gift,
will or intestate succession.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we have agreed that, subject to certain exceptions, we will not conduct any issuances of our Common Stock for a period of forty-five
(45) days following closing of this offering. Furthermore, we are also prohibited from entering into any agreement to issue Common
Stock or Common Stock Equivalent involving a Variable Rate Transaction (as each such term is defined in the placement agency agreement),
subject to certain exceptions, for ninety (90) days after the closing of this offering. A Variable Rate Transaction will not include
any at-the-market offering of the Company&rsquo;s Common Stock, and sales under any at-the-market offering may commence starting on the
sixty-first (61st) day following the closing date of this offering. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Regulation
M</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Placement Agents may be deemed to be underwriters within the meaning of Section 2(a)(11) of the Securities Act, and any commissions received
by them and any profit realized on the resale of the securities sold by them while acting as principal might be deemed to be underwriting
discounts or commissions under the Securities Act. As underwriters, the Placement Agents would be required to comply with the requirements
of the Securities Act and the Exchange Act, including, without limitation, Rule 10b-5 and Regulation M under the Exchange Act. These
rules and regulations may limit the timing of purchases and sales of our securities by the Placement Agents acting as principal. Under
these rules and regulations, the Placement Agents (i) may not engage in any stabilization activity in connection with our securities
and (ii) may not bid for or purchase any of our securities or attempt to induce any person to purchase any of our securities, other than
as permitted under the Exchange Act, until they have completed their participation in the distribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Discretionary
Accounts</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Placement Agents do not intend to confirm sales of the securities offered hereby to any accounts over which they have discretionary authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other
Activities and Relationships</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Placement Agents and certain of their affiliates are full service financial institutions engaged in various activities, which may include
securities trading, commercial and investment banking, financial advisory, investment management, investment research, principal investment,
hedging, financing and brokerage activities. The Placement Agents and certain of their affiliates have, from time to time, performed,
and may in the future perform, various commercial and investment banking and financial advisory services for us and our affiliates, for
which they received or will receive customary fees and expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the ordinary course of their various business activities, the Placement Agents and certain of their affiliates may make or hold a broad
array of investments and actively trade debt and equity securities (or related derivative securities) and financial instruments (including
bank loans) for their own account and for the accounts of their customers, and such investment and securities activities may involve
securities and/or instruments issued by us and our affiliates. If the Placement Agents or their affiliates have a lending relationship
with us, they routinely hedge their credit exposure to us consistent with their customary risk management policies. The Placement Agents
and their affiliates may hedge such exposure by entering into transactions that consist of either the purchase of credit default swaps
or the creation of short positions in our securities or the securities of our affiliates, including potentially the Common Stock offered
hereby. Any such short positions could adversely affect future trading prices of the Common Stock offered hereby. The Placement Agents
and certain of their affiliates may also communicate independent investment recommendations, market color or trading ideas and/or publish
or express independent research views in respect of such securities or instruments and may at any time hold, or recommend to clients
that they acquire, long and/or short positions in such securities and instruments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On July 30, 2024, we entered
into a securities purchase agreement with certain institutional and other accredited investors, pursuant to which we issued and sold
5,000,000 shares of our Common Stock in a registered direct offering and warrants to purchase 5,000,000 shares of Common Stock in a concurrent
private placement, for a combined purchase price of $2.00 per share of Common Stock and accompanying warrant. The closing of the private
placement took place on August 1, 2024 and we received total gross proceeds of $10.0 million. Brookline acted as co-placement agent and
H.C. Wainwright &amp; Co., LLC acted as the lead placement agent, for the registered direct offering and concurrent private placement.
The placement agents were entitled to fees equal to 7.0% of the gross proceeds from the registered direct offering and concurrent private
placement.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
stated above, the Placement Agents and their respective affiliates have and may in the future provide, from time to time, investment
banking and financial advisory services to us in the ordinary course of business, for which they may receive customary fees and commissions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing does not purport to be a complete statement of the terms and conditions of the placement agency agreement or the securities
purchase agreement entered into in connection with this offering, copies of which have been filed as exhibits to the registration statement
of which this prospectus is a part. See <I>&ldquo;Where You Can Find More Information.&rdquo;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Listing</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Stock on is listed Nasdaq under the symbol &ldquo;IMNN.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Offer
Restrictions Outside the United States</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than in the United States, no action has been taken by us or the Placement Agents that would permit a public offering of the securities
offered by this prospectus in any jurisdiction where action for that purpose is required. The securities offered by this prospectus may
not be offered or sold, directly or indirectly, nor may this prospectus or any other offering material or advertisements in connection
with the offer and sale of any such securities be distributed or published in any jurisdiction, except under circumstances that will
result in compliance with the applicable rules and regulations of that jurisdiction. Persons into whose possession this prospectus comes
are advised to inform themselves about and to observe any restrictions relating to the offering and the distribution of this prospectus.
This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any securities offered by this prospectus in
any jurisdiction in which such an offer or a solicitation is unlawful.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="Aa_012"></A>MATERIAL
UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of the material U.S. federal income tax consequences of the acquisition, ownership and disposition of our Common
Stock, and the acquisition, ownership, exercise, expiration or disposition of the common warrants and pre-funded warrants, but does not
purport to be a complete analysis of all the potential tax considerations relating thereto. This summary is based upon the provisions
of the Internal Revenue Code of 1986, as amended (the &ldquo;<U>Code</U>&rdquo;), Treasury Regulations promulgated thereunder, administrative
rulings and judicial decisions, all as of the date hereof. These authorities may be changed or subject to differing interpretations,
possibly with retroactive effect, so as to result in U.S. federal income tax consequences different from those set forth below. We have
not sought and will not seek any ruling from the Internal Revenue Service (the &ldquo;<U>IRS</U>&rdquo;) with respect to the statements
made and the conclusions reached in the following summary, and there can be no assurance that the IRS or a court will agree with such
statements and conclusions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
summary also does not address the tax considerations arising under the laws of any U.S. state or local or any non-U.S. jurisdiction,
estate or gift tax, the 3.8% Medicare tax on net investment income or any alternative minimum tax consequences. In addition, this discussion
does not address tax considerations applicable to a holder&rsquo;s particular circumstances or to a holder that may be subject to special
tax rules, including, without limitation:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">banks,
    insurance companies or other financial institutions;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">tax-exempt
    or government organizations;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">brokers
    or dealers in securities or currencies;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">traders
    in securities that elect to use a mark-to-market method of accounting for their securities holdings;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    that own, or are deemed to own, more than five percent of our capital stock;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">certain
    U.S. expatriates (such as former citizens or former long-term residents of the United States);</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    who hold our Common Stock, pre-funded warrants or common warrants as a position in a hedging transaction, &ldquo;straddle,&rdquo;
    &ldquo;conversion transaction,&rdquo; synthetic security, other integrated investment, or other risk reduction transaction;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    who do not hold our Common Stock, pre-funded warrants and common warrants as a capital asset within the meaning of Section 1221 of
    the Code (generally, for investment purposes);</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    deemed to sell our Common Stock, pre-funded warrants or common warrants under the constructive sale provisions of the Code;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">pension
    plans;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">partnerships,
    S corporations, or other entities or arrangements treated as partnerships for U.S. federal income tax purposes, or investors in any
    such entities;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulated
    investment companies or real estate investment trusts;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    for whom our stock constitutes &ldquo;qualified small business stock&rdquo; within the meaning of Section 1202 of the Code;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">integral
    parts or controlled entities of foreign sovereigns;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">controlled
    foreign corporations;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">passive
    foreign investment companies and corporations that accumulate earnings to avoid U.S. federal income tax; </FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    that acquire our Common Stock, pre-funded warrants or common warrants as compensation for services; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    Non-U.S. Holder (as defined below under &ldquo;&mdash;<I>Definition of a U.S. Holder</I>.&rdquo;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if a partnership, including any entity or arrangement classified as a partnership for U.S. federal income tax purposes, holds
our Common Stock, pre-funded warrants or common warrants, the tax treatment of a partner generally will depend on the status of the partner,
the activities of the partnership, and certain determinations made at the partner level. Accordingly, partnerships that hold our Common
Stock, pre-funded warrants or common warrants, and partners in such partnerships, should consult their tax advisors regarding the U.S.
federal income tax consequences to them of the acquisition, ownership, and disposition of our Common Stock, and the acquisition, ownership,
exercise, expiration, and disposition of the pre-funded warrants and common warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
are urged to consult your tax advisor with respect to the application of the U.S. federal income tax laws to your particular situation,
as well as any tax consequences of the acquisition, ownership and disposition of our Common Stock, and the acquisition, ownership, exercise,
expiration, and disposition of the pre-funded warrants and common warrants arising under the U.S. federal estate or gift tax rules or
under the laws of any U.S. state or local or any non-U.S. or other taxing jurisdiction or under any applicable tax treaty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Definition
of a U.S. Holder</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this summary, a &ldquo;U.S. Holder&rdquo; is any beneficial owner of our Common Stock, pre-funded warrants or common warrants
that is a &ldquo;U.S. person,&rdquo; and is not a partnership, or an entity treated as a partnership or disregarded from its owner, each
for U.S. federal income tax purposes. A U.S. person is any person that, for U.S. federal income tax purposes, is or is treated as any
of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    individual who is a citizen or resident of the United States;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    corporation (or other entity taxable as a corporation for U.S. federal income tax purposes) created or organized under the laws of
    the United States, any state thereof, or the District of Columbia;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    estate, the income of which is subject to U.S. federal income tax regardless of its source; or</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    trust that (1) is subject to the primary supervision of a U.S. court and the control of one or more U.S. persons (within the meaning
    of Section 7701(a)(30) of the Code), or (2) has a valid election in effect to be treated as a U.S. person for U.S. federal income
    tax purposes.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this summary, a &ldquo;Non-U.S. Holder&rdquo; is any beneficial owner of our Common Stock, pre-funded warrants or common
warrants that is neither a U.S. Holder nor a partnership, or other entity treated as a partnership or disregarded from its owner, each
for U.S. federal income tax purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Treatment
of Pre-funded Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
it is not entirely free from doubt, a pre-funded warrant should be treated as a share of our Common Stock for U.S. federal income tax
purposes and a holder of pre-funded warrants should generally be taxed in the same manner as a holder of Common Stock, as described below.
Accordingly, no gain or loss should be recognized upon the exercise of a pre-funded warrant and, upon exercise, the holding period of
a pre-funded warrant should carry over to the share of Common Stock received. Similarly, the tax basis of the pre-funded warrant should
carry over to the share of Common Stock received upon exercise, increased by the exercise price of $0.0001. However, our characterization
of a pre-funded warrant is not binding on the IRS, and the IRS may treat the pre-funded warrants as warrants to acquire Common Stock
and, if so, the amount and character of a holder&rsquo;s gain with respect to an investment in a pre-funded warrant could change. Each
holder should consult his, her or its own tax advisor regarding the risks associated with the acquisition of pre-funded warrants pursuant
to this offering (including potential alternative characterizations). The balance of this discussion generally assumes that the characterization
described above is respected for U.S. federal income tax purposes and the discussion below, to the extent it pertains to shares of our
Common Stock, is generally intended also to pertain to pre-funded warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Allocation
of Purchase Price for Investment Units</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
pre-funded warrant will be sold as a unit with a common warrant and each share of Common Stock will be sold as a unit with a common warrant,
and each of the items is referred to as a component of a unit. For U.S. federal income tax purposes, each unit consisting of the pre-funded
warrants and common warrants in one case, and the Common Stock and common warrants in the other, should each be treated as an &ldquo;investment
unit&rdquo; consisting of one share of Common Stock (see discussion above under the section titled &ldquo;&mdash;<I>Treatment of Pre-funded
Warrants</I>&rdquo; regarding a pre-funded warrant being treated as a share of our Common Stock for U.S. federal income tax purposes)
and one common warrant to acquire one share of our Common Stock. The purchase price for each investment unit should be allocated between
the two components in proportion to their relative fair market values at the time the unit is purchased by the holder. This allocation
of the purchase price for each unit will establish the holder&rsquo;s initial tax basis for U.S. federal income tax purposes in the components
included in each unit; the pre-funded warrants and common warrants in one case, and the Common Stock and common warrants in the other.
Each holder should consult his, her or its own tax advisor regarding the allocation of the purchase price for a unit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Tax
Consequences to U.S. Holders</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Distributions
on Common Stock</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed in &ldquo;<I>Dividend Policy</I>,&rdquo; we do not currently expect to make distributions on our Common Stock. In the event
that we do make distributions of cash or other property, distributions paid on Common Stock, other than certain pro rata distributions
of Common Stock, will be treated as a dividend for U.S. federal income tax purposes to the extent paid out of our current or accumulated
earnings and profits (as determined under U.S. federal income tax principles) and will be includible in income by the U.S. Holder and,
except as described below with respect to dividends paid to certain non-corporate U.S. Holders, taxable as ordinary income when received.
Distributions in excess of our current and accumulated earnings and profits will constitute a return of capital that is applied against
and reduces, but not below zero, a U.S. Holder&rsquo;s adjusted tax basis in our Common Stock. Any remaining excess will be treated as
a capital gain realized on the sale or exchange of our Common Stock as described below under the section titled &ldquo;&mdash;Sale or
Other Disposition of Common Stock or Common Warrants.&rdquo; Subject to applicable limitations, dividends paid to certain non-corporate
U.S. Holders may be eligible for taxation as &ldquo;qualified dividend income&rdquo; and therefore may be taxable at rates applicable
to long-term capital gains. U.S. Holders should consult their tax advisers regarding the availability of the reduced tax rate on dividends
in their particular circumstances. Dividends received by a corporate U.S. Holder will be eligible for the dividends-received deduction
if the U.S. Holder meets certain holding period and other applicable requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Constructive
Dividends on Common Warrants or Pre-Funded Warrants</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Section 305 of the Code, an adjustment to the number of shares of Common Stock that will be issued on the exercise of the common warrants
or the pre-funded warrants, or an adjustment to the exercise price of the common warrants or the pre-funded warrants, may be treated
as a constructive distribution to a U.S. Holder of the common warrants or pre-funded warrants if, and to the extent that, such adjustment
has the effect of increasing such U.S. Holder&rsquo;s proportionate interest in our &ldquo;earnings and profits&rdquo; or assets, depending
on the circumstances of such adjustment (for example, if such adjustment is to compensate for a distribution of cash or other property
to our stockholders). Adjustments to the exercise price of a common warrant or pre-funded warrant made pursuant to a bona fide reasonable
adjustment formula that has the effect of preventing dilution of the interest of the holders of such warrants should generally not result
in a constructive distribution. Any constructive distributions would generally be subject to the tax treatment described above under
&ldquo;<I>&mdash; Distributions on Common Stock</I>&rdquo; whether or not there is an actual distribution of cash or other property to
the holders of the common warrants or pre-funded warrants. U.S. Holders should consult their tax advisors regarding the proper treatment
of any adjustments to the common warrants and pre-funded warrants and any distributions with respect to such warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Sale
or Other Disposition of Common Stock or Common Warrants</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
U.S. federal income tax purposes, gain or loss realized on the sale or other disposition (other than a redemption treated as a distribution
which will be taxed as described above under &ldquo;&mdash;<I>Distributions on Common Stock</I>&rdquo;) of Common Stock (see discussion
above under the section titled &ldquo;&mdash;<I>Treatment of Pre-funded Warrants</I>&rdquo; regarding a pre-funded warrant being treated
as a share of our Common Stock for U.S. federal income tax purposes) or common warrants (other than by exercise) will be capital gain
or loss and will be long-term capital gain or loss if the U.S. Holder held the Common Stock or common warrants for more than one year.
The amount of the gain or loss will equal the difference between the amount realized and the U.S. Holder&rsquo;s adjusted tax basis in
the Common Stock or common warrants disposed of. Long-term capital gains recognized by non-corporate U.S. Holders will be subject to
reduced tax rates. The deductibility of capital losses is subject to limitations. U.S. Holders who realize losses with respect to a disposition
of our Common Stock or common warrants should consult their own tax advisors regarding the tax treatment of such losses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Exercise
or Expiration of Common Warrants or Pre-Funded Warrants</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, a U.S. Holder will not be required to recognize income, gain or loss upon the exercise of a common warrant or pre-funded warrant
by payment of the exercise price, except to the extent of cash paid in lieu of a fractional share (which fractional share is generally
treated as received and then exchanged for cash). A U.S. Holder&rsquo;s tax basis in a share of Common Stock received upon exercise will
be equal to the sum of (1) the U.S. Holder&rsquo;s tax basis in the common warrant or pre-funded warrant (except to the extent of any
tax basis allocated to a fractional share for which a cash payment is received) and (2) the exercise price of the common warrant or pre-funded
warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
U.S. Holder&rsquo;s holding period in the Common Stock received upon exercise of a common warrant will generally commence on the day
after such U.S. Holder exercises the common warrant. Assuming a pre-funded warrant is treated as our Common Stock, a U.S. Holder&rsquo;s
holding period in the stock received upon exercise of a pre-funded warrant will generally include such holder&rsquo;s holding period
in the pre-funded warrant exchanged therefor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
discussion is provided herein regarding the U.S. federal income tax treatment on the exercise of a common warrant or a pre-funded warrant
on a cashless basis, and U.S. Holders are urged to consult their tax advisors as to the exercise of a warrant on a cashless basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a common warrant expires without being exercised, a U.S. Holder will recognize a capital loss in an amount equal to such U.S. Holder&rsquo;s
tax basis in the common warrant. This loss will be long-term capital loss if, at the time of the expiration, the U.S. Holder&rsquo;s
holding period in the common warrant is more than one year. The deductibility of capital losses is subject to limitations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Information
Reporting and Backup Withholding</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
returns may be filed with the IRS in connection with distributions on Common Stock or constructive dividends on common warrants and pre-funded
warrants, and the proceeds of a sale or other disposition of Common Stock or pre-funded warrants or common warrants. A non-exempt U.S.
Holder may be subject to U.S. backup withholding on these payments if it fails to provide its taxpayer identification number to the withholding
agent and comply with certification procedures or otherwise establish an exemption from backup withholding, or if the U.S. Holder is
notified by the IRS that it has failed to report in full payments of interest and dividend income.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Backup
withholding is not an additional tax. The amount of any backup withholding from a payment generally will be allowed as a credit against
a U.S. Holder&rsquo;s U.S. federal income tax liability and may entitle the holder to a refund, provided that the required information
is timely furnished to the IRS.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
PRECEDING DISCUSSION OF U.S. FEDERAL TAX CONSIDERATIONS IS FOR GENERAL INFORMATION ONLY. IT IS NOT TAX ADVICE. EACH PROSPECTIVE INVESTOR
SHOULD CONSULT ITS TAX ADVISOR REGARDING THE PARTICULAR U.S. FEDERAL, STATE AND LOCAL AND NON-U.S. TAX CONSEQUENCES OF PURCHASING, HOLDING
AND DISPOSING OF OUR COMMON STOCK, PRE-FUNDED WARRANTS OR COMMON WARRANTS, INCLUDING THE CONSEQUENCES OF ANY PROPOSED CHANGE IN APPLICABLE
LAWS.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;<BR STYLE="clear: both">
</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="Aa_013"></A>DIVIDEND
POLICY</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never declared or paid any cash dividends on our Common Stock and we do not currently intend to pay any cash dividends on our Common
Stock in the foreseeable future. We expect to retain all available funds and future earnings, if any, to fund the development and growth
of our business. Any future determination to pay dividends, if any, on our Common Stock will be at the discretion of our board of directors
and will depend on, among other factors, the terms of any outstanding preferred stock, our results of operations, financial condition,
capital requirements and contractual restrictions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="Aa_014"></A>LEGAL
MATTERS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
validity of the securities being offered hereby will be passed upon by Thompson Hine LLP. The Placement Agents are being represented
by Sullivan &amp; Worcester LLP, New York, New York, in connection with this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="Aa_015"></A>EXPERTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements incorporated in this prospectus by reference to our Annual Report on Form&#8239;10-K for the year ended December
31, 2024 have been so incorporated in reliance on the report of WithumSmith+Brown, PC, an independent registered public accounting firm,
which report includes an explanatory paragraph about the existence of substantial doubt concerning the Company&rsquo;s ability to continue
as a going concern, given on the authority of said firm as experts in auditing and accounting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="Aa_016"></A>WHERE
YOU CAN FIND MORE INFORMATION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
file reports, proxy statements and other information with the SEC. The SEC maintains a website that contains reports, proxy and information
statements and other information about issuers, such as us, who file electronically with the SEC. The address of that website is <I>http://www.sec.gov</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
web site address is <I>http://www.imunon.com</I>. There we make available free of charge, on or through the investor relations section
of our website, annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports
filed pursuant to Section 13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after we electronically file such material
with the SEC. The information on our web site, however, is not, and should not be deemed to be, a part of this prospectus. All website
addresses in this prospectus are intended to be inactive textual references only.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus is part of a registration statement we filed with the SEC. This prospectus does not contain all of the information set forth
in the registration statement and the exhibits to the registration statement. The registration statement, its exhibits and the documents
incorporated by reference in this prospectus and their exhibits, all contain information that is material to the offering of the securities
hereby. Whenever a reference is made in this prospectus to any of our contracts or other documents, the reference may not be complete.
You should refer to the exhibits that are a part of the registration statement in order to review a copy of the contract or documents.
The full registration statement and exhibits may be obtained from the SEC or us, as provided below. You may inspect a copy of the registration
statement through the SEC&rsquo;s website, as provided above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="Aa_017"></A>INCORPORATION
OF CERTAIN INFORMATION BY REFERENCE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC&rsquo;s rules allow us to &ldquo;incorporate by reference&rdquo; information into this prospectus, which means that we can disclose
important information to you by referring you to another document filed separately with the SEC. The information incorporated by reference
is deemed to be part of this prospectus, and subsequent information that we file with the SEC will automatically update and supersede
that information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
incorporate by reference into this prospectus and the registration statement of which this prospectus is a part the information or documents
listed below (except in each case the information contained in such document to the extent &ldquo;furnished&rdquo; and not &ldquo;filed&rdquo;)
that we have filed with the SEC:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9679;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    <A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315225008460/form10-k.htm" STYLE="-sec-extract: exhibit">Annual Report on Form 10-K for the fiscal year ended December 31, 2024</A> filed on February 27, 2025;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9679;</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    Current <FONT STYLE="background-color: white">Reports</FONT> on Form 8-K filed with the SEC on <A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315225005536/form8-k.htm" STYLE="-sec-extract: exhibit">February
    10, 2025</A> <FONT STYLE="background-color: white">and</FONT> <FONT STYLE="background-color: white"> <A HREF="https://www.sec.gov/Archives/edgar/data/749647/000164117225000207/form8-k.htm" STYLE="-sec-extract: exhibit">March 24, 2025</A>, </FONT>
    excluding any information furnished in such reports under Item 2.02, Item 7.01 or Item 9.01); and </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9679;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description
    of Securities of the Company, incorporated herein by reference to <A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315225008460/ex4-7.htm" STYLE="-sec-extract: exhibit">Exhibit 4.7</A> to the Annual Report on Form 10-K of the Company for
    the fiscal year ended December 31, 2024. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, all documents subsequently filed by us pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, prior to the termination
of the offering (excluding any information furnished rather than filed), shall be deemed to be incorporated by reference into this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
statement contained in this prospectus or in a document incorporated or deemed to be incorporated by reference into this prospectus will
be deemed to be modified or superseded for purposes hereof to the extent that a statement contained in this prospectus or any other subsequently
filed document that is deemed to be incorporated by reference into this prospectus modifies or supersedes the statement. Any statement
so modified or superseded will not be deemed, except as so modified or superseded, to constitute a part of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
may request a free copy of any of the documents incorporated by reference in this prospectus (other than exhibits, unless they are specifically
incorporated by reference in the documents) by writing or telephoning us at the following address:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Imunon,
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">997
Lenox Drive, Suite 100</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lawrenceville,
NJ 08648</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(609)
896-9100</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibits
to the filings will not be sent, however, unless those exhibits have specifically been incorporated by reference in this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
documents incorporated by reference may be accessed at our website: <I>http://www.imunon.com</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="form_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Up
to 10,000,000 Shares of Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Up
to 10,000,000 Common Warrants to Purchase 10,000,000 Shares of Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Up
to 10,000,000 Pre-Funded Warrants to Purchase 10,000,000 Shares of Common Stock</B></FONT></P>

<P STYLE="text-indent: 20pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Up
to 10,000,000 Shares of Common Stock Underlying such Common Warrants and Pre-Funded Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Up
to 10,000,000 Shares of Common Stock Underlying Such Pre-Funded Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font: small-caps 10pt Times New Roman, Times, Serif"><B>Preliminary
Prospectus</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Lead
Placement Agent</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>A.G.P.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Co-Placement
Agent</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 14pt"><B>Brookline
Capital Markets</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
division of Arcadia Securities, LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2025</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PART
II</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INFORMATION
NOT REQUIRED IN PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
13. Other Expenses of Issuance and Distribution.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the expenses to be incurred in connection with the offering described in this registration statement, all
of which will be paid by the Company. All amounts are estimates except for the SEC registration fee and the Financial Industry Authority,
Inc. (FINRA) filing fee:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 80%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SEC
    registration fee</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,062</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINRA
    filing fee</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
    fees and expenses</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">175,000</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting
    fees and expenses</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,000</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Printing
    and related expenses</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miscellaneous</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35,000</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total
    expenses</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>$</B></FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>250,062</B></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
14. Indemnification of Directors and Officers.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is incorporated under the laws of the State of Delaware. Our Bylaws provide that we shall, to the maximum extent and in the manner
permitted by the DGCL, indemnify each of our directors and officers against expenses (including attorneys&rsquo; fees), judgments, fines,
settlements and other amounts actually and reasonably incurred in connection with any proceeding, arising by reason of the fact that
such person is or was an agent of the Company; provided, however, that the Company may modify the extent of such indemnification by individual
contracts with its directors and executive officers and, provided, further, that the Company shall not be required to indemnify any director
or officer in connection with any proceeding (or part thereof) initiated by such person unless (i) such indemnification is expressly
required to be made by law, (ii) the proceeding was authorized in advance by our board of directors, (iii) such indemnification is provided
by the Company, in its sole discretion, pursuant to the powers vested in the corporation under the DGCL or (iv) such indemnification
is required to be made pursuant to an individual contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
DGCL provides that a Delaware corporation has the power generally to indemnify its current and former directors, officers, employees
and other agents (each, a &ldquo;<U>corporation agent</U>&rdquo;) against expenses and liabilities, including amounts paid in settlement,
in connection with any proceeding involving such person by reason of his being a corporation agent, other than a proceeding by or in
the right of the corporation, if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed
to the best interests of the corporation and, with respect to any criminal proceeding, such person had no reasonable cause to believe
such person&rsquo;s conduct was unlawful.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the case of an action brought by or in the right of the corporation, indemnification of a corporation agent is permitted if such person
acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the corporation.
However, no indemnification is permitted in respect of any claim, issue or matter as to which such person shall have been adjudged to
be liable to the corporation, unless and only to the extent that the court in which such proceeding was brought shall determine upon
application that despite the adjudication of liability, but in view of all the circumstances of the case, such person is fairly and reasonably
entitled to such indemnification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent that a corporation agent has been successful on the merits or otherwise in the defense of such proceeding, whether or not
by or in the right of the corporation, or in the defense of any claim, issue or matter therein, the corporation is required to indemnify
such person for expenses in connection therewith. Under the DGCL, the corporation may advance expenses incurred by a corporation agent
in connection with a proceeding, provided that the corporation agent undertakes to repay such amount if it shall ultimately be determined
that such person is not entitled to indemnification. Our Bylaws require us to advance expenses to any director or officer entitled to
indemnification, provided that such person undertakes to repay the advancement if it is determined in a final judicial decision from
which there is no appeal that such person is not entitled to indemnification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 37; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
power to indemnify and advance the expenses under the DGCL does not exclude other rights to which a corporation agent may be entitled
to under our Certificate of Incorporation, Bylaws, agreement, vote of stockholders or disinterested directors or otherwise. Insofar as
indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling the Company
pursuant to the foregoing provisions, we have been informed that, in the opinion of the SEC, such indemnification is against public policy
as expressed in the Securities Act and is therefore unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Bylaws permit us to secure insurance on behalf of our directors, officers, employees and agents for any expense, liability or loss incurred
in such capacities, whether or not the Company would have the power to indemnify such person against such liability under the provisions
of the DGCL. We maintain general liability insurance that covers certain liabilities of our directors and officers arising out of claims
based on acts or omissions in their capacities as directors or officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of these provisions is to assist us in retaining qualified individuals to serve as our directors, officers, employees and agents
by limiting their exposure to personal liability for serving as such.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
15. Recent Sales of Unregistered Securities.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 30, 2024, we entered into a securities purchase agreement with certain institutional and other accredited investors, pursuant to
which we issued and sold 5,000,000 shares of our Common Stock in a registered direct offering and warrants to purchase 5,000,000
shares of Common Stock in a concurrent private placement, for a combined purchase price of $2.00 per share of Common Stock
and accompanying warrant. The closing of the private placement took place on August 1, 2024 and we received total gross proceeds of $10.0
million. H.C. Wainwright &amp; Co., LLC acted as the lead placement agent, and Brookline Capital Markets, a division of Arcadia Securities,
LLC, acted as co-placement agent for the registered direct offering and concurrent private placement. The placement agents were entitled
to fees equal to 7.0% of the gross proceeds from the registered direct offering and concurrent private placement. The sales and issuances
of securities in the transaction were not registered under the Securities Act in reliance upon the exemption from registration provided
by Section 4(a)(2) thereof or Regulation D promulgated thereunder. The recipients of the securities in each of these transactions represented
their intentions to acquire the securities for investment only and not with a view to or for sale in connection with any distribution
thereof, and appropriate legends were placed upon the stock certificates issued in these transactions. All recipients had adequate access,
through their relationships with us, to information about us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 7, 2023, we granted (i) an option to purchase 80,000 shares of the Common Stock with an exercise price of $0.88 per share
and (ii) a restricted stock award of 20,000 restricted shares to Dr. S&eacute;bastien Hazard, our then-Executive Vice President and Chief
Medical Officer, as an &ldquo;inducement&rdquo; grant pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules. On October 7, 2024, we
granted: (i) an inducement stock option to purchase 60,000 shares of the Common Stock with an exercise price of $1.02 per share to one
individual hired by the Company during the fourth quarter of 2024 and (ii) an inducement stock option to purchase 50,000 shares of the
Common Stock with an exercise price of $1.02 per share to Susan Eylward, our General Counsel, in each case as an &ldquo;inducement&rdquo;
grant pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules. On February 18, 2025, we granted an inducement stock option to purchase
100,000 shares of Common Stock with an exercise price of $0.862 to Dr. Douglas Faller, our Chief Medical Officer, as an &ldquo;inducement&rdquo;
grant pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules. The grants of these awards were exempt from registration under the Securities
Act, pursuant to Section 4(a)(2) thereof as a transaction by an issuer not involving a public offering.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
16. Exhibits and Financial Statement Schedules.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The exhibits set forth below have been or are being filed herewith and are numbered in accordance with Item 601 of Regulation S-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Financial statement schedules have been omitted, as the information required to be set forth therein is included in the consolidated
financial statements or notes thereto incorporated by reference into the prospectus forming part of this registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
    NO.</B></FONT></TD>
    <TD STYLE="width: 0.1in">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DESCRIPTION</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1+</FONT> </TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex1-1.htm">Form of Placement Agency Agreement.</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1*</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000143774914014489/ex2-1.htm" STYLE="-sec-extract: exhibit">Asset Purchase Agreement dated as of June 6, 2014, by and between Imunon, Inc. and EGEN, Inc., incorporated herein by reference to Exhibit 2.1 to the Quarterly Report on Form 10-Q of the Company for the quarter ended June 30, 2014 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315219004381/ex10-1.htm" STYLE="-sec-extract: exhibit">Amendment to Asset Purchase Agreement between Celsion Corporation and EGWU, Inc., dated March 28, 2019 incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company filed on April 1, 2019 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315223008888/ex3-1.htm" STYLE="-sec-extract: exhibit">Amended and Restated Certificate of Incorporation of Imunon, dated March 24, 2023, incorporated herein by reference to Exhibit 3.1 to the Current Report on Form 8-K of the Company filed on March 24, 2023 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315224010195/ex3-1.htm" STYLE="-sec-extract: exhibit">Amended and Restated Bylaws of the Company, effective on March 15, 2024, incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K of the Company, filed on March 18, 2024 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000143774917017965/ex_98287.htm" STYLE="-sec-extract: exhibit">Form of Representative&rsquo;s Common Stock Purchase Warrant, incorporated herein by reference to Exhibit 4.2 to the Current Report on Form 8-K of the Company, filed on October 31, 2017 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000143774917012481/ex4-4.htm" STYLE="-sec-extract: exhibit">Form of Placement Agent Common Stock Purchase Warrant incorporated herein by reference to Exhibit 4.4 to the Current Report on Form 8-K of the Company, filed on July 11, 2017 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315220017312/ex4-1.htm" STYLE="-sec-extract: exhibit">Form of Amended and Restated Warrant (issued under First Amendment of Venture Loan and Security Agreement, dated as of August 1, 2020, by and among Imunon, Inc., Horizon Funding I, LLC, Horizon Funding Trust 2019-1, and Horizon Technology Finance Corporation, as Collateral Agent), incorporated herein by reference to Exhibit 4.1 to the Current Report on Form 8-K of the Company, filed on September 4, 2020 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315220003910/ex4-1.htm" STYLE="-sec-extract: exhibit">Form of Exchange Warrant, incorporated herein by reference to Exhibit 4.1 to the Current Report on Form 8-K of the Company, filed on March 13, 2020 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315219007214/ex4-1.htm" STYLE="-sec-extract: exhibit">Warrant to purchase Shares of Common Stock of Celsion Corporation between Celsion Corporation and EGWU, Inc., dated March 28, 2019, incorporated herein by reference to Exhibit 4.1 to the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2019 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315224029697/ex4-1.htm" STYLE="-sec-extract: exhibit">Form of Warrant, incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K of the Company filed on July 31, 2024 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315225008460/ex4-7.htm" STYLE="-sec-extract: exhibit">Description of Securities of the Registrant, incorporated by reference to Exhibit 4.7 to the Annual Report on Form 10-K of the Company for the year ended December 31, 2024 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8+</FONT> </TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex4-8.htm">Form of Pre-Funded Warrant.</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9+</FONT> </TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex4-9.htm">Form of Common Stock Purchase Warrant.</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1+</FONT> </TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="ex5-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion of Thompson Hine LLP.</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1**</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000143774917009400/ex10-1.htm" STYLE="-sec-extract: exhibit">Imunon, Inc. 2007 Stock Incentive Plan, as amended, incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company, filed on May 16, 2017 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000143774917019215/ex_99691.htm" STYLE="-sec-extract: exhibit">Form Inducement Offer to Exercise Common Stock Purchase Warrants, incorporated herein by reference to Exhibit 10.3 to the Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2017 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3**</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000143774918010040/ex_114605.htm" STYLE="-sec-extract: exhibit">Imunon, Inc. 2018 Stock Incentive Plan, incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company filed May 15, 2018 (SEC File No. 001-15911).</A></FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4**
    </FONT></TD>
    <TD STYLE="width: 0.1in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315219007203/ex10-1.htm" STYLE="-sec-extract: exhibit">First Amendment to the Imunon, Inc. 2018 Stock Incentive Plan, incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company, filed on May 15, 2019 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5**</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315220011263/ex10-1.htm" STYLE="-sec-extract: exhibit">Second Amendment to the Imunon, Inc. 2018 Stock Incentive Plan, incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company, filed on June 16, 2020 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6**</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315221014023/ex10-1.htm" STYLE="-sec-extract: exhibit">Third Amendment to the Celsion Corporation 2018 Stock Incentive Plan, incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company, filed with the Commission on June 10, 2021 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7**</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315223021447/ex10-1.htm" STYLE="-sec-extract: exhibit">Imunon, Inc. 2018 Stock Incentive Plan, as amended as of June 14, 2023, incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company, filed with the Commission on June 15, 2023 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8**</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315224018795/ex10-1.htm" STYLE="-sec-extract: exhibit">Form of Incentive Stock Option Grant Agreement under the 2018 Stock Incentive Plan, incorporated herein by reference to Exhibit 10.1 to the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2024 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9**</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315224018795/ex10-2.htm" STYLE="-sec-extract: exhibit">Form of Restricted Stock Agreement under the 2018 Stock Incentive Plan, incorporated herein by reference to Exhibit 10.2 to the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2024 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10**</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315224034310/ex99-1.htm" STYLE="-sec-extract: exhibit">Form of Nonqualified Stock Option and Restricted Stock Grant Agreement for employment inducement awards, incorporated by reference to Exhibit 99.1 to the Company&rsquo;s Registration Statement on Form S-8 filed on August 29, 2024 (No. 333-281833).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11**</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000074964710000024/offerletter.htm" STYLE="-sec-extract: exhibit">Employment Offer Letter, entered into on June 15, 2010, between the Company and Jeffrey W. Church, incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company filed on June 18, 2010 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12**</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000143774915004805/ex10-27.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment Offer Letter effective as of June 2, 2014, between the Company and Khursheed Anwer incorporated herein by reference to Exhibit 10.27 to the Annual Report of the Company for the year ended December 31, 2014 (SEC File No. 001-15911).</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13**</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315222019765/ex10-2.htm" STYLE="-sec-extract: exhibit">Employment Agreement between the Company and Michael H. Tardugno, effective as of July 18, 2022, incorporated herein by reference to Exhibit 10.2 to the Current Report on Form 8-K of the Company filed with the Commission on July 19, 2022 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14**</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315222019765/ex10-1.htm" STYLE="-sec-extract: exhibit">Employment Agreement between the Company Corporation and Corinne Le Goff, effective as of July 18, 2022 incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company filed with the Commission on July 19, 2022 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15**</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000143774916041670/ex10-1.htm" STYLE="-sec-extract: exhibit">Amended and Restated Change in Control Agreement dated as of September 6, 2016, by and between the Company and Michael H. Tardugno, incorporated herein by reference to Exhibit 10.1 to the Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2016 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16**</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315224018166/ex10-1.htm" STYLE="-sec-extract: exhibit">Employment Agreement, dated as of May 3, 2024, between the Company and Stacy Lindborg, Ph.D., incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company filed on May 8, 2024 (SEC File No. 001-15911).</A></FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17**</FONT></TD>
    <TD STYLE="width: 0.1in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315224020543/ex10-1.htm" STYLE="-sec-extract: exhibit">Retirement and Consulting Agreement, dated May 17, 2024, between Imunon, Inc. and Jeffrey Church, incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company filed on May 20, 2024 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.18**</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315224020543/ex10-2.htm" STYLE="-sec-extract: exhibit">Consulting Agreement, dated April 15, 2024, by and between Imunon, Inc. and Monomoy Advisors, LLC incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K of the Company filed on May 20, 2024 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.19**</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315224039646/ex10-1.htm" STYLE="-sec-extract: exhibit">Offer Letter of Employment, dated October 2, 2024, between Imunon, Inc. and Susan Eylward, incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company filed on October 7, 2024 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.20**</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315224043931/ex10-5.htm" STYLE="-sec-extract: exhibit">Separation Agreement, dated August 9, 2024 by and between the Company and S&eacute;bastien Hazard, M.D., incorporated by reference to Exhibit 10.5 to the Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2024 (SEC file No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.21</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000074964711000106/exhibit99_1.htm" STYLE="-sec-extract: exhibit">Lease Agreement, executed July 21, 2011, by and between Imunon, Inc. and Brandywine Operating Partnership, L.P., incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company filed on July 25, 2011 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.22</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000143774917019215/ex_99690.htm" STYLE="-sec-extract: exhibit">First Amendment to Lease Agreement, executed April 20, 2017, by and between Imunon, Inc. and Lenox Drive Office Park, LLC, incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 10-Q of the Company filed on November 14, 2017 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.23</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315219007214/ex10-1.htm" STYLE="-sec-extract: exhibit">Second Amendment to Lease Agreement, dated January 9, 2019, by and between Celsion Corporation and Lenox Drive Office Park, LLC, successor in interest to Brandywine Operating Partnership, L.P., incorporated herein by reference to Exhibit 10-Q to the Current Report on Form 10-Q of the Company for the quarter ended March 31, 2019 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.24</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000143774918009535/ex_113795.htm" STYLE="-sec-extract: exhibit">Lease Agreement dated January 15, 2018, by and between Imunon, Inc. and HudsonAlpha Institute of Biotechnology for office and lab space located in Huntsville, Alabama incorporated herein by reference to Exhibit 10.1 to the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2018 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.25</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315220011263/ex10-2.htm" STYLE="-sec-extract: exhibit">Settlement Agreement and Release, by and between the plaintiff to the shareholder action captioned O&rsquo;Connor v. Braun, et al., N.J. Super., Dkt. No. MERC-00068-19, William J. O&rsquo;Connor, derivatively on behalf of Imunon, Inc. and individually on behalf of himself and all other similarly situated stockholders of Imunon, Inc. and defendants, incorporated herein by reference to Exhibit 10.2 to the Current Report on Form 8-K of the Company, filed on June 16, 2020 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.26</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315220003910/ex10-1.htm" STYLE="-sec-extract: exhibit">Form of Exercise Agreement, incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company, filed on March 13, 2020 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.27</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315222015061/ex10-1.htm" STYLE="-sec-extract: exhibit">At the Market Offering Agreement, dated May 25, 2022 by and between Celsion Corporation and H.C. Wainwright &amp; Co. LLC, incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company, filed on May 25, 2022, (SEC File NO. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.28</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315224019876/ex1-3.htm" STYLE="-sec-extract: exhibit">Amendment No. 1, dated May 15, 2024, to At the Market Offering Agreement, by and between Imunon, Inc. and H.C. Wainwright &amp; Co. LLC, incorporated by reference to Exhibit 1.3 to the Company&rsquo;s Registration Statement on Form S-3 (No. 333-279425) filed on May 15, 2024.</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.29</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315224029697/ex10-1.htm" STYLE="-sec-extract: exhibit">Form of Securities Purchase Agreement, dated as of July 30, 2024, by and among the Company and each purchaser party thereto, incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of the Company, filed on July 31, 2024 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.30+</FONT> </TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex10-30.htm">Form of Securities Purchase Agreement.</A></FONT></TD></TR>
</TABLE>
<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</FONT></TD>
    <TD STYLE="width: 0.1in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/749647/000149315225008460/ex21-1.htm" STYLE="-sec-extract: exhibit">Subsidiaries of Imunon, Inc., incorporated by reference to Exhibit 21.1 to the Annual Report on Form 10-K of the Company for the year ended December 31, 2024 (SEC File No. 001-15911).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1+</FONT> </TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex23-1.htm">Consent of WithumSmith+Brown, PC, independent registered public accounting firm for the Company.</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2+</FONT> </TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="ex5-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Thompson Hine LLP (included in Exhibit 5.1).</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1+</FONT> </TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#Aa_018">Power of Attorney (included on signature page hereto).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">107+</FONT> </TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex107.htm">Filing Fee Table.</A></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Portions
    of this exhibit have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act
    of 1934, amended, and the omitted material has been separately filed with the Securities and Exchange Commission.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
    contract or compensatory plan or arrangement.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">+</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
    herewith.</FONT> </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
17. Undertakings.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned registrant hereby undertakes:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
To include any prospectus required by Section 10(a)(3) of the Securities Act;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration
statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities
offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range
may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and
price represent no more than 20% change in the maximum aggregate offering price set forth in the &ldquo;Calculation of Registration Fee&rdquo;
table in the effective registration statement; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or
any material change to such information in the registration statement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>provided,
however,</I> that paragraphs (1)(i), (1)(ii) and (1)(iii) above do not apply if the information required to be included in a post-effective
amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the registrant pursuant to Section 13 or
Section 15(d) of the Exchange Act that are incorporated by reference in the registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be
a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed
to be the initial bona fide offering thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the
termination of the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
That, for the purpose of determining liability under the Securities Act to any purchaser, each prospectus filed pursuant to Rule 424(b)
as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses
filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used
after effectiveness; provided, however, that no statement made in a registration statement or prospectus that is part of the registration
statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is
part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify
any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such
document immediately prior to such date of first use.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)
That, for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution
of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant
to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities
are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to
the purchaser and will be considered to offer or sell such securities to such purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule
    424;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by
    the undersigned registrant;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant
    or its securities provided by or on behalf of the undersigned registrant; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)
The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of
the registrant&rsquo;s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing
of an employee benefit plan&rsquo;s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in
the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering
of such securities at that time shall be deemed to be the initial bona fide offering thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)
For purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed
as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant
to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time
it was declared effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)
For the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of
prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of
the registrant pursuant to the indemnification provisions described herein, or otherwise, the registrant has been advised that in the
opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.
In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred
or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is
asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless
in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the
question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final
adjudication of such issue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act, the Registrant has duly caused this registration statement to be signed on its behalf by the
undersigned, thereunto duly authorized, in the City of Lawrenceville, State of New Jersey, on April 4, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IMUNON,
    INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Stacy R. Lindborg</I></FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stacy
    R. Lindborg, Ph.D.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
    and Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="Aa_018"></A>POWER
OF ATTORNEY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">KNOW
ALL BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Stacy Lindborg, David Gaiero, and Susan
Eylward and each of them, as his or her true and lawful attorneys-in-fact and agents, each with the full power of substitution and resubstitution,
for him or her and in his or her name, place or stead, in any and all capacities, to (i) act on, sign and file with the Securities and
Exchange Commission any and all amendments (including post-effective amendments) to this registration statement together with all schedules
and exhibits thereto and any subsequent registration statement filed pursuant to Rule 462(b) under the Securities Act, together with
all schedules and exhibits thereto, (ii) act on, sign and file such certificates, instruments, agreements and other documents as may
be necessary or appropriate in connection therewith, (iii) act on and file any supplement to any prospectus included in this registration
statement or any such amendment or any subsequent registration statement filed pursuant to Rule 462(b) under the Securities Act, and
(iv) take any and all actions which may be necessary or appropriate to be done, as fully for all intents and purposes as he or she might
or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his substitute or substitutes, may
lawfully do or cause to be done by virtue hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act, this registration statement has been signed by the following persons in the capacities and
on the dates indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 24%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 48%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Position</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 24%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Stacy R. Lindborg</I></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President,
    Chief Executive Officer and</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    4, 2025</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stacy
    R. Lindborg, Ph.D.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
    (Principal Executive Officer)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    David Gaiero</I></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 4,</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2025</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    Gaiero</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Financial and Accounting Officer) </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Michael H. Tardugno</I></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Chairman and Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 4,</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2025</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    H. Tardugno</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Frederick J. Fritz</I></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 4,</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2025</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Frederick
    J. Fritz</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    James E. Dentzer</I></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 4,</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2025</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">James
    E. Dentzer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Donald Braun</I></FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 4,</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2025</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Donald
    Braun, Ph.D.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <I>/s/ Christine Pellizzari</I> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 4,</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2025</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christine
    Pellizzari, J.D.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 44; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ex1-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
1.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[___],
2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Imunon,
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Stacy R. Lindborg</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">997
Lenox Drive, Suite 100</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lawrenceville,
NJ 08648</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Re:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Placement Agency
    Agreement</U></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Dr. Lindborg:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the terms and conditions of this letter agreement (the &ldquo;<B>Agreement</B>&rdquo;) between A.G.P./Alliance Global Partners, as
lead placement agent (&ldquo;<B>A.G.P.</B>&rdquo;), Brookline Capital Markets, a division of Arcadia Securities, LLC, as a co-placement
agent (&ldquo;<B>Brookline</B>,&rdquo; and together with A.G.P., the &ldquo;<B>Placement Agents</B>&rdquo;), and Imunon, Inc., a Delaware
corporation (the &ldquo;<B>Company</B>&rdquo;), the parties hereby agree that the Placement Agents shall serve as the placement agents
for the Company, on a &ldquo;reasonable best efforts&rdquo; basis, in connection with the proposed offering (the &ldquo;<B>Placement</B>&rdquo;)
of securities of the Company, consisting of: (i) shares of common stock, par value $0.01 per share (&ldquo;<B>Common Stock</B>&rdquo;),
(ii) pre-funded warrants to purchase Common Stock (the &ldquo;<B>Pre-Funded Warrants</B>&rdquo;), and (iii) warrants to purchase Common
Stock (the &ldquo;<B>Common Warrants</B>&rdquo; and collectively with the Pre-Funded Warrants, the &ldquo;<B>Warrants</B>&rdquo;). The
Common Stock and Warrants actually sold by the Placement Agents are referred to herein as the &ldquo;<B>Placement Agent Securities</B>.&rdquo;
The Placement Agent Securities and shares of Common Stock issuable upon the exercise of the Warrants shall be offered and sold under
the Company&rsquo;s registration statement on Form S-1 (File No. [_]), which was declared effective by the Securities and Exchange Commission
(the &ldquo;<B>Commission</B>&rdquo;) on [___], 2025. This agreement (this &ldquo;<B>Agreement</B>&rdquo;), together with the other documents
executed and delivered by the Company and/or the Purchasers (as defined below) in connection with the Placement, including, without limitation,
a securities purchase agreement (the &ldquo;<B>Purchase Agreement</B>&rdquo;), shall be collectively referred to herein as the &ldquo;<B>Transaction
Documents</B>.&rdquo; The terms of the Placement shall be mutually agreed upon by the Company and the purchasers party to the Purchase
Agreement (each, a &ldquo;<B>Purchaser</B>&rdquo; and collectively, the &ldquo;<B>Purchasers</B>&rdquo;), and nothing herein constitutes
that the Placement Agents would have the power or authority to bind the Company or any Purchaser, or an obligation for the Company to
issue any Placement Agent Securities or complete the Placement. The Company expressly acknowledges and agrees that the Placement Agents&rsquo;
obligations hereunder are on a reasonable best-efforts basis only and that the execution of this Agreement does not constitute a commitment
by the Placement Agents to purchase the Placement Agent Securities and does not ensure the successful placement of the Placement Agent
Securities or any portion thereof or the success of the Placement Agent with respect to securing any other financing on behalf of the
Company. The Placement Agents may retain other brokers or dealers to act as sub-agents or selected dealers on its behalf in connection
with the Placement. Certain affiliates of the Placement Agents may participate in the Placement by purchasing some of the Placement Agent
Securities. The sale of Placement Agent Securities to any Purchaser will be evidenced by the Purchase Agreement between the Company and
such Purchaser, in a form reasonably acceptable to the Company and the Purchaser; provided, that, at a Purchaser&rsquo;s option, Purchasers
who do not enter into a securities purchase agreement shall rely solely on the Preliminary Prospectus and the Prospectus in connection
with the purchase of securities in the offering. Capitalized terms that are not otherwise defined herein have the meanings given to such
terms in the Purchase Agreement. Prior to the signing of any Purchase Agreement, officers of the Company will be available to answer
inquiries from prospective Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
1. REPRESENTATIONS AND WARRANTIES OF THE COMPANY; COVENANTS OF THE COMPANY</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Representations
    of the Company</U>. With respect to the Placement Agent Securities, each of the representations and warranties (together with any
    related disclosure schedules thereto) and covenants made by the Company to the Purchasers in the Purchase Agreement in connection
    with the Placement, is hereby incorporated herein by reference into this Agreement (as though fully restated herein) and is, as of
    the date of this Agreement and as of the Closing Date, hereby made to, and in favor of, the Placement Agents. In addition to the
    foregoing, the Company represents and warrants that there are no affiliations with any Financial Industry Regulatory Authority (&ldquo;<B>FINRA</B>&rdquo;)
    member firm participating in the Placement among the Company&rsquo;s officers, directors or, to the knowledge of the Company, any
    five percent (5.0%) or greater stockholder of the Company.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Covenants
    of the Company</U>. The Company covenants and agrees to continue to retain (i) a firm of Public Company Accounting Oversight Board
    independent registered public accountants for a period of at least two (2) years after the Closing Date and (ii) a reputable transfer
    agent for a period of two (2) years after the Closing Date, provided the Company is then subject to the reporting requirement of
    the Exchange Act (as defined below). Furthermore, for forty-five (45) days after the Closing Date, the Company shall not,
    without the prior written consent of the Placement Agents, (i) issue, enter into any agreement to issue or announce the issuance
    or proposed issuance of any shares of Common Stock or (ii) file any registration statement or amendment or supplement thereto, other
    than the Preliminary Prospectus, the Prospectus or a registration statement on Form S-8 in connection with any employee benefit plan;
    provided, however, such restrictions shall not apply with respect to an Exempt Issuance. In addition, for ninety (90) days
    after the Closing Date, the Company shall not effect or enter into an agreement to effect any issuance of Common Stock or Common
    Stock Equivalents involving a Variable Rate Transaction (as defined in the Purchase Agreement), except such restriction shall not
    apply with respect to an Exempt Issuance. For the avoidance of doubt, a Variable Rate Transaction shall not include any at-the-market
    offering of the Company&rsquo;s Common Stock, and sales under any at-the-market offering may commence starting on the sixty-first
    (61st) day following the Closing Date.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
2. REPRESENTATIONS OF THE PLACEMENT AGENTS</U>. Each of the Placement Agents represents and warrants that it (i) is a member in good
standing of the FINRA, (ii) is a registered broker/dealer under the Securities Exchange Act of 1934, as amended (the &ldquo;<B>Exchange
Act</B>&rdquo;), (iii) is licensed as a broker/dealer under the laws of the United States of America, applicable to the offers and sales
of the Placement Agent Securities by the Placement Agents, (iv) is validly existing under the laws of its place of organization or incorporation,
and (v) has full power and authority to enter into and perform its obligations under this Agreement. Each Placement Agent will immediately
notify the Company in writing of any change in its status with respect to subsections (i) through (v) above. Each Placement Agent covenants
that it will use its reasonable best efforts to conduct the Placement hereunder in compliance with the provisions of this Agreement and
the requirements of applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
3. COMPENSATION</U>. In consideration of the services to be provided for hereunder, the Company shall pay to A.G.P and/or their respective
designees a cash fee of seven percent (7.0%) of the aggregate purchase price paid by any and all Purchasers at the Closing (the &ldquo;<B>Cash
Fee</B>&rdquo;). A.G.P will retain Brookline as a co-placement agent for an offering hereunder for up to 15.0% of the Cash Fee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
4. EXPENSES</U>. The Company agrees to pay all costs, fees and expenses incurred by the Company in connection with the performance of
its obligations hereunder and in connection with the transactions contemplated hereby, including, without limitation: (i) all expenses
incident to the issuance, delivery and qualification of the Placement Agent Securities (including all printing and engraving costs);
(ii) all fees and expenses of the transfer agent; (iii) all necessary issue, transfer and other stamp taxes in connection with the issuance
and sale of the Placement Agent Securities other than any transfer taxes payable upon the assignment of Warrants by their holders pursuant
to the terms of the Warrants; (iv) all fees and expenses of the Company&rsquo;s counsel, independent public or certified public accountants
and other advisors; (v) all costs and expenses incurred in connection with the preparation, printing, filing, shipping and distribution
of the Registration Statement (including financial statements, exhibits, schedules, consents and certificates of experts), the Preliminary
Prospectus and the Prospectus, and all amendments and supplements thereto, and this Agreement; (vi) all filing fees, reasonable attorneys&rsquo;
fees and expenses incurred by the Company in connection with qualifying or registering (or obtaining exemptions from the qualification
or registration of) all or any part of the Placement Agent Securities for offer and sale under the state securities or blue sky laws
or the securities laws of any other country; (vii) the fees and expenses associated with including the Placement Agent Securities on
the Trading Market; (viii) up to $75,000 for accountable expenses related to legal fees of counsel to the Placement Agents; and (ix)
non-accountable expenses, including IPREO software related expenses, background check expenses, tombstones and marketing related expenses,
including road show expenses, and any other non-accountable expenses incurred by the Placement Agents in connection with the Placement,
provided, however, that such reimbursement for non-accountable expenses shall not exceed $20,000. The Placement Agents reserve the right
to reduce any item of compensation or adjust the terms thereof as specified herein in the event that a determination shall be made by
FINRA to the effect that the Placement Agents&rsquo; aggregate compensation is in excess of FINRA Rules or that the terms thereof require
adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
5. INDEMNIFICATION</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    the extent permitted by law, with respect to the Placement Agent Securities, the Company shall indemnify and hold harmless the Placement
    Agents and their affiliates, agents, stockholders, directors, officers, employees, members and controlling persons (within the meaning
    of Section 15 of the Securities Act or Section 20 of the Exchange Act) (each such entity or person, an &ldquo;<B>Indemnified Person</B>&rdquo;)
    from and against all claims, actions, suits, proceedings (including those of stockholders), damages, costs and liabilities (collectively,
    &ldquo;<B>Claims</B>&rdquo;), and shall reimburse each Indemnified Person for all reasonable fees and expenses (including the reasonable
    fees and expenses of counsel) (collectively, the &ldquo;<B>Expenses</B>&rdquo;) as they are incurred by an Indemnified Person in
    investigating, preparing, pursuing or defending any Claim that is caused by, arises out of, or is based upon (i) any untrue statements
    made or any statements omitted to be made in the Registration Statement, the Preliminary Prospectus or the Prospectus, or by any
    omission or alleged omission to state therein a material fact necessary to make the statements therein, in light of the circumstances
    under which they were made, not misleading (other than untrue statements or alleged untrue statements in, or omissions or alleged
    omissions from, information relating to an Indemnified Person furnished in writing by or on behalf of such Indemnified Person for
    use in the Registration Statement, Preliminary Prospectus or any Prospectus) or (ii) any other actions taken or omitted to be taken
    by the Company or any Indemnified Person in connection with this Agreement; provided, however, the Company will not be responsible
    for any Claims or Expenses of any Indemnified Person that are judicially determined to have resulted primarily from such Indemnified
    Person&rsquo;s (x) willful misconduct, violation of law or gross negligence in connection with any of the action, inaction or the
    services described herein, or (y) use of any offering materials or information concerning the Company in connection with the offer
    or sale of the Placement Agent Securities in the Placement, which were not authorized for such use by the Company and which use constitutes
    gross negligence, violation of law or willful misconduct.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promptly
    after receipt by the Placement Agents of notice of any Claim or the commencement of any action or proceeding with respect to which
    any Indemnified Person is entitled to indemnity hereunder, the Placement Agents will notify the Company in writing of such Claim
    or of the commencement of such action or proceeding, but failure to so notify the Company shall not relieve the Company from any
    obligation it may have hereunder, except and only to the extent such failure results in the forfeiture by the Company of substantial
    rights and defenses. If the Company so elects or is requested by the Placement Agents, the Company will assume the defense of such
    action or proceeding and will employ counsel reasonably satisfactory to the Placement Agents and will pay the fees and expenses of
    such counsel. Notwithstanding the preceding sentence, the Placement Agents will be entitled to employ their own counsel separate
    from counsel for the Company and from any other party in such action if counsel for the Placement Agents reasonably determine that
    they would be inappropriate under the applicable rules of professional responsibility for the same counsel to represent both the
    Company and the Placement Agents. In such event, the reasonable fees and disbursements of no more than one such separate counsel
    will be paid by the Company, in addition to fees of local counsel.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company may not settle, compromise or consent to the entry of any judgment in any pending or threatened Claim, in which indemnification
    may be sought hereunder (whether or not any Indemnified Person is an actual or potential party thereto), without the prior written
    consent of the Placement Agents (which will not be unreasonably delayed or withheld) unless such settlement, compromise or consent
    provides for an unconditional and irrevocable release of each Indemnified Person from any and all liability arising out of such Claim.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company agrees to notify the Placement Agents promptly of the assertion against either of them or any other person of any Claim or
    the commencement of any action or proceeding relating to a transaction contemplated by this Agreement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    for any reason the foregoing indemnity is unavailable to the Placement Agents or insufficient to hold the Placement Agents harmless,
    then the Company shall contribute to the amount paid or payable by the Placement Agents as a result of such Claim or Expenses in
    such proportion as is appropriate to reflect (a) the relative benefits to the Company on the one hand, and the Placement Agents on
    the other hand, in connection with the Placement, (b) the relative fault of the parties, and (c) other equitable considerations;
    provided, however, that in no event shall the amount to be contributed by the Placement Agents exceed the fees actually received
    by the Placement Agents under this Agreement. Notwithstanding the immediately preceding sentence, to the extent the exception to
    indemnification contemplated by Paragraph A of this Section applies with respect to the Placement Agent, the Company shall contribute
    to the amount paid or payable by the Placement Agent as a result of such Claim or Expenses in such proportion as is appropriate to
    reflect the relative fault of the Company, on the one hand, and the Placement Agent, on the other hand, in connection with the matters
    contemplated by the Agreement; provided, however, that in no event shall the amount to be contributed by the Placement Agent exceed
    the fees actually received by the Placement Agent under the Agreement. The Company agrees that for the purposes of this paragraph,
    the relative benefits to the Company and the Placement Agents of the contemplated transaction (whether or not such transaction is
    consummated) shall be deemed to be in the same proportion that the aggregate cash consideration payable (or contemplated to be payable)
    in such transaction bears to the fees paid or payable to the Placement Agents under the Agreement.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
    indemnification provisions shall remain in full force and effect whether or not the transaction contemplated by this Agreement is
    completed, survive the termination of this Agreement, and be in addition to any liability that the Company might otherwise have to
    any Indemnified Person.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
6. ENGAGEMENT TERM</U>. The Placement Agents&rsquo; engagement hereunder will be until the earlier of the Closing Date and May 13, 2025.
The date of termination of this Agreement is referred to herein as the &ldquo;<B>Termination Date</B>.&rdquo; In the event, however,
in the course of the Placement Agents&rsquo; performance of due diligence they deem it necessary to terminate the engagement, the Placement
Agents may do so prior to the Termination Date. The Company may elect to terminate the engagement hereunder for any reason prior to the
Termination Date but will remain responsible for fees pursuant to Section 3 hereof with respect to the Placement Agent Securities, if
sold in the Placement. Notwithstanding anything to the contrary contained herein, the provisions concerning the Company&rsquo;s obligation
to pay any fees actually earned pursuant to Section 3 hereof and the provisions concerning confidentiality, indemnification and contribution
contained herein, as well as provisions in Sections 10 &ndash; 14 hereof will survive any expiration or termination of this Agreement.
If this Agreement is terminated prior to the completion of the Placement, all fees and expenses due to the Placement Agents as set forth
in Section 3 and Section 4 (except for the $20,000 non-accountable expense allowance) shall be paid by the Company to the Placement Agents
on or before the Termination Date (in the event such fees are earned or owed as of the Termination Date). The Placement Agents agree
not to use any confidential information concerning the Company provided to the Placement Agents by the Company for any purposes other
than those contemplated under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
7. PLACEMENT AGENT INFORMATION</U>. The Company agrees that any information or advice rendered by the Placement Agents in connection
with this engagement is for the confidential use of the Company only in its evaluation of the Placement and, except as otherwise required
by law, the Company will not disclose or otherwise refer to the advice or information in any manner without the Placement Agents&rsquo;
prior written consent (which will not be unreasonably delayed or withheld).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
8. NO FIDUCIARY RELATIONSHIP</U>. This Agreement does not create, and shall not be construed as creating rights enforceable by any person
or entity not a party hereto, except those entitled hereto by virtue of the indemnification provisions hereof. The Company acknowledges
and agrees that the Placement Agents are not and shall not be construed as fiduciaries of the Company and shall have no duties or liabilities
to the equity holders or the creditors of the Company or any other person by virtue of this Agreement or the retention of the Placement
Agents hereunder, all of which are hereby expressly waived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
9. CLOSING</U>. The obligations of the Placement Agents, and the closing of the sale of the Placement Agent Securities hereunder are
subject to the accuracy, when made and on the Closing Date, of the representations and warranties on the part of the Company contained
herein and in the Purchase Agreement, to the performance by the Company of its obligations hereunder, and to each of the following additional
terms and conditions, except as otherwise disclosed to and acknowledged and waived by the Placement Agents:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    corporate proceedings and other legal matters incident to the authorization, form, execution, delivery and validity of each of this
    Agreement, the Placement Agent Securities, and all other legal matters relating to this Agreement and the transactions contemplated
    hereby with respect to the Placement Agent Securities shall be reasonably satisfactory in all material respects to the Placement
    Agents.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Placement Agents shall have received from Company Counsel such counsel&rsquo;s written opinion and negative assurance letter with
    respect to the Placement Agent Securities, addressed to the Placement Agents and dated as of the Closing Date, in form and substance
    reasonably satisfactory to the Placement Agents.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Placement Agents shall have received an executed Lock-Up Agreements from the Company&rsquo;s executive officers and directors.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    of Common Stock sold in the Placement, including shares of Common Stock issuable upon the exercise of the Warrants, must be registered
    under the Exchange Act. The Company shall have taken no action designed to, or likely to have the effect of, terminating the registration
    of the Common Stock under the Exchange Act or delisting or suspending from trading the Common Stock from the Trading Market or other
    applicable U.S. national exchange, nor shall the Company have received any information suggesting that the Commission or the Trading
    Market or other U.S. applicable national exchange is contemplating terminating such registration or listing, except as disclosed
    in the Registration Statement, the Preliminary Prospectus and the Prospectus.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    action shall have been taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any governmental
    agency or body which would, as of the Closing Date, prevent the issuance or sale of the Placement Agent Securities or materially
    and adversely affect or potentially and adversely affect the business or operations of the Company; and no injunction, restraining
    order or order of any other nature by any federal or state court of competent jurisdiction shall have been issued as of the Closing
    Date which would prevent the issuance or sale of the Placement Agent Securities or materially and adversely affect or potentially
    and adversely affect the business or operations of the Company.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company shall have entered into a Purchase Agreement with each of the Purchasers who elect to purchase the Placement Agent Securities
    through the Purchase Agreement (and not by reliance on the Preliminary Prospectus or Prospectus), and such agreements shall be in
    full force and effect and shall contain representations, warranties and covenants of the Company as agreed upon between the Company
    and the Purchasers.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">G.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINRA
    shall have raised no objection to the fairness and reasonableness of the terms and arrangements of this Agreement. In addition, the
    Company shall, if requested by the Placement Agents, make or authorize Placement Agents&rsquo; counsel to make on the Company&rsquo;s
    behalf, any filing with the FINRA Corporate Financing Department pursuant to FINRA Rule 5110 with respect to the Placement and pay
    all filing fees required in connection therewith.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Placement Agents shall have received a customary &ldquo;comfort&rdquo; letter from Withum Smith + Brown, PC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Placement Agents shall have received customary certificates of the Company&rsquo;s executive officers, as to the accuracy of the
    representations and warranties contained in the Purchase Agreement, and a certificate of the Company&rsquo;s secretary certifying
    (i) that the Company&rsquo;s charter documents are true and complete, have not been modified and are in full force and effect; (ii)
    that the resolutions of the Company&rsquo;s Board of Directors relating to the Placement are in full force and effect and have not
    been modified; and (iii) as to the incumbency of the officers of the Company.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the conditions specified in this Section 9 shall not have been fulfilled when and as required by this Agreement, all obligations
of the Placement Agents hereunder may be cancelled by the Placement Agents at, or at any time prior to, the Closing Date. Notice of such
cancellation shall be given to the Company in writing or orally. Any such oral notice shall be confirmed promptly thereafter in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
10. GOVERNING LAW</U>. This Agreement will be governed by, and construed in accordance with, the laws of the State of New York applicable
to agreements made and to be performed entirely in such State, without regard to principles of conflicts of law. This Agreement may not
be assigned by either party without the prior written consent of the other party. This Agreement shall be binding upon and inure to the
benefit of the parties hereto, and their respective successors and permitted assigns. Any right to trial by jury with respect to any
dispute arising under this Agreement or any transaction or conduct in connection herewith is waived. Any dispute arising under this Agreement
may be brought into the courts of the State of New York or into the Federal Court located in New York, New York and, by execution and
delivery of this Agreement, the Company hereby accepts for itself and in respect of its property, generally and unconditionally, the
jurisdiction of aforesaid courts. Each party hereto hereby irrevocably waives personal service of process and consents to process being
served in any such suit, action or proceeding by delivering a copy thereof via overnight delivery (with evidence of delivery) to such
party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
manner permitted by law. If either party shall commence an action or proceeding to enforce any provisions of this Agreement, then the
prevailing party in such action or proceeding shall be reimbursed by the other party for its attorney&rsquo;s fees and other costs and
expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
11. ENTIRE AGREEMENT/MISCELLANEOUS</U>. This Agreement embodies the entire agreement and understanding between the parties hereto, and
supersedes all prior agreements and understandings, relating to the subject matter hereof. If any provision of this Agreement is determined
to be invalid or unenforceable in any respect, such determination will not affect such provision in any other respect or any other provision
of this Agreement, which will remain in full force and effect. This Agreement may not be amended or otherwise modified or waived except
by an instrument in writing signed by both the Placement Agents and the Company. The representations, warranties, agreements and covenants
contained herein shall survive the Closing Date of the Placement and delivery of the Placement Agent Securities for the applicable statutes
of limitations. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one
and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party,
it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission
or a .pdf format file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature
is executed) with the same force and effect as if such facsimile or .pdf signature page were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
12. NOTICES</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in
writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is sent
to the email address specified on the signature pages attached hereto prior to 6:30 p.m. (New York City time) on a business day, (b)
the next business day after the date of transmission, if such notice or communication is sent to the email address on the signature pages
attached hereto on a day that is not a business day or later than 6:30 p.m. (New York City time) on any business day, (c) the third (3<SUP>rd</SUP>)
business day following the date of mailing, if sent by an internationally recognized air courier service, or (d) upon actual receipt
by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the
signature pages hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
13. PRESS ANNOUNCEMENTS</U>. The Company agrees that the Placement Agents shall, on and after the Closing Date, have the right to reference
the Placement and the Placement Agents&rsquo; role in connection therewith in the Placement Agents&rsquo; marketing materials and on
its website and to place advertisements in financial and other newspapers and journals, in each case at its own expense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
14. PAYMENTS</U>. All payments made or deemed to be made by the Company to the Placement Agents, its affiliates, stockholders, directors,
officers, employees, members and controlling persons (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange
Act) (each, a &ldquo;<B>Payee</B>&rdquo;), if any, will be made without withholding or deduction for or on account of any present or
future taxes, duties, assessments or governmental charges of whatever nature (other than taxes on net income or similar taxes) imposed
or levied by or on behalf of the United States or any political subdivision or any taxing authority thereof or therein unless the Company
is or becomes required by law to withhold or deduct such taxes, duties, assessments or other governmental charges. In such event, the
Company will pay such additional amounts as will result, after such withholding or deduction, in the receipt by the Payee of the amounts
that would otherwise have been receivable in respect thereof. For the avoidance of doubt, all sums payable, paid or deemed payable under
this Agreement shall be considered exclusive of value added tax, sales tax or other similar taxes which shall be borne by, paid, collected
and remitted by the Company in accordance with applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
confirm that the foregoing correctly sets forth our agreement by signing and returning to the Placement Agents the enclosed copy of this
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[The
remainder of this page has been intentionally left blank.]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing Agreement is hereby accepted and agreed to as of the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A.G.P./ALLIANCE
    GLOBAL PARTNERS</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thomas
    J. Higgins</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Managing
    Director</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
for Notice</U>:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">590
    Madison Avenue, 28th Floor</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    York, NY 10022</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
    Thomas J. Higgins</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
    [***]</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Tmes New Roman, Times, Serif; font-size: 10pt"><B>BROOKLINE CAPITAL MARKETS</B></FONT></P>
                                                                     <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A Division of Arcadia Securities, LLC </B></FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp; </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
    for Notice</U>:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">600
    Lexington Avenue, 30th Floor</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    York, NY 10022</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
    [_]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
    [***]</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accepted
and agreed to as of the date first written above:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IMUNON,
    INC. </B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stacy
    R. Lindborg</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
    and Chief Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
    for Notice</U>:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">997
    Lenox Drive, Suite 100</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lawrenceville,
    NJ 08648</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
    Stacy R. Lindborg</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
    [***]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signature
Page to Placement Agent Agreement]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.8
<SEQUENCE>3
<FILENAME>ex4-8.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.8</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PRE-FUNDED
WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TO
PURCHASE SHARES OF COMMON STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IMUNON,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: _________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Original
    Exercise Date: [__], 2025</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
PRE-FUNDED WARRANT TO PURCHASE SHARES OF COMMON STOCK (this &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, [_____________]
or its assigns (the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions
hereinafter set forth, at any time on or after the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) until this Warrant is
exercised in full (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from <B>IMUNON, INC.</B>,
a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to [______] shares of Common Stock, par value $0.01 per share (the &ldquo;<U>Common
Stock</U>&rdquo;), of the Company (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;). The purchase price of
one Warrant Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities
Purchase Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated [___], 2025, among the Company and the purchasers signatory thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile
copy or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form attached hereto as <U>Exhibit A</U>
(the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising
the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver
the unpaid portion of the aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer
or cashier&rsquo;s check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified
in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other
type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder
shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available
hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation
within three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this
Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering
the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased.
The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The
Company shall deliver any objection to any Notice of Exercise within one (1) Business Day of receipt of such notice. Notwithstanding
the foregoing, with respect to any Notice(s) of Exercise delivered on or prior to 12:00 p.m. (New York City time) on the Initial Exercise
Date, which may be delivered at any time after the time of execution of the Purchase Agreement, the Company agrees to deliver, or cause
to be delivered, the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise Date, and the
Initial Exercise Date shall be the Warrant Share Delivery Date (as defined below) for purposes hereunder, provided that payment of the
aggregate Exercise Price (other than in the case of a cashless exercise) is received by such Warrant Share Delivery Date. <B>The
Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following
the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given
time may be less than the amount stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the avoidance of doubt, there is no circumstance that would require the Company to net cash settle the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Exercise Price</U>. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share,
was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the
nominal exercise price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise
of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise
price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to
the Termination Date. The remaining unpaid exercise price per Warrant Share under this Warrant shall be $0.0001, subject to adjustment
hereunder (the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Cashless Exercise</U>. Notwithstanding anything to the contrary set forth herein, if at the time of exercise hereof there is no effective
registration statement registering, or the prospectus contained therein is not available for the issuance of the Warrant Shares to the
Holder, then this Warrant may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which
the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=
    as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice
    of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed
    and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined
    in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder,
    either (x) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (y) the Bid Price of
    the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of
    the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading
    hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of
    &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable
    Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered
    pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=
    the Exercise Price of this Warrant, as adjusted hereunder; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=
    the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if
    such exercise were by means of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not
to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock as of the time in question (or the nearest preceding
date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from
9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the OTCQB Venture Market (&ldquo;<U>OTCQB</U>&rdquo;) or the
OTCQX Best Market (&ldquo;<U>OTCQX</U>&rdquo;) is not a Trading Market, the VWAP of the Common Stock for such date (or the nearest preceding
date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices
for the Common Stock are then reported on The Pink Open Market, operated by the OTC Markets Group Inc. (the &ldquo;<U>Pink Market</U>&rdquo;)
(or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of Common
Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the
Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Mechanics of Exercise</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to, or resale
of the Warrant Shares by, the Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery
of the Warrant Shares, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of
Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise
by the date that is the earliest of (i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise, (ii) one (1)
Trading Day after delivery of the aggregate Exercise Price to the Company, and (iii) the number of Trading Days comprising the Standard
Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;);
provided that payment of the aggregate Exercise Price (other than in the instance of a cashless exercise) is received by the Company
by such date. Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder
of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant
Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the
earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of
the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise
by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each
$1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise),
$10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after the Warrant Share Delivery Date) for each Trading
Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees
to maintain a registrar (which may be the Transfer Agent) that is a participant in the FAST program so long as this Warrant remains outstanding
and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a
number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery
of the Notice of Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date (subject to receipt of the aggregate exercise
price for the applicable exercise (other than in the case of a cashless exercise)), and if after such date the Holder is required by
its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases shares of Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise
of Warrants with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding
sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts
payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein
shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation,
a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common
Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
<U>Charges, Taxes and Expenses</U>. The issuance and delivery of Warrant Shares shall be made without charge to the Holder for any issue
or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall
be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed
by the Holder; provided, however, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder,
this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto as <U>Exhibit B</U> duly executed
by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax
incidental thereto, and this Warrant shall be surrendered to the Company and, if any portion of this Warrant remains unexercised, a new
Warrant in the form hereof shall be delivered by the Company to the assignee. The Company shall pay all Transfer Agent fees required
for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation
performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the
right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with (i) the Holder&rsquo;s Affiliates, (ii) any
other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates, and (iii) any other Persons whose beneficial
ownership of shares of Common Stock would or could be aggregated with the Holder&rsquo;s for the purposes of Section 13(d) (such Persons,
&ldquo;<U>Attribution Parties</U>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).
For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and
Attribution Parties shall include the number of Warrant Shares issuable upon exercise of this Warrant with respect to which such determination
is being made, but shall exclude the number of Warrant Shares which would be issuable upon (i) exercise of the remaining, nonexercised
portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion
of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock
Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the
Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e),
beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance
with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith.
To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in
relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant
is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation,
and the Company shall have no obligation to verify or confirm the accuracy of such determination and shall have no liability for exercises
of this Warrant that are not in compliance with the Beneficial Ownership Limitation, except to the extent the Holder has detrimentally
relied on the number of outstanding shares of Common Stock that was provided in writing by the Company. In addition, a determination
as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and
regulations promulgated thereunder, and the Company shall have no obligation to verify or confirm the accuracy of such determination
and shall have no liability for exercises of this Warrant that are not in compliance with the Beneficial Ownership Limitation, except
to the extent the Holder relies on the number of outstanding shares of Common Stock that was provided by the Company. For purposes of
this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares
of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Securities and Exchange
Commission (the &ldquo;<U>Commission</U>&rdquo;), as the case may be, (B) a more recent public announcement by the Company or (C) a more
recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written
or oral request of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number of shares
of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect
to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties
since the date as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;
shall be [4.99/9.99]% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of the Warrant
Shares issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership
Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number
of shares of Common Stock outstanding immediately after giving effect to the issuance of Warrant Shares upon exercise of this Warrant
held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation
will not be effective until the 61st day after such notice is delivered to the Company. The provisions of this paragraph shall be construed
and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any
portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make
changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph
shall apply to a successor holder of this Warrant. If the Warrant is unexercisable as a result of the Holder&rsquo;s Beneficial Ownership
Limitation, no alternate consideration is owing to the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any Warrant Shares issued by the Company upon exercise of this Warrant),
(ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock
split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of Common Stock
any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator
shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which
the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable
upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant remains unchanged.
Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders
entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision,
combination or reclassification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>[RESERVED]</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time that the Warrant is
outstanding the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other
property pro rata to all of the record holders of any class of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder
will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could
have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without
regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the
date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as
of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided,
however, that, to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial
ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall
be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial
Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to all of the holders of stock of Common Stock, by way of return of
capital or otherwise (including, without limitation, any distribution of cash, shares or other securities, property or options by way
of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided,
however, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in
the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person and the Company is not the surviving
entity, (ii) the Company (or any Subsidiary), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance
or other disposition of all or substantially all of the Company&rsquo;s assets in one or a series of related transactions, (iii) any,
direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to
which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been
accepted by the holders of greater than 50% of the outstanding Common Stock or greater than 50% of the voting power of the common equity
of the Company, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization
or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted
into or exchanged for other securities, cash or property (other than a stock split), or (v) the Company, directly or indirectly, in one
or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation,
a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other
Person or group acquires greater than 50% of the outstanding shares of Common Stock or greater than 50% of the voting power of the common
equity of the Company, (each, a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the
Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to
the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the
exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is
the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result
of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately
prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes
of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration
based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and
the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value
of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash
or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in
a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all
of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section
3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder prior to such Fundamental Transaction
and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced
by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of
shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable
upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction,
and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative
value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number
of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately
prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder.
Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from
and after the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring to the
&ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume
all of the obligations of the Company under this Warrant and the other Transaction Documents with the same effect as if such Successor
Entity had been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions
of this Section 3(e) regardless of (i) whether the Company has sufficient authorized Common Stock for the issuance of Warrant Shares
and/or (ii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>[RESERVED]</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share of Common
Stock, as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as
of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting
adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment; provided, however,
that the Company may satisfy this notice requirement in this Section 3(h) by filing such notice with the Commission pursuant to a Current
Report on Form 8-K or Quarterly or Annual Report.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company declares a dividend (or any other distribution in whatever form other than
a stock split) on the shares of Common Stock, (B) the Company declares a special nonrecurring cash dividend on, or a redemption of, the
shares of Common Stock, (C) the Company authorizes the granting to all holders of the shares of Common Stock rights or warrants to subscribe
for or purchase any shares of capital stock of any class or of any rights (excluding any granting or issuance of rights to all of the
Company&rsquo;s stockholders pursuant to a stockholder rights plan), (D) the approval of any stockholders of the Company is required
in connection with a Fundamental Transaction, or (E) the Company authorizes the voluntary or involuntary dissolution, liquidation or
winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder
at its last facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least 4 calendar days prior
to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for
the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the
holders of Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined
or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective
or close, and the date as of which it is expected that holders of Common Stock of record shall be entitled to exchange their shares of
Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or
share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the
validity of the corporate action required to be specified in such notice and provided, further that no notice shall be required if the
information is disseminated in a press release or document filed with the Commission. To the extent that any notice provided in this
Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall
simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise
this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except
as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Voluntary Adjustment By the Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during
the term of this Warrant, subject to the prior written consent of the Holders of a majority of the Warrant Shares, reduce the then current
Exercise Price to any amount and for any period of time deemed appropriate by the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Transferability</U>. This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable,
in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written
assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient
to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not
so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the
Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of
this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Currency</U>. Unless otherwise indicated, all dollar amounts referred to in this Warrant are in United States Dollars (&ldquo;<U>U.S.
Dollars</U>&rdquo;). All amounts owing under this Warrant shall be paid in U.S. Dollars. All amounts denominated in other currencies
shall be converted in the U.S. Dollar equivalent amount in accordance with the Exchange Rate on the date of calculation. &ldquo;<U>Exchange
Rate</U>&rdquo; means, in relation to any amount of currency to be converted into U.S. Dollars pursuant to this Warrant, the U.S. Dollar
exchange rate as published in the Wall Street Journal (NY edition) on the relevant date of calculation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be
required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding Trading
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Authorized Shares</U>. The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized
and unissued shares of Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares underlying this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued and delivered, as provided herein without
violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed.
The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant
will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be
duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect
of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any shares of Common Stock above the amount payable therefor upon such
exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that
the Company may validly and legally issue fully paid and nonassessable shares of Common Stock upon the exercise of this Warrant and (iii)
use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having
jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
if the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state, federal or foreign securities
laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. No provision of this Warrant
shall be construed as a waiver by the Holder of any rights which the Holder may have under the federal securities laws and the rules
and regulations of the Commission thereunder. Without limiting any other provision of this Warrant or the Purchase Agreement, if the
Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder,
the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to,
reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant
hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any shares of Common Stock or as a stockholder of the Company, whether such liability is asserted
by the Company or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and
the Holders of a majority of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Signature
Page Follows)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IMUNON,
    INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stacy
    R. Lindborg</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
    and Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO:
<B>IMUNON, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
    OF HOLDER]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Investing Entity:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
    of Authorized Signatory of Investing Entity</I>:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Authorized Signatory:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of Authorized Signatory:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSIGNMENT
FORM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.9
<SEQUENCE>4
<FILENAME>ex4-9.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.9</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WARRANT
TO PURCHASE SHARES OF COMMON STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IMUNON,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: [________]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    Exercise Date: [__], 2025</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
    Date: [__], 2025</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
WARRANT TO PURCHASE SHARES OF COMMON STOCK (this &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, [_____________] or
its assigns (the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions
hereinafter set forth, at any time on or after the [Stockholder Approval Date]<SUP>1</SUP> (the &ldquo;<U>Initial Exercise Date</U>&rdquo;)
and on or prior to 5:00 pm (New York City time) on the [fifth (5<SUP>th</SUP>) anniversary of the Initial Exercise Date] (the &ldquo;<U>Termination
Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from <B>IMUNON, INC.</B>, a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;),
up to [______] shares of Common Stock, par value $0.01 per share (the &ldquo;<U>Common Stock</U>&rdquo;), of the Company (as subject
to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;). The purchase price of one Warrant Share under this Warrant shall be
equal to the Exercise Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities
Purchase Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated [___], 2025, among the Company and the purchasers signatory thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[(a)
&ldquo;Stockholder Approval&rdquo; means such approval as may be required by the applicable rules and regulations of The Nasdaq Stock
Market LLC (or any successor entity) from the stockholders of the Company with respect to the issuance of all of the Warrants and the
Warrant Shares upon the exercise thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
&ldquo;Stockholder Approval Date&rdquo; means the date on which Stockholder Approval is received and deemed effective under Delaware
law<SUP>2</SUP>.]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile
copy or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form attached hereto as <U>Exhibit A</U>
(the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising
the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver
the aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s
check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable
Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee
or notarization) of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and
the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within
three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant
resulting in purchases of a portion of the total number of Warrant Shares purchasable hereunder shall have the effect of lowering the
outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The
Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company
shall deliver any objection to any Notice of Exercise within one (1) Business Day of receipt of such notice. <B>The Holder and any assignee,
by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a
portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less
than the amount stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the avoidance of doubt, there is no circumstance that would require the Company to net cash settle the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt; width: 25%"><DIV STYLE="margin: 0pt; font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1
</SUP>Replace bracketed language with &ldquo;the date hereof&rdquo; if and only if (A) the Per Share Purchase Price (as defined
in the Purchase Agreement) equals or exceeds the sum of (a) the applicable &ldquo;Minimum Price&rdquo; per share under Nasdaq listing
rule 5635(d) plus (b) $0.125 per whole Warrant Share; or (B) the offering is a discounted offering where the pricing and discount (including
attributing a value of $0.125 per whole Warrant Share) meet the pricing requirements under Nasdaq&rsquo;s listing rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>2
</SUP>Stockholder Approval concept to be removed if warrants are immediately exercisable.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Exercise Price</U>. The exercise price of this Warrant, shall be $[&bull;] per share, subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Cashless Exercise</U>. Notwithstanding anything to the contrary set forth herein, if at the time of exercise hereof there is no effective
registration statement registering, or the prospectus contained therein is not available for the issuance of the Warrant Shares to the
Holder, then this Warrant may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which
the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=
    as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice
    of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed
    and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined
    in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder,
    either (x) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (y) the Bid Price of
    the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of
    the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading
    hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of
    &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable
    Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered
    pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=
    the Exercise Price of this Warrant, as adjusted hereunder; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=
    the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if
    such exercise were by means of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not
to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant
to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock as of the time in question (or the nearest preceding
date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from
9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the OTCQB Venture Market (&ldquo;<U>OTCQB</U>&rdquo;) or the
OTCQX Best Market (&ldquo;<U>OTCQX</U>&rdquo;) is not a Trading Market, the VWAP of the Common Stock for such date (or the nearest preceding
date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices
for the Common Stock are then reported on The Pink Open Market, operated by the OTC Markets Group Inc. (the &ldquo;<U>Pink Market</U>&rdquo;)
(or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of Common
Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the
Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Mechanics of Exercise</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to, or resale
of the Warrant Shares by, the Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery
of the Warrant Shares, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of
Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise
by the date that is the earliest of (i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise, (ii) one (1)
Trading Day after delivery of the aggregate Exercise Price to the Company, and (iii) the number of Trading Days comprising the Standard
Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;);
provided that payment of the aggregate Exercise Price (other than in the instance of a cashless exercise) is received by the Company
by such date. Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder
of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant
Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the
earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of
the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise
by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each
$1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise),
$10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after the Warrant Share Delivery Date) for each Trading
Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees
to maintain a registrar (which may be the Transfer Agent) that is a participant in the FAST program so long as this Warrant remains outstanding
and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a
number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery
of the Notice of Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date (subject to receipt of the aggregate exercise
price for the applicable exercise (other than in the case of a cashless exercise)), and if after such date the Holder is required by
its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases shares of Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise
of Warrants with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding
sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts
payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein
shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation,
a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common
Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
<U>Charges, Taxes and Expenses</U>. The issuance and delivery of Warrant Shares shall be made without charge to the Holder for any issue
or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall
be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed
by the Holder; provided, however, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder,
this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto as <U>Exhibit B</U> duly executed
by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax
incidental thereto, and this Warrant shall be surrendered to the Company and, if any portion of this Warrant remains unexercised, a new
Warrant in the form hereof shall be delivered by the Company to the assignee. The Company shall pay all Transfer Agent fees required
for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation
performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the
right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with (i) the Holder&rsquo;s Affiliates, (ii) any
other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates, and (iii) any other Persons whose beneficial
ownership of shares of Common Stock would or could be aggregated with the Holder&rsquo;s for the purposes of Section 13(d) (such Persons,
&ldquo;<U>Attribution Parties</U>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).
For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and
Attribution Parties shall include the number of Warrant Shares issuable upon exercise of this Warrant with respect to which such determination
is being made, but shall exclude the number of Warrant Shares which would be issuable upon (i) exercise of the remaining, nonexercised
portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion
of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock
Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the
Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e),
beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance
with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith.
To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in
relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant
is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation,
and the Company shall have no obligation to verify or confirm the accuracy of such determination and shall have no liability for exercises
of this Warrant that are not in compliance with the Beneficial Ownership Limitation, except to the extent the Holder has detrimentally
relied on the number of outstanding shares of Common Stock that was provided in writing by the Company. In addition, a determination
as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and
regulations promulgated thereunder, and the Company shall have no obligation to verify or confirm the accuracy of such determination
and shall have no liability for exercises of this Warrant that are not in compliance with the Beneficial Ownership Limitation, except
to the extent the Holder relies on the number of outstanding shares of Common Stock that was provided by the Company. For purposes of
this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares
of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Securities and Exchange
Commission (the &ldquo;<U>Commission</U>&rdquo;), as the case may be, (B) a more recent public announcement by the Company or (C) a more
recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written
or oral request of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number of shares
of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect
to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties
since the date as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;
shall be [4.99%/9.99%] of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of the Warrant
Shares issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership
Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number
of shares of Common Stock outstanding immediately after giving effect to the issuance of Warrant Shares upon exercise of this Warrant
held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation
will not be effective until the 61st day after such notice is delivered to the Company. The provisions of this paragraph shall be construed
and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any
portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make
changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph
shall apply to a successor holder of this Warrant. If the Warrant is unexercisable as a result of the Holder&rsquo;s Beneficial Ownership
Limitation, no alternate consideration is owing to the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any Warrant Shares issued by the Company upon exercise of this Warrant),
(ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock
split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of Common Stock
any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator
shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which
the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable
upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant remains unchanged.
Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders
entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision,
combination or reclassification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>[RESERVED]</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time that the Warrant is
outstanding the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other
property pro rata to all of the record holders of any class of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder
will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could
have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without
regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the
date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as
of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided,
however, that, to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial
ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall
be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial
Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to all of the holders of stock of Common Stock, by way of return of
capital or otherwise (including, without limitation, any distribution of cash, shares or other securities, property or options by way
of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided,
however, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in
the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person and the Company is not the surviving
entity, (ii) the Company (or any Subsidiary), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance
or other disposition of all or substantially all of the Company&rsquo;s assets in one or a series of related transactions, (iii) any,
direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to
which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been
accepted by the holders of greater than 50% of the outstanding Common Stock or greater than 50% of the voting power of the common equity
of the Company, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization
or recapitalization of shares of Common Stock or any compulsory share exchange pursuant to which the shares of Common Stock are effectively
converted into or exchanged for other securities, cash or property (other than a stock split), or (v) the Company, directly or indirectly,
in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby
such other Person or group acquires greater than 50% of the outstanding shares of Common Stock or greater than 50% of the voting power
of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this
Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately
prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e)
on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if
it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a
result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately
prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes
of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration
based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and
the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value
of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash
or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the
event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable
at any time concurrently with, or within thirty (30) days after, the consummation of the Fundamental Transaction (or, if later, the date
of the public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder,
as described below, an amount of consideration equal to the Black Scholes Value (as defined below) of the remaining unexercised portion
of this Warrant on the date of consummation of such Fundamental Transaction, <I>provided</I>, however, that, if the Fundamental Transaction
is not within the Company&rsquo;s control, including not approved by the Company&rsquo;s Board of Directors, the Holder shall only be
entitled to receive from the Company or any Successor Entity as of the date of consummation of such Fundamental Transaction the same
type or form of consideration (and in the same proportion), valued at the Black Scholes Value of the unexercised portion of this Warrant,
that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction, whether
that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given the choice
to receive from among alternative forms of consideration in connection with the Fundamental Transaction; <I>provided</I> further, that
if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction, such holders of
Common Stock will be deemed to have received shares of the Successor Entity (which Successor Entity may be the Company following such
Fundamental Transaction) in such Fundamental Transaction and a Holder shall receive shares of the Successor Entity in the amount of the
Black Scholes Value. &ldquo;Black Scholes Value&rdquo; means the value of this Warrant based on the Black-Scholes Option Pricing Model
obtained from the &ldquo;OV&rdquo; function on Bloomberg determined as of the day of consummation of the applicable Fundamental Transaction
for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time
between the date of the public announcement of the applicable contemplated Fundamental Transaction and the Termination Date, (B) an expected
volatility equal to the 100 day volatility obtained from the HVT function on Bloomberg (determined utilizing a 365-day annualization
factor) as of the Trading Day immediately following the public announcement of the applicable Fundamental Transaction, (C) the underlying
price per share used in such calculation shall be the greater of (i) the sum of the price per share being offered in cash, if any, plus
the value of any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii) the greater of (x) the last VWAP
immediately prior to the public announcement of such Fundamental Transaction and (y) the last VWAP immediately prior to the consummation
of such Fundamental Transaction, (D) a remaining option time equal to the time between the date of the public announcement of the applicable
Fundamental Transaction and the Termination Date, and (E) a zero cost of borrow. In the event of a cash payment in connection with a
Fundamental Transaction, the payment of the Black Scholes Value will be made by wire transfer of immediately available funds within five
Trading Days of the Holder&rsquo;s election (or, if later, on the effective date of the Fundamental Transaction). The Company shall cause
any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;)
to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with
the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder prior
to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security
of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable
for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common
Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior
to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock
(but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such
shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic
value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in
form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and
be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction
Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right and power
of the Company and shall assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the
same effect as if such Successor Entity had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>[RESERVED]</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share of Common
Stock, as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as
of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting
adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment; provided, however,
that the Company may satisfy this notice requirement in this Section 3(h) by filing such notice with the Commission pursuant to a Current
Report on Form 8-K or Quarterly or Annual Report.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company declares a dividend (or any other distribution in whatever form other than
a stock split) on the shares of Common Stock, (B) the Company declares a special nonrecurring cash dividend on, or a redemption of, the
shares of Common Stock, (C) the Company authorizes the granting to all holders of the shares of Common Stock rights or warrants to subscribe
for or purchase any shares of capital stock of any class or of any rights (excluding any granting or issuance of rights to all of the
Company&rsquo;s stockholders pursuant to a stockholder rights plan), (D) the approval of any stockholders of the Company is required
in connection with a Fundamental Transaction, or (E) the Company authorizes the voluntary or involuntary dissolution, liquidation or
winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder
at its last facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least four (4) calendar
days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be
taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as
of which the holders of Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to
be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to
become effective or close, and the date as of which it is expected that holders of the shares of Common Stock of record shall be entitled
to exchange their shares of Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation,
merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof
shall not affect the validity of the corporate action required to be specified in such notice and provided, further that no notice shall
be required if the information is disseminated in a press release or document filed with the Commission. To the extent that any notice
provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries,
the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain
entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering
such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Voluntary Adjustment By the Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during
the term of this Warrant, subject to the prior written consent of the Holders of a majority of the Warrant Shares, reduce the then current
Exercise Price to any amount and for any period of time deemed appropriate by the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Transferability</U>. This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable,
in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written
assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient
to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not
so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the
Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of
this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Currency</U>. Unless otherwise indicated, all dollar amounts referred to in this Warrant are in United States Dollars (&ldquo;<U>U.S.
Dollars</U>&rdquo;). All amounts owing under this Warrant shall be paid in U.S. Dollars. All amounts denominated in other currencies
shall be converted in the U.S. Dollar equivalent amount in accordance with the Exchange Rate on the date of calculation. &ldquo;<U>Exchange
Rate</U>&rdquo; means, in relation to any amount of currency to be converted into U.S. Dollars pursuant to this Warrant, the U.S. Dollar
exchange rate as published in the Wall Street Journal (NY edition) on the relevant date of calculation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be
required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding Trading
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Authorized Shares</U>. The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized
and unissued shares of Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares underlying this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued and delivered, as provided herein without
violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed.
The Company covenants that all Warrant Shares underlying this Warrant which may be issued upon the exercise of the purchase rights represented
by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance
herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the
Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any shares of Common Stock above the amount payable therefor upon such
exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that
the Company may validly and legally issue fully paid and nonassessable shares of Common Stock upon the exercise of this Warrant and (iii)
use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having
jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
if the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state, federal or foreign securities
laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. No provision of this Warrant
shall be construed as a waiver by the Holder of any rights which the Holder may have under the federal securities laws and the rules
and regulations of the Commission thereunder. Without limiting any other provision of this Warrant or the Purchase Agreement, if the
Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder,
the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to,
reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant
hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any shares of Common Stock or as a stockholder of the Company, whether such liability is asserted
by the Company or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and
the Holders of a majority of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Signature
Page Follows)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IMUNON,
    INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stacy
    R. Lindborg</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
    and Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO:
<B>IMUNON, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
    OF HOLDER]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Investing Entity:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
    of Authorized Signatory of Investing Entity</I>:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Authorized Signatory:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of Authorized Signatory:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSIGNMENT
FORM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>5
<FILENAME>ex5-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex5-1_001.jpg" ALT="" STYLE="height: 62px; width: 670px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
4,</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Imunon,
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">997
Lenox Drive, Suite 100</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lawrenceville,
New Jersey 08648</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Re:</B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registration Statement on Form S-1</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have acted as counsel for Imunon, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), in connection with the preparation
and filing of a Registration Statement on Form S-1 (the &ldquo;<U>Registration Statement</U>&rdquo;), including a related prospectus
filed with the Registration Statement (the <U>&ldquo;Prospectus</U>&rdquo;), with the U.S. Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;)
pursuant to the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), covering an offering of (i) up to 10,000,000
shares (the &ldquo;<U>Shares</U>&rdquo;) of the Company&rsquo;s common stock, par value $0.01 per share (the &ldquo;<U>Common Stock</U>&rdquo;),
(ii) common warrants (the &ldquo;<U>Common Warrants</U>&rdquo;) to purchase up to 10,000,000 shares of Common Stock (&ldquo;<U>Common
Warrant Shares</U>&rdquo;), and (iii) pre-funded warrants (the &ldquo;<U>Pre-Funded Warrants</U>&rdquo; and, together with the Common
Warrants, the &ldquo;<U>Warrants</U>&rdquo;) to purchase up to 10,000,000 shares of Common Stock (together with the Common Warrant
Shares, the &ldquo;<U>Warrant Shares</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with this opinion, we have examined originals or copies (certified or otherwise identified to our satisfaction) of (i) the
Company&rsquo;s Amended and Restated Certificate of Incorporation, (ii) the Company&rsquo;s Amended and Restated Bylaws, (iii) the Registration
Statement and the Prospectus, (iv) the form of Common Warrant, (v) the form of Pre-Funded Warrant, and (vi) such corporate records, agreements,
documents, and other instruments, and such certificates or comparable documents of public officials or of officers and representatives
of the Company, as we have deemed relevant and necessary as a basis for the opinion hereinafter set forth.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
such examination, we have assumed the genuineness of all signatures, the legal capacity of all natural persons, the authenticity of all
documents submitted to us as originals, the conformity to original documents of all documents submitted to us as certified, conformed
or photostatic copies, and the authenticity of the originals of such latter documents. As to certain questions of fact material to this
opinion, we have relied upon certificates or comparable documents of officers and representatives of the Company and have not sought
to independently verify such facts. For purposes of the opinion set forth in subsection (iii) in the following paragraph, we have assumed
that, before the Warrant Shares are issued, the Company will not issue shares of Common Stock or reduce the total number of shares of
Common Stock that the Company is authorized to issue under its then-effective certificate of incorporation such that the number of unissued
shares of Common Stock authorized under the certificate of incorporation is less than the aggregate number of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the foregoing, and subject to the assumptions, limitations and qualifications stated herein, we are of the opinion that (i) the Shares,
when duly issued and sold by the Company as contemplated in the Registration Statement and the Prospectus, will be validly issued, fully
paid, and non-assessable, (ii) the Warrants, when duly issued and sold by Company as contemplated in the Registration Statement and the
Prospectus, will constitute the legal, valid, and binding obligations of the Company, enforceable against the Company in accordance with
their terms, and (iii) the Warrant Shares have been duly authorized and, when issued upon the due exercise of the Warrants, will be validly
issued, fully paid, and non-assessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex5-1_002.jpg" ALT="" STYLE="height: 71px; width: 670px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex5-1_003.jpg" ALT="" STYLE="height: 61px; width: 670px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
opinion expressed herein is limited to the General Corporation Law of the State of Delaware and, with respect to the enforceability of
the Warrants, the laws of the State of New York, and we express no opinion as to the effect on the matters covered by this opinion of
the laws of any other jurisdiction. We express no opinion as to (a) any provision for liquidated damages, default interest, late charges,
monetary penalties, make-whole premiums or other economic remedies to the extent such provisions are deemed to constitute a penalty,
(b) consents to, or restrictions upon, governing law, jurisdiction, venue, arbitration, remedies or judicial relief, (c) waivers of rights
or defenses, (d) any provision requiring the payment of attorneys&rsquo; fees, where such payment is contrary to law or public policy,
(e) the creation, validity, attachment, perfection or priority of any lien or security interest, (f) advance waivers of claims, defenses,
rights granted by law or notice, opportunity for hearing, evidentiary requirements, statutes of limitation, trial by jury or at law or
other procedural rights, (g) waivers of broadly or vaguely stated rights, (h) provisions for exclusivity, election or cumulation of rights
or remedies, (i) provisions authorizing or validating conclusive or discretionary determinations, (j) grants of setoff rights, (k) proxies,
powers and trusts, (l) provisions prohibiting, restricting or requiring consent to assignment or transfer of any right or property and
(m) the severability, if invalid, of provisions to the foregoing effect. Our opinions set forth above are subject to bankruptcy, insolvency,
fraudulent transfer, reorganization, moratorium and other similar laws of general application affecting the rights and remedies of creditors
and to general principles of equity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
opinion letter is expressly limited to the matters set forth above, and we render no opinion, whether by implication or otherwise, as
to any other matters relating to the Company, the Registration Statement or the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hereby consent to being named in the Registration Statement and in the Prospectus under the caption &ldquo;Legal Matters&rdquo; and to
the use of this opinion for filing with said Registration Statement as Exhibit 5.1 thereto. In giving this consent, we do not hereby
admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended,
or the rules and regulations of the Commission promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
truly yours,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
Thompson Hine LLP</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thompson
Hine LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex5-1_004.jpg" ALT="" STYLE="height: 1px; width: 670px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.30
<SEQUENCE>6
<FILENAME>ex10-30.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><B>Exhibit 10.30</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>SECURITIES PURCHASE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">This Securities Purchase Agreement
(this &ldquo;<U>Agreement</U>&rdquo;) is dated as of [____], 2025, between Imunon, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;),
and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a &ldquo;<U>Purchaser</U>&rdquo;
and collectively the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, subject to the terms
and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act (as defined below),
the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company,
securities of the Company as more fully described in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, IN CONSIDERATION
of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are
hereby acknowledged, the Company and each Purchaser agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>ARTICLE I.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>DEFINITIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">1.1 <U>Definitions</U>. In addition to the terms defined
elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings set forth in this Section 1.1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Acquiring Person</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Action</U>&rdquo; shall
have the meaning ascribed to such term in Section 3.1(j).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>A.G.P.</U>&rdquo; means
A.G.P./Alliance Global Partners.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board of Directors</U>&rdquo;
means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Brookline</U>&rdquo;
means Brookline Capital Markets, LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business Day</U>&rdquo;
means any day other than Saturday, Sunday, or other day on which banking institutions in the State of New York are authorized or required
by law to remain closed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing</U>&rdquo; means
the closing of the purchase and sale of the Shares and Warrants pursuant to Section 2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing Date</U>&rdquo;
means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties thereto, and
all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount at the Closing and (ii) the Company&rsquo;s
obligations to deliver the Shares and Warrants, in each case, at the Closing have been satisfied or waived, but in no event later than
the first (1st) Trading Day following the date hereof if this Agreement is entered into before 4:00 p.m. Eastern time on a Trading Day,
or not later than the second (2<SUP>nd</SUP>)Trading Day following the date hereof, if this Agreement is entered at or after 4:00 p.m.
Eastern time on a Trading day or on a day that is not a Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common Stock</U>&rdquo;
means common stock of the Company, par value $0.01 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common Stock Equivalents</U>&rdquo;
means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including,
without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable
or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common Warrants</U>&rdquo;
means, collectively, the Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance with Section 2.2(a) hereof,
in substantially the form of Exhibit A attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company Counsel</U>&rdquo;
means Thompson Hine LLP, with offices located at 3900 Key Center, 127 Public Square, Cleveland, Ohio 44114.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure Schedules</U>&rdquo;
means the Disclosure Schedules of the Company delivered concurrently herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure Time</U>&rdquo;
means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and before midnight
(New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the date hereof, unless
otherwise instructed as to an earlier time by the Placement Agents, and (ii) if this Agreement is signed between midnight (New York City
time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time) on the date hereof, unless otherwise
instructed as to an earlier time by the Placement Agents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>DVP</U>&rdquo; shall
have the meaning ascribed to such term in Section 2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Evaluation Date</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange Act</U>&rdquo;
means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exempt Issuance</U>&rdquo;
means the issuance of (a) shares of Common Stock, restricted stock units, options or other equity awards to employees, consultants, officers,
or directors of the Company pursuant to any share or option plan in existence as of the date hereof or subsequently approved by a vote
of the stockholders of the Company, (b) shares of Common Stock upon the exercise or exchange of or conversion of any Securities issued
hereunder and other securities exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the
date of this Agreement, provided that such securities have not been amended since the date of this Agreement to increase the number of
such securities or to decrease the exercise price, exchange price or conversion price of such securities (other than in connection with
stock splits or combinations) or to extend the term (but not, for purposes of clarity, the exercise period of stock options) of such securities,
(c) securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors of the
Company, provided that such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry no registration
rights that require or permit the filing of any registration statement in connection therewith during the prohibition period in Section
4.10(a) herein, and provided that any such issuance shall only be to a Person (or to the equity holders of a Person) which is, itself
or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the Company and
shall provide to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which
the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing in
securities (for avoidance of doubt, securities issued to a venture arm of a strategic investor shall be deemed an &ldquo;Exempt Issuance&rdquo;),
(d) issuances of shares of Common Stock to consultants or vendors of the Company, provided that such securities are issued as &ldquo;restricted
securities&rdquo; (as defined in Rule 144) and carry no registration rights during the prohibition period in Section 4.10(a) herein; and
(e) issuances of shares of Common Stock to existing holders of the Company&rsquo;s securities in compliance with the terms of agreements
entered into with, or instruments issued to, such holders as of or prior to the date hereof, provided that such agreements regarding such
securities have not been amended since the date of this Agreement to increase the number of such securities or to decrease the exercise
price, exchange price or conversion price of such securities (other than in connection with stock splits or combinations) or to extend
the term of such securities, and provided further that such securities are issued as &ldquo;restricted securities&rdquo; (as defined in
Rule 144) and carry no registration rights during the prohibition period in Section 4.10(a) herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>FCPA</U>&rdquo; means
the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>GAAP</U>&rdquo; means
generally accepted accounting principles in the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(aa).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Intellectual Property
Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(p).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Liens</U>&rdquo; means
a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Lock-Up Agreement</U>&rdquo;
means the Lock-Up Agreement, dated as of the date hereof, signed by the directors and officers of the Company, in the form of <U>Exhibit
C</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material Adverse Effect</U>&rdquo;
shall have the meaning assigned to such term in Section 3.1(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material Permits</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(n).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Per Share Purchase Price</U>&rdquo;
equals $[___], subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions
of shares of Common Stock that occur between the date hereof and the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Per Pre-Funded Warrant
Purchase Price</U>&rdquo; equals $[___], subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations
and other similar transactions relating to shares of Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo; means
an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement Agents</U>&rdquo;
means each of A.G.P. and Brookline.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement Agent Counsel</U>&rdquo;
means Sullivan &amp; Worcester LLP, with offices located at 1251 Avenue of the Americas, 19<SUP>th</SUP> Floor, New York, New York 10020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Funded Warrants</U>&rdquo;
means, collectively, the pre-funded warrants delivered to the Purchasers at Closing in accordance with Section 2.2(a) hereof, which Pre-Funded
Warrants shall be exercisable immediately upon issuance and shall expire in accordance with the terms thereof, in the form of <U>Exhibit
B</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Preliminary Prospectus</U>&rdquo;
means any preliminary prospectus included in the Registration Statement, as originally filed or as part of any amendment thereto, or filed
with the Commission pursuant to Rule 424(a) of the rules and regulations of the Commission under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus</U>&rdquo;
means the final prospectus filed pursuant to Rule 424(b) under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Purchaser Party</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration Statement</U>&rdquo;
means the effective registration statement filed with the Commission on Form S-1 (File No. [*]), including all information, documents
and exhibits filed with or incorporated by reference into such registration statement, which registers the sale of the Securities and
includes any Rule 462(b) Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Required Approvals</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 144</U>&rdquo;
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 462(b) Registration
Statement</U>&rdquo; means any registration statement prepared by the Company registering additional Securities, which was filed with
the Commission on or prior to the date hereof and became automatically effective pursuant to Rule 462(b) promulgated by the Commission
pursuant to the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC Reports</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities</U>&rdquo;
means the Shares, the Warrants, and the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities Act</U>&rdquo;
means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Shares</U>&rdquo; means
the shares of Common Stock issued and issuable to each Purchaser pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Short Sales</U>&rdquo;
means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be deemed to include
locating and/or borrowing shares of Common Stock).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subscription Amount</U>&rdquo;
means, as to each Purchaser, the aggregate amount to be paid for Shares and Warrants, purchased hereunder as specified below such Purchaser&rsquo;s
name on the signature page of this Agreement and next to the heading &ldquo;Subscription Amount,&rdquo; in United States dollars and in
immediately available funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth on Schedule 3.1(a), and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading Day</U>&rdquo;
means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading Market</U>&rdquo;
means any of the following markets or exchanges on which the shares of Common Stock are listed or quoted for trading on the date in question:
the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, or the New York Stock Exchange
(or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transaction Documents</U>&rdquo;
means this Agreement, the Warrants, the Lock-Up Agreements and all exhibits and schedules thereto and hereto and any other documents or
agreements executed in connection with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer Agent</U>&rdquo;
means <FONT STYLE="background-color: white">Equiniti Trust Company, LLC. Equiniti Trust Company, LLC is located at 6201 15th Avenue, Brooklyn,
NY 11219. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Variable Rate Transaction</U>&rdquo;
shall have the meaning ascribed to such term in Section 4.10(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Common Warrants and the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant Shares</U>&rdquo;
means the shares of Common Stock issuable upon exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>ARTICLE II.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>PURCHASE AND SALE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">2.1 <U>Closing</U>. On the Closing Date, upon the
terms and subject to the conditions set forth herein, substantially concurrent with the execution and delivery of this Agreement by the
parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase, (i) the number of shares
of Common Stock set forth under the heading &ldquo;Subscription Amount&rdquo; on the Purchaser&rsquo;s signature page hereto, at the Per
Share Purchase Price, and (ii) Common Warrants exercisable for shares of Common Stock as calculated pursuant to Section 2.2(a); provided,
however, that, to the extent that a Purchaser determines, in its sole discretion, that such Purchaser (together with such Purchaser&rsquo;s
Affiliates, and any Person acting as a group together with such Purchaser or any of such Purchaser&rsquo;s Affiliates) would beneficially
own in excess of the Beneficial Ownership Limitation, or as such Purchaser may otherwise choose, in lieu of purchasing shares of Common
Stock, such Purchaser may elect to purchase Pre-Funded Warrants in lieu of shares of Common Stock in such manner to result in the full
Subscription Amount being paid by such Purchaser to the Company. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99%
(or, at the election of the Purchaser, 9.99%) of the number of shares of Common Stock, in each case, outstanding immediately after giving
effect to the issuance of the Securities on the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">Each Purchaser&rsquo;s Subscription
Amount as set forth on the signature page hereto executed by such Purchaser shall be made available for Delivery Versus Payment (&ldquo;<U>DVP</U>&rdquo;)
settlement with the Company or its designees. The Company shall deliver to each Purchaser its respective Shares and Warrants as determined
pursuant to Section 2.2(a), and the Company and each Purchaser shall deliver the other items set forth in Section 2.2 at the Closing.
Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall occur at the offices of A.G.P.
or such other location as the parties shall mutually agree. Unless otherwise directed by the Placement Agents, settlement of the Shares
shall occur via DVP (i.e., on the Closing Date, the Company shall issue the Shares registered in the Purchasers&rsquo; names and addresses
and released by the Transfer Agent directly to the account(s) at the Placement Agents identified by each Purchaser; upon receipt of such
Shares, the Placement Agents shall promptly electronically deliver such Shares to the applicable Purchaser, and payment therefor shall
be made by the Placement Agents (or one of their clearing firms) by wire transfer to the Company). Notwithstanding anything herein to
the contrary, if at any time on or after the time of execution of this Agreement by the Company and an applicable Purchaser through the
Closing (the &ldquo;<U>Pre-Settlement Period</U>&rdquo;), such Purchaser sells to any Person all, or any portion, of any Shares to be
issued hereunder to such Purchaser at the Closing (collectively, the &ldquo;<U>Pre-Settlement Shares</U>&rdquo;), such Person shall, automatically
hereunder (without any additional required actions by such Purchaser or the Company), be deemed to be a Purchaser under this Agreement
unconditionally bound to purchase, and the Company shall be deemed unconditionally bound to sell, such Pre-Settlement Shares to such Person
at the Closing; provided, that the Company shall not be required to deliver any Pre-Settlement Shares to such Purchaser prior to the Company&rsquo;s
receipt of the Subscription Amount for such Pre-Settlement Shares hereunder; provided, further, that the Company hereby acknowledges and
agrees that the forgoing shall not constitute a representation or covenant by such Purchaser as to whether or not such Purchaser will
elect to sell any Pre-Settlement Shares during the Pre-Settlement Period. The decision to sell any Shares will be made in the sole discretion
of such Purchaser from time to time, including during the Pre-Settlement Period. Notwithstanding the foregoing, with respect to any Notice(s)
of Exercise (as defined in the Warrants) delivered on or prior to 12:00 p.m. (New York City time) on the Closing Date, which may be delivered
at any time after the time of execution of this Agreement, the Company agrees to deliver the Warrant Shares subject to such notice(s)
by 4:00 p.m. (New York City time) on the Closing Date and the Closing Date shall be the Warrant Share Delivery Date (as defined in the
Warrants) for purposes hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">2.2 <U>Deliveries</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 0.25in">&nbsp;</TD>
  <TD STYLE="text-align: left; width: 0.25in">(a)</TD>
  <TD STYLE="text-align: justify">On or prior to
the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: -0.25in"> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in">(i)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">this Agreement duly executed by the Company;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(ii)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">a legal opinion of Company Counsel, in form and substance reasonably satisfactory to the Placement Agents;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(iii)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">the Company&rsquo;s wire instructions, on Company letterhead and executed by the Company&rsquo;s Chief Executive Officer or Chief Financial Officer;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(iv)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">subject to the last sentence in Section 2.1, a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver on an expedited basis via The Depository Trust Company Deposit or Withdrawal at Custodian system shares of Common Stock equal to the portion of such Purchaser&rsquo;s Subscription Amount divided by the Per Share Purchase Price, registered in the name of such Purchaser;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(v)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">for each Purchaser of Pre-Funded Warrants pursuant to Section 2.1, a Pre-Funded Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to the portion of such Purchaser&rsquo;s Subscription Amount applicable to Pre-Funded Warrants divided by the sum of the Per Pre-Funded Warrant Purchase Price plus the exercise price per Warrant Share underlying such Pre-Funded Warrants, subject to adjustment therein;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(vi)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">the Preliminary Prospectus and the Prospectus (which may be delivered in accordance with Rule 172 under the Securities Act);</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(vii)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">an originally signed Common Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to 100% of such Purchaser&rsquo;s Shares or Pre-Funded Warrants, as applicable, with an exercise price equal to $[___] per share, subject to adjustment therein;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(viii)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">the duly executed Lock-Up Agreements;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(ix)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">a certificate executed by the Chief Executive Officer and Chief Financial Officer of the Company, dated as of the date of the Closing Date, in form and substance reasonably acceptable to the Purchasers and Placement Agents; and</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(x)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">a certificate executed by the Secretary of the Company, dated as of the Closing Date, in form and substance reasonable acceptable to the Purchasers and Placement Agents.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 0.25in">&nbsp;</TD>
  <TD STYLE="text-align: left; width: 0.25in">(b)</TD>
  <TD STYLE="text-align: justify">At the time this
Agreement is executed, the Placement Agents shall have received from WithumSmith+Brown, PC a cold comfort letter containing statements
and information of the type customarily included in accountants&rsquo; comfort letters with respect to the financial statements and certain
financial information contained in the Registration Statement, the Preliminary Prospectus and any issuer free writing prospectus, as defined
in Rule 433 under the Securities Act, addressed to the Placement Agents and in form and substance satisfactory in all respects to the
Placement Agents, dated as of the date of this Agreement.</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD STYLE="text-align: left">&nbsp;</TD>
  <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD STYLE="text-align: left">(c)</TD>
  <TD STYLE="text-align: justify">On or prior to
the Closing Date, the Placement Agents shall have received from WithumSmith+Brown, PC a bringdown comfort letter containing statements
and information of the type customarily included in accountants&rsquo; comfort letters, (i) reaffirming the statements made in the letter
furnished by them pursuant to &lrm;Section 2.2(b), except that the specified date referred to therein for the carrying out of procedures
shall be no more than three business days prior to the Closing Date; and (ii) covering certain financial information contained in the
Prospectus, addressed to the Placement Agents and in form and substance satisfactory in all respects to the Placement Agents, dated as
of the Closing Date.</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD STYLE="text-align: left">&nbsp;</TD>
  <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD STYLE="text-align: left">(d)</TD>
  <TD STYLE="text-align: justify">On or prior to
the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following:</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: -0.25in"> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in">(i)</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">this Agreement duly executed by such Purchaser; and </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(ii)</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">such Purchaser&rsquo;s Subscription Amount with respect to the Securities purchased by such Purchaser, which shall be made available for DVP settlement with the Company or its designees.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">2.3 <U>Closing Conditions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 0.25in">&nbsp;</TD>
  <TD STYLE="text-align: left; width: 0.25in">(a)</TD>
  <TD STYLE="text-align: justify">The obligations
of the Company hereunder in connection with the Closing are subject to the following conditions being met:</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in">(i)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Purchasers contained herein (unless such representation or warranty is as of a specific date therein in which case they shall be accurate as of such date);</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(ii)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed; and</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(iii)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">the delivery by each Purchaser
of the items set forth in Section 2.2(d) of this Agreement.</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 0.25in">&nbsp;</TD>
  <TD STYLE="width: 0.25in">(b)</TD>
  <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify">The respective
obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.5in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in">(i)</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless such representation or warranty is as of a specific date therein in which case they shall be accurate as of such date);</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(ii)</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(iii)</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">the delivery by the Company of the items set forth in Section 2.2 of this Agreement and if the Company files a Rule 462(b) Registration Statement, then the Rule 462(b) Registration Statement having been filed with the Commission;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(iv)</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">there shall have been no Material Adverse Effect with respect to the Company since the date hereof; and</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(v)</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">from the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities nor shall there have occurred after the date of this Agreement any material outbreak or escalation of hostilities or other national or international calamity of such magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser, makes it impracticable or inadvisable to purchase the Shares and the Warrants at the Closing.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>ARTICLE III.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>REPRESENTATIONS AND WARRANTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">3.1 <U>Representations and Warranties of the Company</U>.
Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be deemed a part hereof and shall qualify any representation
made herein to the extent of the disclosures contained in the corresponding section of the Disclosure Schedules, the Company hereby makes
the following representations and warranties to each Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in">(a)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;<U>Subsidiaries</U>. All of the direct and indirect subsidiaries of the Company are set forth on <U>Schedule 3.1(a)</U>. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary, free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. There are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which any Subsidiary is or may become bound to issue capital stock. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded. </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in">(b)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Organization and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing, and, if applicable under the laws of the jurisdiction in which it was formed, in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in violation nor default of any of the provisions of its respective articles of association, certificate or articles of incorporation, bylaws, operating agreement, or other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, would not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;<U>Material Adverse Effect</U>&rdquo;) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(c)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Authorization; Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further action is required by the Company, the Board of Directors, a committee of the Board of Directors, or the Company&rsquo;s stockholders in connection herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which the Company is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(d)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>No Conflicts</U>. Except as set forth in <U>Schedule 3.1(d)</U>, the execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles of incorporation, bylaws, or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as would not have or reasonably be expected to result in a Material Adverse Effect.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in">(e)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Filings, Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings required pursuant to Section 4.4 of this Agreement, (ii) the filing with the Commission of the Prospectus, (iii) notices and/or application(s) to and approvals by each applicable Trading Market for the listing of the applicable Securities for trading thereon in the time and manner required thereby, and (iv) filings required by the Financial Industry Regulatory Authority (&ldquo;<U>FINRA</U>&rdquo;) (collectively, the &ldquo;<U>Required Approvals</U>&rdquo;).</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(f)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Issuance of the Securities; Registration</U>. The Shares and Warrant Shares are duly authorized and, when issued and paid for in accordance with the applicable Transaction Documents, will be duly and validly issued, fully paid and non-assessable, free and clear of all Liens imposed by the Company. The Warrants are duly authorized and, when issued in accordance with this Agreement, will be duly and validly issued, fully paid and non-assessable, and free and clear of all Liens imposed by the Company. The Company has reserved from its duly authorized capital stock the maximum number of shares of Common Stock issuable pursuant to this Agreement and the Warrants. The Company has prepared and filed the Registration Statement in conformity with the requirements of the Securities Act, which Registration Statement became effective on [&bull;], 2025, including the Prospectus, and such amendments and supplements thereto as may have been required to the date of this Agreement. The Registration Statement is effective under the Securities Act and no stop order preventing or suspending the effectiveness of the Registration Statement or suspending or preventing the use of the Preliminary Prospectus or the Prospectus has been issued by the Commission and no proceedings for that purpose have been instituted or, to the knowledge of the Company, are threatened by the Commission. The Company, if required by the rules and regulations of the Commission, shall file the Prospectus with the Commission pursuant to Rule 424(b) under the Securities Act. At the time the Registration Statement and any amendments thereto became effective as determined under the Securities Act, at the date of this Agreement and at the Closing Date, the Registration Statement and any amendments thereto conformed and will conform in all material respects to the requirements of the Securities Act and did not and will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading; and the Prospectus and any amendments or supplements thereto, at the time the Preliminary Prospectus, the Prospectus or any amendment or supplement thereto was issued and at the Closing Date, conformed and will conform in all material respects to the requirements of the Securities Act and did not and will not contain an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in">(g)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Capitalization</U>. The capitalization of the Company
    as of the date hereof is as set forth on <U>Schedule 3.1(g)</U>, which <U>Schedule 3.1(g)</U> shall also include the number of shares
    of Common Stock owned beneficially, and of record, by Affiliates of the Company as of the date hereof. Except as set forth on <U>Schedule
    3.1(g)</U>, the Company has not issued any capital stock since its most recently filed periodic report under the Exchange Act, other
    than pursuant to the exercise of employee stock options under the Company&rsquo;s stock option plans, the issuance of shares of Common
    Stock to employees pursuant to the Company&rsquo;s employee stock purchase plans and pursuant to the conversion and/or exercise of
    Common Stock Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act. No Person
    has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions
    contemplated by the Transaction Documents. Except as set forth on <U>Schedule 3.1(g)</U> and as a result of the purchase and sale
    of the Securities, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character
    whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person
    any right to subscribe for or acquire, any shares of Common Stock, or contracts, commitments, understandings or arrangements by which
    the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents. The
    issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue shares of Common Stock or other securities
    to any Person (other than the Purchasers). Except as set forth on <U>Schedule 3.1(g)</U>, here are no outstanding securities or instruments
    of the Company or any Subsidiary with any provision that adjusts the exercise, conversion, exchange or reset price under any of such
    securities. Except as set forth on <U>Schedule 3.1(g)</U>, there are no outstanding securities or instruments of the Company
    or any Subsidiary that contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements
    by which the Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company
    does not have any share appreciation rights or &ldquo;phantom share&rdquo; plans or agreements or any similar plan or agreement.
    All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and non-assessable,
    have been issued in compliance with all federal and state securities laws where applicable, and none of such outstanding shares was
    issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities. Except for the Required Approvals,
    no further approval or authorization of any shareholder, the Board of Directors or others is required for the issuance and sale of
    the Securities. There are no shareholder agreements, voting agreements or other similar agreements with respect to the Company&rsquo;s
    share capital to which the Company is a party or, to the knowledge of the Company, between or among any of the Company&rsquo;s shareholders.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(h)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>SEC Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the one year preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such materials) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with the Preliminary Prospectus and the Prospectus, being collectively referred to herein as the &ldquo;<U>SEC Reports</U>&rdquo;) and on a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. The Company has never been an issuer subject to Rule 144(i) under the Securities Act. As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The financial statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with GAAP, except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in">(i)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Material Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included within the SEC Reports, except as set forth on <U>Schedule 3.1(i)</U>, (i) there has been no event, occurrence or development that has had or that would reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any material liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and strategic acquisitions and (B) liabilities not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of cash or other property to its shareholders or purchased, redeemed or made any agreements to purchase or redeem any of its shares of capital stock other than the repurchase of Common Stock pursuant to a stock buyback program and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company share option plans. Except for the issuance of the Securities contemplated by this Agreement or as set forth on <U>Schedule 3.1(i)</U>, no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations, assets or financial condition that would be required to be disclosed by the Company under applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed at least one (1) Trading Day prior to the date that this representation is made.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(j)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Litigation</U>. Except as set forth on <U>Schedule 3.1(j)</U>, there is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, an &ldquo;<U>Action</U>&rdquo;) which (i) adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents, the Shares, the Warrants or the Warrant Shares or (ii) could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Except as set forth on <U>Schedule 3.1(j)</U>, neither the Company nor any Subsidiary, nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty, which could reasonably be expected to result in a Material Adverse Effect. There has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation by the Commission involving the Company or any current or former director or officer of the Company. The Commission has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(k)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Labor Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company, which would reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo; employees is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary, is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all applicable U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except where the failure to be in compliance would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in">(l)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Compliance</U>. Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except in each case of (i), (ii) and (iii) as would not have or reasonably be expected to result in a Material Adverse Effect.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(m)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Environmental Laws</U>. The Company and its Subsidiaries (i) are in compliance with all applicable federal, state, local and foreign laws relating to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;); (ii) have received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses; and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and (iii), the failure to so comply would be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(n)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Regulatory Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except where the failure to possess such certificates, authorizations or permits would not reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material Permits</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification of any Material Permit.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(o)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Title to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the payment of which is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance in all material respects.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in">(p)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Intellectual Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights necessary or required for use in connection with their respective businesses as described in the SEC Reports and which the failure to so have would reasonably be expected to have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). None of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement except as would not reasonably be expected to have a Material Adverse Effect. Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights of any Person, except as would not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company has no knowledge of any facts that would preclude it from having valid license rights or clear title to the Intellectual Property Rights. The Company has no knowledge that it lacks or will be unable to obtain any rights or licenses to use all Intellectual Property Rights that are necessary to conduct its business.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(q)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Insurance</U>. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not limited to, directors and officers insurance coverage at least equal to the aggregate Subscription Amount. Neither the Company nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(r)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Transactions with Affiliates and Employees</U>. Except as set forth on Schedule 3.1(r), none of the officers or directors of the Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee, shareholder, member or partner, in each case in excess of $120,000 other than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company or a Subsidiary and (iii) other employee benefits, including share option agreements under any share option plan of the Company.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in">(s)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Sarbanes-Oxley; Internal Accounting Controls</U>. The Company and the Subsidiaries are in material compliance with any and all applicable requirements of the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations promulgated by the Commission thereunder that are effective as of the date hereof and as of the Closing Date. The Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance with management&rsquo;s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management&rsquo;s general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company and the Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls and procedures to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&rsquo;s rules and forms. The Company&rsquo;s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as of the end of the period covered by the most recently filed Form 10-K under the Exchange Act (such date, the &ldquo;<U>Evaluation Date</U>&rdquo;). The Company presented in its most recently filed Form 10-K under the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange Act) that have materially affected, or is reasonably likely to materially affect, the internal control over financial reporting of the Company and its Subsidiaries.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(t)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Certain Fees</U>. Except as set forth in the Preliminary Prospectus and the Prospectus, no brokerage or finder&rsquo;s fees or commissions are or will be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents (for the avoidance of doubt, the foregoing shall not include any fees and/or commissions owed to the Transfer Agent). Other than for Persons engaged by any Purchaser, if any, the Purchasers shall have no obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section 3.1(t) that may be due in connection with the transactions contemplated by the Transaction Documents.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(u)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Investment Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will not be or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended. The Company shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration under the Investment Company Act of 1940, as amended.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(v)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Registration Rights</U>. Except as set forth on <U>Schedule 3.1(v)</U>, no Person has any right to cause the Company to effect the registration under the Securities Act of any securities of the Company or any Subsidiary.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in">(w)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Listing and Maintenance Requirements</U>. The shares
    of Common Stock are registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company has taken no action designed
    to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange
    Act nor has the Company received any notification that the Commission is contemplating terminating such registration. Except as set
    forth in <U>Schedule 3.1(w)</U>, the Company has not, in the 12 months preceding the date hereof, received notice from any Trading
    Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing
    or maintenance requirements of such Trading Market. Except as set forth in <U>Schedule 3.1(w)</U>, the Company is, and has
    no reason to believe, that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance
    requirements. The Common Stock is currently eligible for electronic transfer through The Depository Trust Company or another established
    clearing corporation and the Company is current in payment of the fees to The Depository Trust Company (or such other established
    clearing corporation) in connection with such electronic transfer.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(x)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Application of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the laws of its state of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation as a result of the Company&rsquo;s issuance of the Securities and the Purchasers&rsquo; ownership of the Securities.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(y)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Disclosure</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information that it believes constitutes or might constitute material, non-public information which is not otherwise disclosed in the Preliminary Prospectus or the Prospectus. The Company understands and confirms that the Purchasers will rely on the foregoing representation in effecting transactions in securities of the Company. All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries, their respective businesses and the transactions contemplated hereby, including the Disclosure Schedules to this Agreement, is true and correct in all material respects and does not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading. The press releases disseminated by the Company during the twelve (12) months preceding the date of this Agreement taken as a whole do not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made and when made, not misleading. The Company acknowledges that no Purchaser makes or has made any representations or warranties with respect to the transactions contemplated hereby other than those specifically set forth in Section 3.2 hereof.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(z)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>No Integrated Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be integrated with prior offerings by the Company for purposes of any applicable shareholder approval provisions of any Trading Market on which any of the securities of the Company are listed or designated.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in">(aa)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Solvency</U>. Based on the consolidated financial condition
    of the Company as of the Closing Date, after giving effect to the receipt by the Company of the proceeds from the sale of the Securities
    hereunder, (i) the fair saleable value of the Company&rsquo;s assets exceeds the amount that will be required to be paid on or in
    respect of the Company&rsquo;s existing debts and other liabilities (including known contingent liabilities) as they mature, (ii)
    the Company&rsquo;s assets do not constitute unreasonably small capital to carry on its business as now conducted and as proposed
    to be conducted including its capital needs taking into account the particular capital requirements of the business conducted by
    the Company, consolidated and projected capital requirements and capital availability thereof, and (iii) the current cash flow of
    the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after taking into account
    all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when such amounts are
    required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature (taking into
    account the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any facts or
    circumstances, which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization
    laws of any jurisdiction within one year from the Closing Date. <U>Schedule 3.1(aa)</U> sets forth, as of the last
    date of the month preceding the date of this Agreement, all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company
    or any Subsidiary has commitments. For the purposes of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo; means (x) any liabilities
    for borrowed money or amounts owed by the Company in excess of $50,000 (other than trade accounts payable incurred in the ordinary
    course of business), (y) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others to third
    parties, whether or not the same are or should be reflected in the Company&rsquo;s consolidated balance sheet (or the notes thereto),
    except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course
    of business; and (z) the present value of any lease payments in excess of $50,000 due under leases required to be capitalized in
    accordance with GAAP. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(bb)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Tax Compliance</U>. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all federal, state and local income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes and other governmental assessments and charges, fines or penalties that are material in amount, shown or determined to be due on such returns, reports and declarations and (iii) has set aside on its financial statements provision reasonably adequate for the payment of all material tax liability of which has not been finally determined and all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis for any such claim.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(cc)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Foreign Corrupt Practices</U>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of which the Company is aware) which is in violation of law, or (iv) violated in any material respect any provision of FCPA.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in">(dd)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Accountants</U>. The Company&rsquo;s independent registered
    public accounting firm is WithumSmith+Brown, PC. To the knowledge and belief of the Company, such accounting firm (i) is a registered
    public accounting firm as required by the Exchange Act and (ii) has expressed its opinion with respect to the financial
    statements included in the Company&rsquo;s Annual Report for the fiscal year ended December 31, 2024.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(ee)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Acknowledgment Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers is acting solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each Purchaser that the Company&rsquo;s decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the transactions contemplated hereby by the Company and its representatives.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(ff)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Acknowledgment Regarding Purchasers&rsquo; Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding (except for Sections 3.2(f) and 4.12 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has been asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the Securities for any specified term; (ii) past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales or &ldquo;derivative&rdquo; transactions, before or after the closing of this or future private placement transactions, may negatively impact the market price of the Company&rsquo;s publicly-traded securities; (iii) any Purchaser, and counter-parties in &ldquo;derivative&rdquo; transactions to which any such Purchaser is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the shares of Common Stock, and (iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party in any &ldquo;derivative&rdquo; transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage in hedging activities (in material compliance with applicable laws) at various times during the period that the shares of Common Stock are outstanding, and (z) such hedging activities (if any) could reduce the value of the existing stockholders&rsquo; equity interests in the Company at and after the time that the hedging activities are being conducted. The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any of the Transaction Documents.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(gg)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Regulation M Compliance</U>. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the shares of Common Stock, (ii) except as previously disclosed in the SEC Reports and pursuant to the Company&rsquo;s stock buyback program, sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any of the shares of Common Stock, or (iii) except as previously disclosed in the SEC Reports and pursuant to the Company&rsquo;s stock buyback program, paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Placement Agents in connection with the placement of the shares of Common Stock.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in">(hh)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Non-Contravention of Existing Instruments; No Further Authorizations or Approvals Required</U>. The Company&rsquo;s execution, delivery and performance of this Agreement and consummation of the transactions contemplated hereby will not (A) result in a material violation of any existing applicable law, rule, regulation, judgment, order or decree of any governmental entity as of the date hereof (including, without limitation, those promulgated by the Food and Drug Administration of the U.S. Department of Health and Human Services (the &ldquo;<U>FDA</U>&rdquo;) or by any foreign, federal, state or local regulatory authority performing functions similar to those performed by the FDA), (B) conflict with, result in any violation or breach of, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, or give to others any right of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) (a &ldquo;<U>Default Acceleration Event</U>&rdquo;) of, any agreement, lease, credit facility, debt, note, bond, mortgage, indenture or other instrument (&ldquo;<U>Contract</U>&rdquo;) or obligation or other understanding to which the Company is a party or by which any property or asset of the Company is bound or affected, except to the extent that such conflict, default, or Default Acceleration Event is not reasonably likely to result in a Material Adverse Effect, or (C) result in a breach or violation of any of the terms and provisions of, or constitute a default under, the Company&rsquo;s articles of incorporation (as the same may be amended or restated from time to time) or bylaws (as the same may be amended or restated from time to time). The Company is not in violation, breach or default under its certificate of incorporation (as the same may be amended or restated from time to time) or bylaws (as the same may be amended or restated from time to time). Neither the Company nor, to its knowledge, any other party is in violation, breach or default of any Contract that has resulted in or could reasonably be expected to result in a Material Adverse Effect. Each approval, consent, order, authorization, designation, declaration or filing by or with any regulatory, administrative or other governmental body necessary in connection with the execution and delivery by the Company of this Agreement and the performance of the Company of the transactions herein contemplated has been obtained or made and is in full force and effect, except filings with the Commission required under the Securities Act or the Exchange Act, or filings with the Exchange pursuant to the rules and regulations of the Exchange, in each case that are contemplated by this Agreement to be made after the date of this Agreement. </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(ii)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Stock Option Plans</U>. Each stock option granted by
    the Company under the Company&rsquo;s stock option plan or pursuant to an inducement option grant was granted (i) in accordance
    with the terms of the Company&rsquo;s stock option plan or inducement option agreements and (ii) with an exercise price at least equal to the fair market
    value of the Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option
    granted under the Company&rsquo;s stock option plan has been backdated. The Company has not knowingly granted, and there is no and
    has been no Company policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of
    stock options with, the release or other public announcement of material information regarding the Company or its Subsidiaries or
    their financial results or prospects.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(jj)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Cybersecurity</U>. (i)(x)To the knowledge of the Company, there has been no material security breach or other compromise of or relating to any of the Company&rsquo;s or any Subsidiary&rsquo;s information technology and computer systems, networks, hardware, software, data (including the data of its respective customers, employees, suppliers, vendors and any third-party data maintained by or on behalf of it), equipment or technology (collectively, &ldquo;<U>IT Systems and Data</U>&rdquo;) and (y) the Company and the Subsidiaries have not been notified of, and has no knowledge of any event or condition that would reasonably be expected to result in, any security breach or other compromise to its IT Systems and Data that would require notification to any third party under applicable law; (ii) the Company and the Subsidiaries are presently in compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as would not, individually or in the aggregate, have a Material Adverse Effect; (iii) the Company and the Subsidiaries have implemented and maintained commercially reasonable safeguards to maintain and protect its material confidential information and the integrity, continuous operation, redundancy and security of all IT Systems and Data; and (iv) the Company and the Subsidiaries have implemented backup and disaster recovery technology consistent with commercially reasonable industry standards and practices.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">(kk)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Office of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">(ll)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>U.S. Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon the Purchasers&rsquo; request.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">(mm)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Bank Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956, as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the &ldquo;<U>Federal Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">(nn)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Money Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;), and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">(oo)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Promotional Stock Activities</U>. Neither the Company nor any Subsidiary of the Company and none of their respective officers, directors, managers, affiliates or agents have engaged in any stock promotional activity that could give rise to a complaint, inquiry, or trading suspension by the Commission alleging (i) a violation of the anti-fraud provisions of the federal securities laws, (ii) violations of the anti-touting provisions, (iii) improper &ldquo;gun-jumping&rdquo;; or (iv) promotion without proper disclosure of compensation.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">(pp)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Regulatory Matters; Compliance</U>. All preclinical and other nonclinical studies and clinical trials conducted by or on behalf of the Company that are material to the Company have been adequately described in the Registration Statement, in all material respects. The clinical trials and nonclinical studies conducted by or on behalf of the Company that are described in the Registration Statement or the results of such trials and studies which are referred to in the Registration Statement were and, if still ongoing, are being conducted in material compliance with all laws and regulations applicable thereto in the jurisdictions in which they are being conducted. The descriptions in the Registration Statement of the results of such trials and studies are accurate and complete in all material respects and fairly present the data derived from such trials and studies, and the Company has no knowledge of any clinical trials the aggregate results of which are inconsistent with or otherwise call into question the results of any clinical trial conducted by or on behalf of the Company that are described in the Registration Statement or the results of which are referred to in the Registration Statement. Except as disclosed in the Registration Statement, the Company has not received any written notices or other communications from the FDA, the European Medicines Agency (&ldquo;<U>EMA</U>&rdquo;) or any other governmental agency or authority imposing, requiring, requesting or suggesting a clinical hold, termination, suspension or material modification of any clinical trial that is described in the Registration Statement or the results of which are referred to in the Registration Statement. Except as disclosed in the Registration Statement, the Company has not received any written notices or other communications from the FDA, the EMA or any other governmental agency, and otherwise has no knowledge of, or reason to believe that, (i) any investigational new drug application for a potential product of the Company is or has been rejected or determined to be non-approvable or conditionally approvable; and (ii) any license, approval, permit or authorization to conduct any clinical trial of any potential product of the Company has been, will be or may be suspended, revoked, modified or limited.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in">(qq)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Compliance with Data Privacy Laws</U>. (i) The Company and the Subsidiaries are, and at all times during the last three (3) years were, in compliance with all applicable state, federal and foreign data privacy and security laws and regulations, (collectively, &ldquo;<U>Privacy Laws</U>&rdquo;); (ii) the Company and the Subsidiaries have in place, comply with, and take commercially reasonable steps designed to comply with their policies and procedures relating to data privacy and security and the collection, storage, use, disclosure, handling and analysis of Personal Data (as defined below) (the &ldquo;<U>Policies</U>&rdquo;); &ldquo;Personal Data&rdquo; means (i) a natural person&rsquo;s name, street address, telephone number, email address, photograph, social security number, bank information, or customer or account number; and (ii) any other piece of information that allows the identification of such natural person, or his or her family, or permits the collection or analysis of any identifiable data related to an identified person&rsquo;s health or sexual orientation. (i) None of such disclosures made or contained in any of the Policies have been inaccurate, misleading, or deceptive in violation of any Privacy Laws and (ii) the execution, delivery and performance of the Transaction Documents will not result in a breach of any Privacy Laws or Policies. Neither the Company nor the Subsidiaries (is a party to any order, decree, or agreement by or with any court or arbitrator or governmental or regulatory authority that imposed any obligation or liability under any Privacy Law.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">3.2 <U>Representations and Warranties of the Purchasers</U>.
Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the date hereof and as of the Closing Date
to the Company as follows (unless as of a specific date therein, in which case they shall be accurate as of such date):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in">(a)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Organization; Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership limited liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(b)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Understandings or Arrangements</U>. Such Purchaser is acquiring the Securities as principal for its own account and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities (this representation and warranty not limiting such Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement or otherwise in compliance with applicable federal and state securities laws).</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in">(c)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Reserved</U>.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(d)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Experience of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(e)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Access to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits and schedules thereto) and the SEC Reports and has been afforded (i) the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the investment. Such Purchaser acknowledges and agrees that neither the Placement Agents nor any Affiliate of the Placement Agents has provided such Purchaser with any information or advice with respect to the Securities nor is such information or advice necessary or desired. Neither the Placement Agents nor any Affiliate has made or makes any representation as to the Company or the quality of the Securities and the Placement Agents and any Affiliate may have acquired non-public information with respect to the Company which such Purchaser agrees need not be provided to it. In connection with the issuance of the Securities to such Purchaser, neither the Placement Agents nor any of its Affiliates has acted as a financial advisor or fiduciary to such Purchaser.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(f)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Certain Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that the Preliminary Prospectus was filed with the Commission from the Company or any other Person representing the Company setting forth the material terms, which terms include definitive pricing terms, of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s assets, the representation set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other than to other Persons party to this Agreement or to such Purchaser&rsquo;s representatives, including, without limitation, its officers, directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.25in">(g)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>No Voting Agreements</U>. The Purchaser is not a party to any agreement or arrangement, whether written or oral, between the Purchaser and any other Purchaser and any of the Company&rsquo;s shareholders as of the date hereof, regulating the management of the Company, the shareholders&rsquo; rights in the Company, the transfer of shares in the Company, including any voting agreements, shareholder agreements or any other similar agreement even if its title is different or has any other relations or agreements with any of the Company&rsquo;s shareholders, directors or officers.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(h)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Brokers</U>. Except as set forth in the Preliminary Prospectus or the Prospectus, no agent, broker, investment banker, person or firm acting in a similar capacity on behalf of or under the authority of the Purchaser is or will be entitled to any broker&rsquo;s or finder&rsquo;s fee or any other commission or similar fee, directly or indirectly, for which the Company or any of its Affiliates after the Closing could have any liabilities in connection with this Agreement, any of the transactions contemplated by this Agreement, or on account of any action taken by the Purchaser in connection with the transactions contemplated by this Agreement.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif">(i)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><U>Independent Advice</U>. Each Purchaser understands that nothing in this Agreement or any other materials presented by or on behalf of the Company to the Purchaser in connection with the purchase of the Securities constitutes legal, tax or investment advice.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">The Company acknowledges and agrees
that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s right to rely on the Company&rsquo;s
representations and warranties contained in this Agreement or any representations and warranties contained in any other Transaction Document
or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation of the transactions
contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation
or warranty, or preclude any actions, except as set forth in this Agreement, with respect to locating or borrowing shares in order to
effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>ARTICLE IV.<BR>
OTHER AGREEMENTS OF THE PARTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">4.1 <U>Legends</U>. The shares of Common Stock, the
Warrants, and, if all or any portion of a Warrant is exercised at a time when there is an effective registration statement to cover the
issuance or resale of the Warrant Shares or if the Warrant is exercised via cashless exercise, the Warrant Shares, shall be issued free
of legends. If at any time following the date hereof the Registration Statement is not effective or is not otherwise available for the
sale of the shares of Common Stock, the Warrants or the Warrant Shares, the Company shall immediately notify the holders of the Warrants
in writing that such Registration Statement is not then effective and thereafter shall promptly notify such holders when the Registration
Statement is effective again and available for the sale of the Shares, the Warrants or the Warrant Shares (it being understood and agreed
that the foregoing shall not limit the ability of the Company to issue, or any Purchaser to sell, any of the Shares, the Warrants or the
Warrant Shares in compliance with applicable federal and state securities laws). The Company shall use commercially reasonable best efforts
to keep a registration statement (including the Registration Statement) registering the issuance of the Warrant Shares effective during
the term of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">4.2 <U>Furnishing of Information; Public Information</U>.
Until the earliest of the time that (i) no Purchaser owns Securities, or (ii) the Common Warrants have expired, the Company covenants
to maintain the registration of the Common Stock under Section 12(b) or 12(g) of the Exchange Act and to timely file (or obtain extensions
in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof
pursuant to the Exchange Act except in the case of a sale of all of substantially all of the assets of the Company, a merger or reorganization
of the Company with one or more other entities in which the Company is not the surviving entity or any transaction or series of related
transactions as a result of which any Person (together with its Affiliates) acquires then outstanding securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">4.3 <U>Integration</U>. The Company shall not sell,
offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the Securities Act)
that would be integrated with the offer or sale of the Securities for purposes of the rules and regulations of any Trading Market such
that it would require shareholder approval prior to the closing of such other transaction unless shareholder approval is obtained before
the closing of such subsequent transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">4.4 <U>Securities Laws Disclosure; Publicity</U>.
The Company shall (a) by the Disclosure Time, issue a press release disclosing the material terms of the transactions contemplated hereby,
and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits thereto, with the Commission within the time
required by the Exchange Act. From and after the issuance of such press release, the Company represents to the Purchasers that it shall
have publicly disclosed all material, non-public information delivered to any of the Purchasers by the Company or any of its Subsidiaries
or Affiliates, or any of their respective officers, directors, employees or agents, including, without limitation, the Placement Agents,
in connection with the transactions contemplated by the Transaction Documents. In addition, effective upon the issuance of such press
release, the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement, whether written
or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates,
including, without limitation, the Placement Agents, on the one hand, and any of the Purchasers or any of their Affiliates on the other
hand, with respect to the transactions contemplated hereby shall terminate and be of no further force or effect. The Company and each
Purchaser shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby, and
neither the Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement without the prior
consent of the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser, with respect
to any press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required
by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement or communication.
Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser
in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except
(a) as required by federal securities law in connection with the filing of final Transaction Documents with the Commission, and (b) to
the extent such disclosure is required by law or Trading Market regulations, in which case the Company shall provide the Purchasers with
prior notice of such disclosure permitted under this clause (b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">4.5 <U>Shareholder Rights Plan</U>. No claim will
be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser is an &ldquo;Acquiring Person&rdquo;
under any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or similar
anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser could be deemed to trigger the
provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents or under any other agreement
between the Company and the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">4.6 <U>Non-Public Information</U>. Except with respect
to the material terms and conditions of the transactions contemplated by the Transaction Documents, which shall be disclosed pursuant
to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting on its behalf will provide any Purchaser
or its agents or counsel with any information that the Company believes constitutes material non-public information, unless prior thereto
such Purchaser shall have entered into a written agreement with the Company regarding the confidentiality and use of such information.
The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities
of the Company. To the extent that the Company delivers any material, non-public information to a Purchaser without such Purchaser&rsquo;s
consent, the Company hereby covenants and agrees that such Purchaser shall not have any duty of confidentiality to the Company, any of
its Subsidiaries, or any of their respective officers, directors, agents, employees or Affiliates, or a duty to the Company, any of its
Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates not to trade on the basis of, such material,
non-public information, provided that the Purchaser shall remain subject to applicable law. To the extent that any notice provided pursuant
to any Transaction Document constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the
Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Company understands and
confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">4.7 <U>Use of Proceeds</U>. The Company shall use
the net proceeds from the sale of the Securities hereunder as disclosed in the Preliminary Prospectus and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">4.8 <U>Indemnification of Purchasers</U>. Subject
to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser and its directors, officers, shareholders, members,
partners, employees and agents (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding
a lack of such title or any other title), each Person who controls such Purchaser (within the meaning of Section 15 of the Securities
Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners or employees (and any other
Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title) of
such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;) harmless from any and all losses, liabilities, obligations, claims,
contingencies, damages, costs and reasonable expenses, including all judgments, amounts paid in settlements, court costs and reasonable
attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or incur as a result of or relating to (a) any
breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement or in the other Transaction
Documents or (b) any action instituted against a Purchaser Party in any capacity, or any of them or their respective Affiliates, by any
shareholder of the Company who is not an Affiliate of such Purchaser Party, with respect to any of the transactions contemplated by the
Transaction Documents (unless such action is based upon a breach of such Purchaser Party&rsquo;s representations, warranties or covenants
under the Transaction Documents or any agreements or understandings such Purchaser Party may have with any such shareholder or any violations
by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which is finally judicially determined
to constitute fraud, gross negligence or willful misconduct). If any action shall be brought against any Purchaser Party in respect of
which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and the Company
shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any
Purchaser Party shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the fees
and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that (i) the employment thereof has
been specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable period of time to assume such defense
and to employ counsel or (iii) in such action there is, in the reasonable opinion of counsel, a material conflict on any material issue
between the position of the Company and the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable
fees and expenses of no more than one such separate counsel. The Company will not be liable to any Purchaser Party under this Agreement
(y) for any settlement or compromise of, or consent to the entry of judgement in, any action, claim or proceeding by a Purchaser Party
effected without the Company&rsquo;s prior written consent, which shall not be unreasonably withheld or delayed; or (z) to the extent,
but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party&rsquo;s breach of any of the representations,
warranties, covenants or agreements made by such Purchaser Party in this Agreement or in the other Transaction Documents. The indemnification
required by this Section 4.8 shall be made by periodic payments of the amount thereof during the course of the investigation or defense,
as and when bills are received or are incurred. The indemnity agreements contained herein shall be in addition to any cause of action
or similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject to pursuant to law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">4.9 <U>Listing of Common Stock</U>. The Company hereby
agrees to use commercially reasonable best efforts to maintain the listing or quotation of the shares of Common Stock on each Trading
Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote all of the Shares
and Warrant Shares on such Trading Markets and promptly secure the listing of all of the Shares and Warrant Shares on such Trading Markets
except in the case of a sale of all of substantially all of the assets of the Company, a merger or reorganization of the Company with
one or more other entities in which the Company is not the surviving entity or any transaction or series of related transactions as a
result of which any Person (together with its Affiliates) acquires then outstanding securities of the Company representing more than fifty
percent (50%) of the voting control of the Company. The Company further agrees, if the Company applies to have the Common Stock traded
on any other Trading Market, it will then include in such application all of the Shares and Warrant Shares, and will take such other action
as is necessary to cause all of the Shares and Warrant Shares to be listed or quoted on such other Trading Market as promptly as possible.
The Company will then take all action reasonably necessary to continue the listing and trading of the Common Stock on a Trading Market
and will comply in all material respects with the Company&rsquo;s reporting, filing and other obligations under the bylaws or rules of
the Trading Market. The Company agrees to use commercially reasonable efforts to maintain the eligibility of the Common Stock for electronic
transfer through the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment
of fees to the Depository Trust Company or such other established clearing corporation in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">4.10 <U>Subsequent Equity Sales</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in">(a)</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">
    <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">From the date hereof until forty-five
    (45) days after the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue
    or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration
    statement or amendment or supplement thereto, other than the Prospectus, filing a registration statement on Form S-8 in connection
    with any employee benefit plan or the filing of a registration statement or post-effective registration statement registering the
    Securities issued pursuant to this Agreement.</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in">(b)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">From the date hereof until ninety
    (90) days after the Closing Date, the Company shall be prohibited from effecting or entering into an agreement to effect any
    issuance by the Company or any of its Subsidiaries of shares of Common Stock or Common Stock Equivalents (or a combination of units
    thereof) involving a Variable Rate Transaction. &ldquo;<U>Variable Rate Transaction</U>&rdquo; means a transaction in which the Company
    issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right to
    receive additional shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or other price that is
    based upon and/or varies with the trading prices of or quotations for the Common Stock at any time after the initial issuance of
    such debt or equity securities, or (B) with a conversion, exercise or exchange price that is subject to being reset at some future
    date after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly
    or indirectly related to the business of the Company or the market for shares of Common Stock, provided, however, that a Variable
    Rate Transaction shall not include any at-the-market offering of the Company&rsquo;s Common Stock, and that sales under any at-the-market offering may commence starting on the sixty-first (61st) day following the Closing Date.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 0.5in">(c)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">
    <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">Notwithstanding the foregoing, this Section 4.10 shall not apply in respect
    of an Exempt Issuance, except that no Variable Rate Transaction shall be an Exempt Issuance.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">4.11 <U>Equal Treatment of Purchasers</U>. No consideration
(including any modification of the Transaction Documents) shall be offered or paid to any Person to amend or consent to a waiver or modification
of any provision of the Transaction Documents unless the same consideration is also offered to all of the parties to the Transaction Documents.
For clarification purposes, this provision constitutes a separate right granted to each Purchaser by the Company and negotiated separately
by each Purchaser, and is intended for the Company to treat the Purchasers as a class and shall not in any way be construed as the Purchasers
acting in concert or as a group with respect to the purchase, disposition or voting of the shares of Common Stock or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">4.12 <U>Certain Transactions and Confidentiality</U>.
Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it nor any Affiliate acting on its behalf
or pursuant to any understanding with it will execute any purchases or sales, including Short Sales of any of the Company&rsquo;s securities
during the period commencing with the execution of this Agreement and ending at such time that the transactions contemplated by this Agreement
are first publicly announced pursuant to the initial press release as described in Section 4.4 hereof. Each Purchaser, severally and not
jointly with the other Purchasers, covenants that until such time as the transactions contemplated by this Agreement are publicly disclosed
by the Company pursuant to the initial press release as described in Section 4.4 hereof, such Purchaser will maintain the confidentiality
of the existence and terms of this transaction and the information included in the Disclosure Schedules. Notwithstanding the foregoing,
and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i) no Purchaser
makes any representation, warranty or covenant hereby that it will not engage in effecting transactions in any securities of the Company
after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release
as described in Section 4.4 hereof, (ii) no Purchaser shall be restricted or prohibited from effecting any transactions in any securities
of the Company in accordance with applicable securities laws from and after the time that the transactions contemplated by this Agreement
are first publicly announced pursuant to the initial press release as described in Section 4.4 hereof and (iii) no Purchaser shall have
any duty of confidentiality or duty not to trade in the securities of the Company to the Company or its Subsidiaries after the issuance
of the initial press release as described in Section 4.4 hereof. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed
investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers
have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s
assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made
the investment decision to purchase the Securities covered by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">4.13 <U>Exercise Procedures</U>. The form of Notice
of Exercise included in the Warrants set forth the totality of the procedures required of the Purchasers in order to exercise the Warrants.
No additional legal opinion, other information or instructions shall be required of the Purchasers to exercise their Warrants. Without
limiting the preceding sentences, no ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type
of guarantee or notarization) of any Notice of Exercise form be required in order to exercise the Warrants. The Company shall honor exercises
of the Warrants and shall deliver Warrant Shares in accordance with the terms, conditions and time periods set forth in the Transaction
Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">4.14 <U>Reservations of Shares</U>. As of the date
hereof, the Company has reserved and the Company shall continue to reserve and keep available at all times, free of preemptive rights,
a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue shares of Common Stock pursuant to this
Agreement and Warrant Shares pursuant to any exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">4.15. <U>Lock-Up Agreements</U>. The Company shall
not amend, modify, waive or terminate any provision of any of the Lock-Up Agreements except to extend the term of the lock-up period specified
therein and shall enforce the provisions of each Lock-Up Agreement in accordance with its terms. If any party to a Lock-Up Agreement breaches
any provision of a Lock-Up Agreement, the Company shall promptly use its best efforts to seek specific performance of the terms of such
Lock-Up Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>ARTICLE V.<BR>
MISCELLANEOUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.1 <U>Termination</U>. This Agreement may be terminated
by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without any effect whatsoever on the obligations between
the Company and the other Purchasers, by written notice to the other parties, if the Closing has not been consummated on or before the
fifth (5th) Trading Day following the date hereof; <U>provided</U>, <U>however</U>, that no such termination will affect the right of
any party to sue for any breach by any other party (or parties).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.2 <U>Fees and Expenses</U>. Except as expressly
set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses of its advisers, counsel, accountants
and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery
and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without limitation, any fees required for
same-day processing of any instruction letter delivered by the Company and any exercise notice delivered by a Purchaser), stamp taxes
and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.3 <U>Entire Agreement</U>. The Transaction Documents,
together with the exhibits and schedules thereto, the Preliminary Prospectus and the Prospectus, contain the entire understanding of the
parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written,
with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.4 <U>Notices</U>. Any and all notices or other communications
or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest
of: (a) the time of transmission, if such notice or communication is delivered via facsimile at the facsimile number or email attachment
at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a Trading Day,
(b) the next Trading Day after the time of transmission, if such notice or communication is delivered via facsimile at the facsimile number
or email attachment at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later
than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2nd) Trading Day following the date of mailing, if sent by U.S.
nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given. The
address for such notices and communications shall be as set forth on the signature pages attached hereto. To the extent that any notice
provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the Company or any
Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.5 <U>Amendments; Waivers</U>. No provision of this
Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the case of an amendment, by the
Company and the Purchasers who, in the aggregate, hold at least 50.1% in interest of the sum of (i) the Shares and (ii) the Pre-Funded
Warrant Shares initially issuable upon exercise of the Pre-Funded Warrants based on the initial Subscription Amounts hereunder (or, if
prior to Closing, the Company and each Purchaser), or, in the case of a waiver, by the party against whom enforcement of any such waived
provision is sought; provided, that if any amendment, modification or waiver disproportionately and adversely impacts a Purchaser (or
group of Purchasers) relative to the comparable rights and obligations of the other Purchasers, the consent of such disproportionately
impacted Purchaser (or group of Purchasers) shall also be required. No waiver of any default with respect to any provision, condition
or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver
of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder
in any manner impair the exercise of any such right. Any amendment effected in accordance with this Section 5.5 shall be binding upon
each Purchaser and holder of Securities and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.6 <U>Headings</U>. The headings herein are for convenience
only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.7 <U>Successors and Assigns</U>. This Agreement
shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. The Company may not assign this
Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser (other than by merger). Any Purchaser
may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or transfers any Securities, provided
that such transferee agrees in writing to be bound, with respect to the transferred Securities, by the provisions of the Transaction Documents
that apply to the &ldquo;Purchasers.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.8 <U>No Third-Party Beneficiaries</U>. The Placement
Agents shall be third-party beneficiaries of the representations and warranties of the Company in Section 3.1 and the representations
and warranties of the Purchasers in Section 3.2. This Agreement is intended for the benefit of the parties hereto and their respective
successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except
as otherwise set forth in Section 4.8 and this Section 5.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.9 <U>Governing Law</U>. All questions concerning
the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed by and construed and enforced
in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. Each party
agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement
and any other Transaction Documents (whether brought against a party hereto or its respective affiliates, directors, officers, shareholders,
partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.
Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough
of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not
to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such
suit, action or proceeding is improper or is an inconvenient venue for such proceeding. Each party hereby irrevocably waives personal
service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this
Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If either party shall commence an
action, suit or proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company
under Section 4.8, the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for its reasonable attorneys&rsquo;
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.10 <U>Survival</U>. The representations and warranties
contained herein shall survive the Closing and the delivery of the Securities for the applicable statutes of limitations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.11 <U>Execution</U>. This Agreement may be executed
in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective
when counterparts have been signed by each party and delivered to each other party, it being understood that the parties need not sign
the same counterpart. In the event that any signature is delivered by facsimile transmission or by e-mail delivery of a &ldquo;.pdf&rdquo;
format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature
is executed) with the same force and effect as if such facsimile or &ldquo;.pdf&rdquo; signature page were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.12 <U>Severability</U>. If any term, provision,
covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable,
the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in
no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts to find and employ
an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction.
It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions,
covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.13 <U>Rescission and Withdrawal Right</U>. Notwithstanding
anything to the contrary contained in (and without limiting any similar provisions of) any of the other Transaction Documents, whenever
any Purchaser exercises a right, election, demand or option under a Transaction Document and the Company does not timely perform its related
obligations within the periods therein provided, then such Purchaser may rescind or withdraw, in its sole discretion from time to time
upon written notice to the Company, any relevant notice, demand or election in whole or in part without prejudice to its future actions
and rights; provided, however, that, in the case of a rescission of an exercise of a Warrant, the applicable Purchaser shall be required
to return any shares of Common Stock subject to any such rescinded exercise notice concurrently with the return to such Purchaser of the
aggregate exercise price paid to the Company for such shares and the restoration of such Purchaser&rsquo;s right to acquire such shares
pursuant to such Purchaser&rsquo;s Warrant (including, issuance of a replacement warrant certificate evidencing such restored right).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.14 <U>Replacement of Securities</U>. If any certificate
or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange
and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of and substitution therefor, a new certificate
or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction. The applicant
for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs (including customary indemnity)
associated with the issuance of such replacement Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.15 <U>Remedies</U>. In addition to being entitled
to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers and the Company will be
entitled to seek specific performance under the Transaction Documents. The parties agree that monetary damages may not be adequate compensation
for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby agree to waive and not
to assert in any action for specific performance of any such obligation the defense that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.16 <U>Payment Set Aside</U>. To the extent that
the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser enforces or exercises its
rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated,
declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise
restored to the Company, a trustee, receiver or any other Person under any law (including, without limitation, any bankruptcy law, state
or federal law, common law or equitable cause of action), then to the extent of any such restoration the obligation or part thereof originally
intended to be satisfied shall be revived and continued in full force and effect as if such payment had not been made or such enforcement
or setoff had not occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.17 <U>Independent Nature of Purchasers&rsquo; Obligations
and Rights</U>. The obligations of each Purchaser under any Transaction Document are several and not joint with the obligations of any
other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance of the obligations of any other
Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document, and no action taken by any Purchaser
pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association, a joint venture or any other
kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group with respect to such obligations
or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently protect and enforce its
rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction Documents, and it shall
not be necessary for any other Purchaser to be joined as an additional party in any proceeding for such purpose. Each Purchaser has been
represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. For reasons of administrative
convenience only, each Purchaser and its respective counsel have chosen to communicate with the Company through Placement Agent Counsel.
Placement Agent Counsel does not represent any of the Purchasers and only represents the Placement Agents. The Company has elected to
provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not because it was required
or requested to do so by any of the Purchasers. It is expressly understood and agreed that each provision contained in this Agreement
and in each other Transaction Document is between the Company and a Purchaser, solely, and not between the Company and the Purchasers
collectively and not between and among the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.18 <U>Saturdays, Sundays, Holidays, etc</U>. If
the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business
Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.19 <U>Liquidated Damages</U>. The Company&rsquo;s
obligations to pay any partial liquidated damages or other amounts owing under the Transaction Documents is a continuing obligation of
the Company and shall not terminate until all unpaid partial liquidated damages and other amounts have been paid notwithstanding the fact
that the instrument or security pursuant to which such partial liquidated damages or other amounts are due and payable shall have been
canceled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.20 <U>Construction</U>. The parties agree that each
of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents and, therefore, the normal
rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation
of the Transaction Documents or any amendments thereto. In addition, each and every reference to share prices and shares of Common Stock
in any Transaction Document shall be subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and
other similar transactions relating to shares of Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">5.21 <B>WAIVER OF JURY TRIAL. IN ANY ACTION, SUIT,
OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST
EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><I>(Signature Pages Follow)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first
indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">IMUNON, INC.</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><U>Address for Notice</U>:</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">997 Lenox Drive, Suite 100,</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">Lawrenceville, NJ 08648</P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 44%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Name: </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Stacy R. Lindborg</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Email: [***] </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">President and Chief Executive Officer</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">With a copy to (which shall not constitute notice):</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="margin-top: 0; margin-bottom: 0"> Imunon, Inc. </P>
                                                                     <P STYLE="margin-top: 0; margin-bottom: 0"> 997 Lenox Drive, Suite
                                            100 </P>
                                                                     <P STYLE="margin-top: 0; margin-bottom: 0"> Lawrenceville, NJ
                                            08648 </P>
                                                                     <P STYLE="margin-top: 0; margin-bottom: 0"> Attention: Susan Eylward </P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Email: [***] </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="margin-top: 0; margin-bottom: 0"> Thompson Hine LLP </P>
                                                                     <P STYLE="margin-top: 0; margin-bottom: 0"> 3900 Key Center </P>
                                                                     <P STYLE="margin-top: 0; margin-bottom: 0"> 127 Public Square </P>
                                                                     <P STYLE="margin-top: 0; margin-bottom: 0"> Cleveland, OH 44114 </P>
                                                                     <P STYLE="margin-top: 0; margin-bottom: 0"> Attention: Jurgita
                                            Ashley </P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Email: <U>Jurgita.Ashley@thompsonhine.com</U> </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">SIGNATURE PAGE FOR PURCHASER FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">[PURCHASER SIGNATURE PAGES TO IMNN SECURITIES PURCHASE
AGREEMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the undersigned
have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">Name of Purchaser: __________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><I>Signature of Authorized Signatory of Purchaser</I>:___________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">Name of Authorized Signatory:___________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">Title of Authorized Signatory: </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">Email Address of Authorized Signatory: ____________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">Facsimile Number of Authorized Signatory: ___________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">Address for Notice to Purchaser:___________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">Address for Delivery of Warrant Shares to the Purchaser (if not same address
for notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">DWAC for Common Stock:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">Subscription Amount: $___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">Shares of Common Stock: ___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">Common Warrants:___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">Shares of Common Stock underlying the Pre-Funded Warrants: ________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">Beneficial Ownership Blocker <FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT>
4.99% or <FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT> 9.99%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">Common Warrant Shares: __________ Beneficial Ownership Blocker <FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT>
4.99% or <FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT> 9.99%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">EIN Number: ___________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT>
Notwithstanding anything contained in this Agreement to the contrary, by checking this box (i) the obligations of the above-signed to
purchase the securities set forth in this Agreement to be purchased from the Company by the above-signed, and the obligations of the
Company to sell such securities to the above-signed, shall be unconditional and all conditions to Closing shall be disregarded, (ii)
the Closing shall occur on the first (1st) Trading Day following the date of this Agreement and (iii) any condition to Closing contemplated
by this Agreement (but prior to being disregarded by clause (i) above) that required delivery by the Company or the above-signed of any
agreement, instrument, certificate or the like or purchase price (as applicable) shall no longer be a condition and shall instead be
an unconditional obligation of the Company or the above-signed (as applicable) to deliver such agreement, instrument, certificate or
the like or purchase price (as applicable) to such other party on the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">[SIGNATURE PAGES CONTINUE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Exhibit A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Form of Common Warrant</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(See Attached)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Exhibit B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Form of Pre-Funded Warrant</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(See Attached)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>Exhibit C</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><B>Form of Lock-Up Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">(See Attached)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 36; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>7
<FILENAME>ex23-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement on Form S-1 of
our report dated February 26, 2025 (which includes explanatory paragraphs relating to the Company&rsquo;s ability to continue
as a going concern), relating to the consolidated financial statements of Imunon, Inc. as of December 31, 2024 and 2023 appearing in
the entity&rsquo;s Annual Report on Form 10-K for the year ended December 31, 2024. We also consent to the reference to us under
the caption &ldquo;Experts&rdquo; in the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
WithumSmith+Brown, PC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">East
Brunswick,</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> New Jersey</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
4,</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>8
<FILENAME>ex107.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
107</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Calculation
of Filing Fee Tables</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
S-1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Form
Type)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Imunon,
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
Name of Registrant as Specified in its Charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Table
1: Newly Registered Securities</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt; text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><P STYLE="font: 11pt/106% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Security
                                            Type</B></FONT></P></TD>
    <TD STYLE="padding-bottom: 1pt; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><P STYLE="font: 11pt/106% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Security</B></FONT></P>
    <P STYLE="font: 9pt/106% Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Class</B></FONT></P>
    <P STYLE="font: 9pt/106% Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT></P></TD>
    <TD STYLE="padding-bottom: 1pt; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><P STYLE="font: 11pt/106% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fee
                                            Calculation</B></FONT></P>
    <P STYLE="font: 9pt/106% Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rule</B></FONT></P></TD>
    <TD STYLE="padding-bottom: 1pt; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><P STYLE="font: 11pt/106% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount<BR>
                                            Registered </B></FONT></P></TD>
    <TD STYLE="padding-bottom: 1pt; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><P STYLE="font: 11pt/106% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposed<BR>
                                            Maximum<BR>
                                            Offering</B></FONT></P>
    <P STYLE="font: 9pt/106% Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Price
    Per Unit</B></FONT></P></TD>
    <TD STYLE="padding-bottom: 1pt; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><P STYLE="font: 11pt/106% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maximum<BR>
                                            Aggregate<BR>
                                            Offering Price<SUP>(1)(2)</SUP></B></FONT></P></TD>
    <TD STYLE="padding-bottom: 1pt; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><P STYLE="font: 11pt/106% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fee
                                            Rate</B></FONT></P></TD>
    <TD STYLE="padding-bottom: 1pt; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><P STYLE="font: 11pt/106% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount
                                            of<BR>
                                            Registration<BR>
                                            Fee<SUP>(3)</SUP></B></FONT></P></TD>
    <TD STYLE="padding-bottom: 1pt; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><B>&nbsp;</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="width: 12%; text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><B>Fees
    to be Paid</B></FONT></TD>
    <TD STYLE="width: 1%; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="width: 6%; text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">Equity</FONT></TD>
    <TD STYLE="width: 1%; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="width: 9%; text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">Common
    stock, par value $0.01 per share (&ldquo;Common Stock&rdquo;)</FONT></TD>
    <TD STYLE="width: 1%; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="width: 10%; text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">457(o)</FONT></TD>
    <TD STYLE="width: 1%; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="width: 9%; text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="width: 9%; text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">$</FONT></TD>
    <TD STYLE="width: 10%; text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">10,000,000</FONT></TD>
    <TD STYLE="width: 2%; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><SUP>(3)</SUP></FONT></TD>
    <TD STYLE="width: 1%; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="width: 9%; text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">0.00015310</FONT></TD>
    <TD STYLE="width: 1%; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">$</FONT></TD>
    <TD STYLE="width: 11%; text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">1,531.00</FONT></TD>
    <TD STYLE="width: 1%; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">Equity</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">Warrants
    to purchase Common Stock</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">Other<SUP>(4)</SUP></FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><SUP>(4)</SUP></FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">Equity</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">Pre-funded
    warrants to purchase Common Stock</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">Other<SUP>(4)</SUP></FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><SUP>(4)</SUP></FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">Equity</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">Common
    Stock issuable upon exercise of warrants</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">457(o)</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">$</FONT></TD>
    <TD STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">10,000,000</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><SUP>&nbsp;</SUP></FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">0.00015310</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">$</FONT></TD>
    <TD STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">1,531.00</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">Equity</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">Common
    Stock issuable upon exercise of pre-funded warrants<SUP>(3)</SUP></FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">457(o)</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><SUP>(3)</SUP></FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="9" STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><B>Total Offering Amount</B></FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">$</FONT></TD>
    <TD STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">20,000,000</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">$</FONT></TD>
    <TD STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">3,062.00</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="9" STYLE="background-color: #CCEEFF; text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><B>Total Fees Previously Paid</B></FONT></TD>
    <TD STYLE="background-color: #CCEEFF; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="background-color: #CCEEFF; text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="background-color: #CCEEFF; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="background-color: #CCEEFF; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="background-color: #CCEEFF; text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="background-color: #CCEEFF; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="background-color: #CCEEFF; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="background-color: #CCEEFF; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="background-color: #CCEEFF; text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="background-color: #CCEEFF; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="background-color: #CCEEFF; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="background-color: #CCEEFF; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="background-color: #CCECFF; text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&mdash;</FONT></TD>
    <TD STYLE="background-color: #CCECFF; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="9" STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><B>Total Fee Offsets</B></FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&mdash;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD COLSPAN="9" STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%"><B>Net Fee Due</B></FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">$</FONT></TD>
    <TD STYLE="text-align: right; line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">3,062.00</FONT></TD>
    <TD STYLE="line-height: 106%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 106%">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>(1)
Pursuant to Rule 416 under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), this Registration Statement also
covers (i) such additional number of shares of Common Stock issuable upon stock splits, stock dividends, reclassifications, recapitalizations,
combinations or similar events or (ii) such reduced number of shares of Common Stock in respect of any reverse stock splits, stock dividends,
reclassifications, recapitalizations, combinations or similar events, in each case with respect to the shares of Common Stock being registered
pursuant to this Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
The proposed maximum aggregate offering price of the Common Stock proposed to be sold in the offering will be reduced on a dollar-for-dollar
basis based on the offering price of any pre-funded warrants sold in the offering, and, as such, the proposed maximum aggregate offering
price of the Common Stock and pre-funded warrants (including the Common Stock issuable upon exercise of the pre-funded warrants), if
any, is $10,000,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
Pursuant to Rule 457(g) of the Securities Act, no separate registration fee is required for the warrants because the warrants are being
registered in the same registration statement as the Common Stock issuable upon exercise of the warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>form_001.jpg
<TEXT>
begin 644 form_001.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !^ 9 # 2(  A$! Q$!_\0
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M?A]=+L=3B9)+/Q!!9+>:U8?H%X3EUZ"UM[#Q#K4/B#5$1&O=3M]-AT>":>6
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M? V\D<,S6][I.II#'+>:'K^E7$,>I:'KMBKC[1I6H6R3PX4Q/+8B.\/X[?\
M!<#]M^U^$OP+N?V7? M])+\6?CO86VG>+4TEFN+WP5\)[V_M8[ZWNK6#;.-8
M^*217G@W0])^S27]_I#^)+L6T!73);C\9?A=^TS\6OV5]7A\??"'78-,O392
M6FLZ)JMJ-2\*^*-):&:.WL->T=V@@NHK&4I>Z7=0W,6H:=>1PR6L\%H^HV.L
M_77[%NG_  T^+7Q*\,?M:^,?$%G^TO\ M8_$[QEXJ/P/_9\35UGOO!OC'P[(
M=+\7?&G]H75$T][#P1X+\ Z5#::KH%S<Z%%IPTR31;;P]I?BCQI?>#= T?\
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M&LSQZ=KJV^P-_9&KW-J[MXMT:&XBCD7POI5AXCU>WN\/:-:(TLX^6?AO\?\
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M1)R=K1?+M*=.+2<D/+<BQV:TIU<.Z,(PJNBE5ER<[4'/FN]DU%JZTO9:/?\
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M8<$0:_XV\2>*?$=Y;M$&/DNNC_\ "/7.&4321WJ2.[JL17^[V<KET. ".PZ
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MNM#]7/\ @A;\.!\1?^"GG[/4LUK]JL/AQ:_$;XI7RM&7BA/ASP#KVEZ/<2.
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MU2<I*"6EY5*D>2/K[RCY^1\*XJ5XPCI+11TU<FE;MJV?YGG_  52^)*_%O\
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MFT?Z3UU/;V$-SJ-U*D%G9037EU-(P6.&WMHVGGE=FX"I%$S,Q( 53G !K_*
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MQ<W=JW,I0C.*V?OJ3VL_].R](<Q1G&YQ(%7H2!L=MH.!DJI4<$"1U!X.UO\
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M=B9J2:3HT?:*BVDG>*:CR+?JT?@9_P $Z_AO_P +9_;U_9!\!M#]JL]2^/\
M\.M:U*)(P\4FB^!_$47C368)T8C%C=Z3X3O897W$BWO54*S)N?[7_P""[/[(
M@_9F_;C\3^-?#>F36GPP_::M;GXQ>';F*V:.QTSQQJ-[>1_%?PVSF3R3>0>)
MHG\=21 0A]/\<6UE:1%=,9WW/^#>;X?R^-?^"EO@GQ'):/-:_"GX9_%GQ[+/
M\NRVO=5T'_A7]HTW&/+9O&\8A8$,);>U\Q5?<@_IY_X+C?LAG]JS]A[Q=?\
MA_2UU#XI?L_-=?&OX?16L+3:GJUGX?TG4%\?^#[1(D-S=GQ!X+_M"_LM*MB9
M-0\2>'/#V8]UO$Z?L/%7'$^'_%;A[ 5:Z>65N&XY3CH<[4:#SC,'BL/C:VEH
MT\JQF&HTI73G&EC))*I&3E#Z#'YE+ \08."O[*6%IRK:VA&O7JN47+_IY:47
MHK<LE>ST7\X__!N]^UU#\"?VM]>^!OB?58-/^'_[2OAF?3+>YU*YM[72="^*
M/PVL-?\ %/AJ_GN;E8A:PZ]X?O\ Q9X;-U)/;)<:A-HEM<OB"!5\>_X+.?\
M!3&\_;L^.$/@;X;ZQ(?V8_@GK6H6OP^2V=_[-^)?BR,7.G:M\7KZ%H8)Y[:[
MLYKK1/!%G<&2VM/#-Q>ZCY,LWB6=H_Q?A>1%BEBD>.55C*3*Q22(E5'F*8V
M#KDL%!"L<J2$)S])?LB?LJ_%#]LCX\^"O@-\)K&1M<\1W,5SK.O7,-S<>&_
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M=9UZ>VN=6U*?;%:VJF'3;*WMM*TS3;>S_P P#XG>/;WXI_$GXC?$_4)&>_\
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M]:!&%Q#.B'+JJ'\/O^"EGQ"'Q2_;_P#VO?&4=RMW;3?''Q?X;LKF.3S!+8^
M;F'P%:.I)(VBW\,H%&<$#>,!]H_K#_X-GOA\?#'[#GQ#\>S6[1S_ !2_:%\:
M7EO<,6+S:-X.\-^#?"EFJ*45/*A\0VOBUE99),I/&Q(D::&#Z3C*M/ASP0P&
M7TDJ>(Q&5\)9734;P<)SS2OF=5*S35J,*=:;B[J-.$G:7NG=F;_L[A:G3DK2
M;P,(5+:JRG.MRO=7DJ?-=;M-;.W\E7_!0']DW6OV*/VK_BI\"M0%P?#&GZJ/
M%'PKUNXBRNM_"?Q9=W-WX(OS,)+FWN;O2;+S_#NOA&*KKGAG51%$L$\,<?[C
M_P#!ME^VI+X-^(?CS]B'QK?F'0OB0M]\3O@O]LN<PZ9XZT.P5OB!X,M,Q.&/
MB+PO90>*+6W^TQ_9]3\'^((O(>;4FDC_ $(_X.*/V+)_C=^S=I7[4'@K2C>?
M$C]F5;N?Q/#8P.]]XC^"/B.[L+;Q1:/Y-L]Q<W'@#5[BS\=:>[7$,-AH/_">
ML?/>=;.Z_B;^&7Q&\8_"'XC> /BQ\.]7;1?&_P .?&/AWQIX5U*)FQ;:YX=O
M_P"V-.CNU4,)]/O'TVXL=4TN:)DO=.>]BNE6,)!>>ADN)P?BMX6U\#CZJAFF
M%PTL-.LWSUL+FF7T_P#8,PJ6BY0AFD(JG*:4G44I1<:25WTX>O#B+(?8XBJE
M7C"\E-WG[:E"U!.T;<TX:PMI9RO9V/\ 34_;V^*1^$'[%'[5_P 28YEBN/"G
MP ^)UWIC;FC+Z]J'AC4]'\.6\<ZY\N2[UJ_L;6"?85CED65E*<5_EV(K);Q0
M1N99! EM"P!5)BMG)!!A>@WV\:21]V4%<J1FO[FO^"JG[97A+X[?\$/[/XT^
M#+F.UL?VG/\ A2/AZ72[:5;D^'_$-]XFLO$WCCP1>2Y61-2\+:OX(U[P]J:M
M$)#-8JSQ16MRLJ_QH?LZ^ &^*_[0?P)^%RJ77XD?&/X:>!YUV-(JVGBKQGH^
MAWD\L:)(TD5M:ZA+<LOEN%,2N5(0UYO@;@99!PQQ;B\P@L/6H9^Z..P]2,H1
MA'(<KQ=#%.2DF_9X&IB&G:<N55XN+K<W,L.&J#PN78_$35JOURK0E&6DH1PV
M'J*3](8B-]&[3VN?Z+UG?Q_L7?\ !+JRU18SI5Q^S7^Q#IVH)"RL'M_$/P]^
M"\,Z*ZPB1_/?Q#8!FV[R;F0LS-\Q/^:!/<W%Q)=7]_+)+>W<\]_J-S*QD>XN
M[S%W=W#,RJS-+/-(TC,-SS;Y9-TDDKO_ *4O_!7>.:W_ ."9/[9D>GJ;8)\%
M=2M52%<&WT\ZEI<5P@5-P6*+3Y9EEQD1Q+(P)"C/^:A<[/L4Z\(AAF8#^((+
M:>\C&.G[E#'&V&PL@*J2H#G/P"I1EE7%^>U(VQ6-S/"T)QE9U5[_ -9YFTW>
M]2OSN[:<W>W0SX5<O99ABHI^]5J0FEKSIVJ._75S;=K7:;N?Z0G_  1J_9\T
M_P#9T_X)^?L_: ;..U\5_$GPP/CEXZF7>L][XA^*<47B&R6[+;A--HGA*Y\*
M^&HV+;D@TA,%5EE1_P!68 55@?[Y(^F%_P __7KRGX+_ -FK\(/A)'HWF'1H
M_A?X"71Y':(!M.7PIHQL7VQ2RJS-:-$#AG0%7*.R[6?U>+HP]&('TP"/Y]^<
MU_,>=XVOF6?9MC\74G/$8G.,UE)N7,I<E>M"\M-U"$(QO:RBDE9(^&Q=9XC$
M5JSNI5*D^=O5SY9S2;?]U62T6BZV):1AE6'3*D>G4>M!( R:1R I)!(P<@8Z
M8/<D #W) ]:X6U%<ST5]'YW_ ,[?YG/MK_6A^*G_  7_ (-,;_@EY\<'OS^]
MLO%GP4NM(?9'))_:T/Q?\'16JJ9'01F>&>XMY9%5BMO+-\A!)'^?UX#,D7C[
MP*UN76:/QSX2>U> !F$D7B73S;20;AABI6-X"1AL(2 #7]EW_!S3^T+IGAW]
MFWX+_LY:?<;_ !'\8?B-/X^UFSBFB'D>"?A3:JL;:HD4[S1V^I^,/$^BC2XI
M;8I>R^'=7:.:)]*E27^5W]@WX1WWQZ_;9_99^&%G:37EOXF^._P_O-?2"+?+
M'X-\-^);'Q3XVO6PLODK:^$M#U>Z9@K(+DQ(SK +FYM_ZQ\&J=7*/"_.LRQD
M7"G6EQ/BZ=2JK*=..7XFBW&^C2G+DTC9M12<FT?HW#?^SY+B,14O2I26+G[1
MZ*4982K3C+JWS3:BDHZMK:]U_HG?M_?$K_A4'[#W[4_Q(>9X;G0/@%\0WM)6
M<12QZSK'AV[\/Z/Y,BAO*NI-5UJW6%R&Q.Z9P!@?Y>R1S>2D-NJRW!5(XU*C
M;)(PVX"'Y&W'(6(C#G$9Z[J_T$O^#A'X@/X(_P"":'Q+T19H(;WXL_$/X1^
MX=DC1W+V]GX[TSXAZK':NJ*SO)I?@)[*4,OS64LY(##*_P -?[+OP^/Q8_:?
M_9V^%B(L\7Q ^/'PE\%7*,QB2?3M=\=Z!INIC>(W,<?]ESW32N8R$3>Q  )K
M#P$4<MX1XCS^3C"#S"KCX7=HSADN5XBO4DFTURX7ZT^:^B6(T4VVH8<+I8?*
M\9B^9)^WJRFE=-4*>$J-N6B7LU53^&_O=.B_L _X*F?\$Y%\=_\ !*3X 1^#
M=%>Z^+?["GP-^&MSI*6T0DUCQ%\/O"WPR\,^%OBUX7\SS!(UW!:>'],^(ENS
MS27DVL^#%BM)&GU.[,W\4GA/Q5XB\"^*?"_COP9JMQH'BSP3X@T7QCX5US3W
M,=SI&O\ AC4K;7=&U"T7"(9[;4K&VFB#0[I700O"\;/"W^LS>Z<FHP/;^3:S
M6T\-S;S17D2W%O-9W,;1RV;PO&Z7%I< 0FY@G5K>Y@0121OY@>+_ #7_ /@J
M=^QD_P"PY^V1\0_A7I&G7=I\*O$3K\1?@A>2>;*'^'7BEEG;18;B53]K?P/X
MB;5?!5WY\\T[0Z!H>J-/%-K]U')YG@3Q:\S6=<(9A^\K5%C\UP$,7)3H5(8B
M&,GG.6N$W>:FJE'$2I<UG5E>,HJ\5'"V8^W^M8"LZLY5*U>M1@I)RJQKIQG#
M5V<:5^=)R6[2O8_OZ_83_:NT#]L[]E;X3?M!Z$+*SOO&'A^WMO'&@VC>8OA7
MXBZ$D6E^./#C,2)/)L-<M[B72Y)E22ZT6[TN[V[+F-F_EE_X.@/B$NK_ +1'
M[,?PLBF0IX'^$7C#QM=0K-EUO/B5XMM-)B\VW"@(MO8_#F)H) 27&H,IX45Q
M_P#P;E?MHGX2?'?Q5^R'XTU=;3P#^T*9_$GPXAN+D16NG?'/0M)M+:ZTZW^U
M2I;P'XB^"],6R8-*S3ZUX+\*Z;;V[S:B6C^./^"\'Q$;XA?\%/?CU%'=?:M/
M^&NB?"[X6Z6^_)MTT+P#I.O:]9*@++&L'B_Q/KY;:Y+,R[U23S$7AX-X*K<,
M^,U7"N%2IEV%RK,LYRNI.%_:4,QK87#X>G?9?4,7B:V'IQNI0=&GS<UXR>.6
MY;+!<2U**C+V,<-4Q-"4DESWFHQAN[MRJ2BM$KQ6O5_0O_!ME\-_^$M_;_\
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MA>(=)N+FSO#!=07%L_DW5GY6HQ6&IZ9_9O\ !?\ X.0_V$_%?A'2;CXP:/\
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M9I$#%OTFC7E@5. !C.><YS[?E_A3DC*J%+!L#' (''IEF(_%C[FG@8S[G/\
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=E*[;;?A22YI24N:524IRNMG)MV]$V[):*^A__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>ex5-1_001.jpg
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !3 X0# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]5/@[_P $
M(?BW^T#\2?V@/VQOVE/V[/V^OV9/B)^TU^T%\7?B[I'P+_9A^-\_P?M_AK\.
M-6\;:O8?!K0O&VK6Z>*VUSQMI_PGT?P!%J45E;Z%%X6AM;?P<\%Y/H;:E)YQ
M_P %,/\ @E-KG[%7[!/[4/[4GPW_ ."J'_!8GQ/\0?@U\.E\5>$-+\<?MY>-
M[[PG-JG_  D6AZ85US3]!T7P_JM]9-;:A/FWM-;TYS*L3F8A2C?UUU^/W_!?
M7_E#O^WW_P!D63_U,?"M;0J3<HIRNN:"MRQ?N\T8J-Y1D]$VOT,)TH1A4DEJ
MH3DW>2YI<KU]V44KO7RZ'\^__!#K]A#XB_\ !33]B.Y_:-^.'_!4#_@K=X/\
M>V?QP^(WPX^P_"W]NGXB:1X8FT'PIIWA*[TN9].\56GB_4%U1IM;OC>7*:N(
M)T\A$M(?*8R?3/\ P4'_ ." 7[0>C_LS_&'QU^S)_P %5?\ @J9\2O'7P]^'
M_BCQUI7P.^-?[1/Q'^,FC_%H^%=%N=:N? 'A^P\%7'A+7X/%WBF"QN-+\+!=
M)\61WVOW.FZ7_8A6Z>[A]Q_X-(_^45.J_P#9V/QL_P#3'\/:_9W]N;]NKP=^
MP%\,+_XX?%SX.?'?QE\%/#MK;W7CWXG?"'0OASXMTCX<'4-<TKP]HL7BWPSK
M7Q1\*?$66+6=5U>U@@U;PKX*\3^']*0-+XEUC0U>W\]RJ35:<8VMSV4>6GK?
MI=03\M&O\XA"$J$)SV=.\G*4VEW;;D]--;I^FY]KV$<T-E:0W#;YX;:WAG?>
MTF^:.%%E;S'^>3<X8[W^9\[FY)JW7R#^Q3^V-X3_ &Z/@OH7[0GPT^%_QA\!
M?"7QI;QZC\-O$GQ>TCP)X=NOB5H1N;ZQN/$GAOPYX7^(GC7Q/I.BVVHZ=<V2
M/X]T;P;>ZNAM]8\/6>L>'KRTU>?T[]H3XT7GP ^&NK_%"+X/?%OXT:5X:CO=
M3\4Z!\&+3X?ZKXPT'PMI6C:KK6L^+/[!\??$3X=/XCL-+@TP6SZ#X)N/%'CS
M4[V_L;?0/!^KJ;R6SQL[M.+4DVFG:]T_6V_GIL=*:Y4T_=LFFKM6LK-:7M\C
MW"BOS0_X)X_\%1O@U_P4X\.>)/B#^S9\*_V@+3X1>%K^_P##U]\8/B?X2\">
M#?!-_P".-.@\-:A=> -#L(/B?K?Q U?Q#'H?BBQUV75;/P/+X'M+2"ZT_4/%
MMGX@DL-'O?K#]I/]J3X ?L@_"[5/C3^TE\5/"WPE^&NE7=KIC^(/$<MY/<ZM
MKM^L[:9X7\)^'-&M=3\4>-O%^K+;7+Z1X/\ !^BZYXGU9;6Z.G:5=>1*4333
MLXOF_ETNO/=B4DX\R::?6^EO70]_HR.F>?2OR:MO^"GOQ-\4:;_PEGPN_P""
M4W_!3+X@_#H---!XQU#X?_LY_!_4]=TI&/V?6/#'PJ^.O[2_PV^,UW;7\0^T
M6-MXA^'WA;4KF!X9H[(QS1L>G_9)_P""NO[&W[7GQ3U?]G?0];^(7P*_:L\/
M17,WB+]D[]J?X<:_\"?V@-/AMK*34Y&T[PMXF$V@^,W32(9-<N+?X?\ BCQ7
M<V.@(==U&&TTIH[MZY9+H_E9_DWIY[=V@YX_S+ROIK>R6JCUTMN^B9^GU&1Z
MTP-E05Q\W0]1WYX(R.">",U\U?LX_M8_!S]J:;X[V?PGU>^O=4_9O_:$^)O[
M,GQ:T76+&/3=5\/_ !0^%FI066M1);1WEZEWX?UBSO+#6_#.M12B/4M,O52X
M@L=6L]5TK3Y_K\;:O_@E>3MS/97ZK?S/IBC('4XH'0<8XZ>GM7S3^U)^U=\'
M?V/OA_X4^(WQHU>YTK0/&OQB^#WP,\,V^G1V,^J:MX]^-?C_ $3P#X9M;2WU
M'4M)M6L=(;5[SQ=XJN6OA/I?@GPUXFUFUM-3NM.ATR\/Z\PVWT77^OO/I:BL
M7Q#JM[HV@ZYK&F>'M8\6ZCI.DZEJ-AX6\/3:!!KWB:]L+2:YM?#VB7'BG7/#
M/A>WUC69XDTW3IO$OB3P]H$%Y<0R:SK>E:<EQ?0?B]X?_P""ZGP1\7?M _%+
M]D_P=^R!^W_XP_:7^"=C?:C\5O@SX8^"WPSUCQ)X*L--GT.VN[^_UJT^.;^!
M=0TUI?$N@?V9JN@^+M6TOQ#%K&G7/AN]U>VNX)9&HRE?EBW;5VMHN[NUIY[$
MN48VNTK[;Z^ED]?+?R/V[HK\N_V7_P#@K_\ L9_M1?'/4_V5K#5_BA\"?VK]
M)M;N^NOV9?VH_A'XS^!'Q?N;.SL/[8EDT+3O%=E_PC7BNX;0A+XCATOPKXGU
MK69O"]K>>*(]./A^SN=2B^J?VK_VO?@5^Q;\+8OBQ\=_%%_H^CZMXHT+P!X&
M\+^&/#>O>.OB1\5OB=XMEEMO!OPL^%/P\\*6.I^*?'?Q!\77L+V^C:#HNGS&
M.&&\U;5KC2]!TW5-6L3EE=+E=WJEW6NJ>S6CNT[*SNT"E%IM--+1^3TT?5/5
M:-)ZK0^FZ*_%?XE_\%DKKX%6?AKQ=^T/_P $T/\ @I%\$_A#XK\4>$?"5C\7
M]?\ A_\ L\>+?#/AO4_'/B#2?"_AFX^)VE?#3]I7QIXD^&6FZEKFMZ;ID5QX
MFTN&?^U;VRT86QUB\M[%_P!I\@8!(R>![D#G'KC!)] "3P*&FK-JUVTOEZ-@
MI1E=)IM;K6ZOKK=+==OG86BORIUG_@K=\%/$OCOQ3\-/V2/@S^TK_P %!/%7
M@/6+_P ,^/\ 6/V0O 'AG7/@WX#\56$,$\_A?Q-^T;\7?'GPA^ 4_B*))T^U
MZ!X2^(OBO7M/<307VEV]U;3P)Y;XR_X+<?!S]GOQ#H&C?MX?LK?MJ_L"Z%XE
MO8-(TCXO_'7X3>%/'O[/\^NWKR1Z=H%U\8?V9OB-\=?#VC:O>R0S,L'B.+18
M+6SB?5;^ZM-)BFOHGRRZ)O2]NK^5[^6WR!SBOM);;WMKKNE;;K>W=G[445S7
M@[QEX2^(7A;P]XY\!^*/#GC;P7XNTBQ\0>$_%_A#7-,\2^%_$_A_5+>.[TO7
M/#_B#1;J^TG6=(U*TECNK#4M.O+FSN[:2.>"9XV#5\Q?#']N?]GSXJ_M:?M(
M_L1Z'XFGTO\ :-_9?M_ FM>-_ 7B*"UTZ[\3>"/B%X!\%>.](^(7P\ECOKD>
M*?">E?\ "<Z7X3\6RK'9ZOX3\5"V@US2;/2/$G@S6/$LJ[Z-6UDGO%>:5^HW
M)*UW\3LO-GV%12 @C((QZY_S^'K7YP?M]_\ !2[X9_\ !.+PK#\2OV@O@E^T
M?J7P6EO_  YH3_&CX6^%?AMXZ\%V?BSQ3<ZC;:3X2U30T^+6E_%'2M1EEL(H
MEUG4_AW:>#;J]U32-*TWQ/>ZS>C3HQ7DXJ*;YMK>EUO;?H$FHIMM)+5MWT7=
MV5_P/T@HKSWX5^.-8^(_@3P_XUUWX9?$#X/:AKUM-=O\//BDO@F/Q[H-NMY<
MP61\0V_P\\;?$/PM97&J64-OJ\&G6_BN\U33K._M[+Q#8Z+K\&HZ-8>A4#"B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0-7U?Q-:?$']H>QTJ39ID_Q)U:#P'%K&D>(;VQN-5TS0?'7A"VAN4O\ X?\
MAJ\L.G_X-$F:7_@DU?LS$N_[4WQC+,222[>'?AL68D$$G<22002>A[U\G?\
M!I]K<GPD^*'_  53_8J\?>3H_P 6_A9^T#I7BN^T.[+1:MJ2Z'KOC[X1>/+F
MW@+S*]GX9U[PCX6%[-'*Z+_PFFDA);B.Y68Z32Y\5*VL9))_W6X\S].EUL8T
MW[F#C?W6FW_>:A)QCZ7NU;>VY_9R$!4@CACDCGOWSG.>,^WMBOYR?^#DO]A+
M1OCS^Q+XE_;'^'%O>>#OVM?V!K"#X^?"_P"+_A"6;0?'EI\// &IP^*?B1X=
M_P"$ITN2#5(+7PKH5OJOQ7\&7*,]WX:\=>$;271+C2K7Q#XG>_\ Z.:^ ?\
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MDFH:)XAT+48RES9WMNV'5XSLN;&\MG@O]-OX;;4-.NK2^MK>YB]!# E@.JD
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M\:^!?!_@.3]GC]LGX^?LD:=;^$O$6M^)D\7'X":W9Z!J/Q"O9];T+P^^A?\
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M8K/KI9I-O17>RO;J"FG:VNC>G6UKM+>ROKV>A^QU%?C/=_\ !0WX[Z5\8_\
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M;0-9\9ZQH5EXP\#R^)TXM='TUZ:ZK7;5:C4DVE?5]+-=6OS37R/O^BD!S['
M)'UI:104444 %%%% !1110 4444 %%%% !1110 4444 (2 "3T )/T'-?@Q_
MP<&>,_&WC;_@GQ\>_P!DKX'? 7]I+X\?'GX\Z%\.-(\+:#\(?V>?B[X_\(Z7
MH ^*_AS7/%&M^*/B=H/@Z]^&N@RZ9X:\'^(#'X?N_%1\62:E<Z!C0H=-U5=5
MA_>9\['P,G:V!ZG!X_&OR_\ VLOVSOVLO@-\5T\"_!C_ ()^?$?]ICP8WA71
M=>;XE>&/&5QH&F#7-2NM3@O?#2V,'@#Q'$]UH\%A8W,\XU+?*FI1K);Q&(._
M)C<QP^54%C<5'$3IPK4X)87"8W'55.;:@_J^ PV+KRA>+YY*CRQ2O.<$TSZK
M@[@C/O$'.?\ 5SAV621S&I@L9C;\0<4\*\'Y=]6P<:+Q%\ZXQSWAW)HXFV(I
M?5\)/,XXG%R<X87#XB=&K&'XH?\ !M/XK^+'[$'[,GQ-_95_:Z_9._;5^"OC
M'7_VD]3^)_@#7]6_9!_:(\3^!O$'ASXA>!?AQX0:QN/%'@+X;>*--\*WWA[Q
M+X&U&YUJ;QC<:)IT>F>(-,U"WOIK6UU=]+_47_@O^_BGQA_P3"_:*^!/PR^%
MOQD^,?Q>^.VB>%_"GPY\#_!WX0?$KXHW^H7VE?%+X=:SKMUK>H>!/"OB'1/!
MMCI6@17NL1W?C+4=!M]9CT^ZL]#DU&^AEMTY'_AYQ_P4-[_\$>/C5[_\7+O?
MI_T2,T#_ (*;_P#!0L?=_P""._QJ'0<?$N]Z#MQ\(A^'\J\5\9Y*ZGM%'-K\
MRDU_JYQ/JU;J\CNMNB/UF/T5O%R-/V7M?"MQY7!2_P")@/H_W2::^SXLV;5W
MO;IT1Z;_ ,$,O%>LZ;_P3E_99^ GQ"^&'QM^$7QD^!/P>TOP3\2/ _Q?^!/Q
MA^%,FD:AH6NZUHMF^F^(?'_@O0?"7BI=5L+2TUF%?!_B'7FM[._C^VQV,T5Q
M;6_Z _M9?$BV^%W[.GQ>\62>&?B)XRO(_ /BW2]"\)_"WX:>.?BQXU\1^)=6
M\.ZI9^'M$TGP?\//#_B779Y=5U5[;3UU"YLK70M.DN8Y];U33;'?=)^6)_X*
M<?\ !0P_\X=_C5GW^)=Z>/\ PT5>E_!C_@H%^W!\1_BS\/? GCS_ ()>?%?X
M2>#/%?B>QT;Q-\3-8^(%[?Z5X)T>ZWB[\07]@WPSTI+NWL@%W0RZC8QNSK_I
M4;A%=T^+,HKXBG2IK->>O6A"$9<.\1PA[2K4C&*E5J9/2ITX<\US5*E2%.G&
M\YSC&,I+FS#Z,_BGE.5X_,L7/PR^J97E^,Q^)^J^.O@7F&+>%R_!XC%XCZME
M^!\4\3CL=B7A\+6]A@\%AL3C,76]GA\)AL1B:U##UOSP_P"#6NP^*'[.'[&7
MB/\ 9+_:1^ 7[2OP*^,G_#0'Q \>Z!IWQ2_9Q^-OA'PAKG@GQ!\/?A[>0:Q:
M?$C5? D'P[TZ1-6T'Q+ICZ+K7BNPUI[VTM8[:SN#J^F)<;?_  4:_P""8O[7
M?P0_;OT'_@L/_P $G=/\->)/CZ-.73/VH/V4M=U6S\,:+^T7X8CTS3M&\07G
MAR_O;K3-".N>*_#>B:+#XJ\/7]YI<]QXJ\*>%?B?X3N;OX@V>IZ5XK^T/^"G
MW_!3C]IW_@F'\/-7_: \4?L7?#?XX_LWP^/_  ]X(M?&'@3]J[6_#GQ*T%/%
M)>T\/:Q\0/ASXD_9G.B:/9ZIK:#0(O\ A%/B'XT^R:I>Z/'<M]GU">[T_KO^
M"57_  4=^/\ _P %.?A=I7[20_9(\"? +]F[5]?\<^%-$\1:[^TKJWQ"^*WB
M76?!-^=$O-2T'X>:3^S_ .'O#"^%!XGMM3\-76I:[\2M&UR&_P!&U2YL_#=[
MIZ6%UJ/U;]HI2KI0Y9MQDN>\6VM8VM?H]]5;5W1_/D532CAW*3E!7C[MI+E;
M2EVBT[K>^EK.^O%_##_@NA^S]JFB6>G?M&_LU_M]_LE?&2**WAU[X/?$;]B/
M]IOQYJ$>L%1%<0^#_%OP@^%?CCP_XST&:]62#0M98:#J&LVYAN)?#^FW$DMK
M#X/^U)X"_:E_X+?VOAC]FRW^#?QF_8F_X)G#QKX:\8_M'?%#X^:$?AE^T[^U
M=IO@?6;/Q)X>^#WP>^!>H7-SXP^$OP[N]=T_2/$&O_$SXP:;X<\27-]::%-X
M>\'21^&=:T3Q?_1B/P]L>E?+?[3OC_\ :I^&WAMO%7[-'[/GPM_:(DT30?$N
MM^)?!7C/X_Z_\#_&VJW.E6EO=:+H'PV6V^!GQ5\)^(=8UU4U"V#>,/$_@#3;
M/4$TRW?4'MK^[OM+R4DK.,%%WTO*ZC>^UTUI?3M>_2QJT^5\\G)6U2BDW;5[
M/RU7:Y\D_P#!4'4[#X&?\$Q/VA/@9\#/A/\ $SQ#XG\6_LJ_$C]G']G3X2_
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MLWUT["4*<$Z:?+[9M14G;XD_=C=NUDVTE9)OS/*/^"%_QXUC3O\ @GU^S/\
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M/Q[P!P&G'&RQ,<-]2?'/%G"ZS)IX:L\0LMECJF#2HRQ4,/3Q.'E5^5/V-/\
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M#O\ &G_PY5[_ /.CK/\ UPR;_J;_ /B,\3?_ #D-/^)6O%O^;PJ_\:"\ ?\
MZ;)^[&\>A_3_ !HWCT/Z?XU^$_\ P\W_ ."AO_2'?XT_^'*O?_G1T?\ #S?_
M (*&_P#2'?XT_P#ARKW_ .='1_KADW_4W_\ $9XF_P#G('_$K7BW_-X5?^-!
M> /_ --D_=C>/0_I_C1O'H?T_P :_"?_ (>;_P#!0W_I#O\ &G_PY5[_ /.C
MH_X>;_\ !0W_ *0[_&G_ ,.5>_\ SHZ/]<,F_P"IO_XC/$W_ ,Y _P")6O%O
M^;PJ_P#&@O '_P"FR?NQO'H?T_QHWCT/Z?XU^$__  \W_P""AO\ TAW^-/\
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M\GX;_P##S?\ X*&_](=_C3_X<J]_^='1_P /-_\ @H;_ -(=_C3_ .'*O?\
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M+G3[U8;VV=)X8W'X[?\ #S?_ (*&_P#2'?XT_P#ARKW_ .='1_P\W_X*&_\
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MTO9_ZL\37LVG:_\ 8FUUIV[B_P")6/%J]^?PJ>U[_2"\ +-I-)V_XBSO9O\
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M>U/6_$NF2:MIUC_9MY#B?\/-_P#@H;_TAW^-/_ARKW_YT='_  \W_P""AO\
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MK7Q,T*+X@^#_ (A?#FZU6^L%\8_X>;_\%#?^D._QI_\ #E7O_P Z.C_AYO\
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M5^U+HVI>!?%>K:)X2\>>&/ MC/X0^(&A>%?$VN)XK^$'Q%U7PWK^E_%;X/\
MC*."SU+P[K&GW5F)M3?4;>#=_P"'F_\ P4,_Z0[_ !I]_P#BY5[_ /.CI/\
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MI5M<SG6K7XBSZ;JENF@3ZK=VOA__  \V_P""A?\ TAV^-'_AR;W_ .='0?\
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M7O$4OACZ8_X>;?\ !0OI_P .=OC1C&,?\+)O.G3'_)(NF.*7_AYM_P %"O\
MI#K\:<^O_"RKSWQ_S2+U)_,^M-<99.FFO[6NDHZ\,\2[*7,O^9+KK^&GF)_1
M8\6G>\_"S5MV_P")@? &UW'E=O\ C;&UM;=]3DO%O[(G[8?PJ\+_ /!2OX-_
M"WX:ZU^T!\%_^"@7[/GQ/\1_"_QI\0OC!X-O?VG?@+^T'XQ^ ;_!J+X#?'SQ
M[\2_&UW=_&7X*:;#;>'9/A7\1['XA>/?%GPHTJRUKX?7VG^-?#T7A_Q2+7_!
M.S]E?]MK_@G38_!7X=>$OAU_PL7]D?XI?##P->_&OX%:A\3/!$GQ=_8S_:LL
MO"&C:7\7/'/PB\3:_P"+)?"GQ5_9T^-'C'3-1\;:]X!D\?Q>*? WBC7KWQ-X
M!TRSL;_5? $_1_\ #S?_ (*%]_\ @CM\:3_W4J][?]TB-(?^"FW_  4*_P"D
M.OQHS[_$F\/;'_1(AV)'T/IU'QGD[33>;=+_ /&,\2IMI63_ .1+O;T[V&OH
ML>+2:?-X672M_P I > .SES?]'9[_A]Y^[(<#W&!@C'/X9X]J-X]#^G^-?A/
M_P /-_\ @H9_TAW^-/\ X<J]_P#G1T?\/-_^"AO_ $AW^-/_ (<J]_\ G1U'
M^N&3?]3?_P 1GB;_ .<A:^BUXMV^+PJ_\:!\ 5^'_$63]V-X]#^G^-&\>A_3
M_&OPG_X>;_\ !0W_ *0[_&G_ ,.5>_\ SHZ/^'F__!0W_I#O\:?_  Y5[_\
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MX1^.K/6-/U716T;^_A?NK]!_+\?YU^"?_! V^6Y\#?\ !4RT$V]]+_X+9?\
M!1&V:,*5, F\7>#[Y8RVU0Q?[6TV07*^9M)7 1<(2<5*2Z<K::NG=\MFNMV_
MQ\CHJ0C/DC)?S6:WC)1NFNS35_E9Z.QZK_P1P_X*^?##_@J;\$+F:[M-.^&G
M[5WPHMK/2OVB_@1(]U97.B:LDITQO'O@73=9GEURZ^&GB+5(+BWC@U%[C7?
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MY(WM>R;M=]';K\_POU'[1V^U>UTN9WDKV]U<WS^X_H<\(_%[X5_$#4_%&B^
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M*?%*>,[WXZ:_'%?>'KGPSJM]I>N7NL6.E:;>>)->NKO4]1X[XQ:LWA/X3_\
M!O5^U]K^C7?C[]B_]GG3/!.J_M6ZIX2T6X\<Z;X!U_5/V1+CX<_L]_';Q[I.
MA6.J7W_"%?LZ?%;7_&-_K?B:YAEB^%FM:]-KDT5EJ*R3P'LX]>9/F:W72*??
MN[+7KWT'SROIMRJ6KGU;3ZZV2N_7MJ?OK\-/VL/V9_C*/'8^%/Q_^#OQ!G^%
MMK%??$_3O"WQ \,:KK/PWLI[.?4;6\^(&AVVHOK'@NSO-.MI]2L;OQ)8Z;;W
MNFQ/J%I)/:*9:Z;Q;\??@AX"^%UA\</&OQA^%WA/X+ZKI_AO6-+^+GB#QQX9
MTKX9ZEH_C);-_"6KV'CJ\U*+PS>:5XG34=/;P_J,&I/9ZP+^R.GS7 N[8R_@
M#^VOXH^&?[0/[>G[.'[5O[)GCCP9\2/ G[-?[#G_  4)A_;4_:$^$/BO1/$/
MPUG^$7Q$^#45C^SK\$?%/Q2\/:E<^"/&'BR^^,SW_P 3?"7PJ.OWVN>'-/TB
M[\?:CI>DZ9J^@:AJWQ!<?#3]HS]B7_@G?\.?"7P?M?$O[2O_  3-_;(^$'[/
M$]GX8T&[O/&OQ!_8 _:"\>7WPZUGQ&FD3ZGJ-QJ/B/\ 9"^)'C\ZM:>)M)N;
MRXU;X'>,=;N[J&Q_LYM6L?%2Y(V3ONTK=E9MV=^ROKWLM=!.<DY;V2;4E)]'
MH[-ZI[.VS/[,X+B.ZMH;RWEAFMKF**>"9 #'+!.BR13(W>-XW616QG:<D#G'
MYM?\/-_ ]]\1_P!I+X8^%?V8OVQOB#K_ .R5XPTCP5\='^'GPH\%^,O^$:U/
MQ%X;L_&GAF?0-!T;XI3^-OB)!XC\%:EI7BS2[+X=>%/%6O?V5JEA;WNC6>LS
M'2D^U? GQM^'7Q*\;_&;X=>#=7O]1\7? #QOH/@#XK:7>^'/$VAKX>\4>*/A
M]X2^*6@VME?Z[I&G:;XFLM0\$>./#>KQZOX8O-8TE&OFL)+Q+ZVN;>+\*_V,
M_P!KO]EOX-_\%(O^"WEM\7OVA_@K\*?[<_:2_9RUOPU-\2?B=X-\#Q>+;'PQ
M^RO\//A]XL;P@?$FLZ:?%$GA/QSX?U#PCXEBT$:C)HOB,0:+J$=OJ=S;6TJ4
M8^]I>R5E=K7F5[Z]OZN4Y.ZM)I.^M[[1UO=Z6E_EL?M1^S+^U-\"?VQ/A-H_
MQN_9S^(6E_$7X=ZOJ.K:$^HV]AJVA:UH'B?P_=&Q\0^#_&?A#Q+I^D>+?!/C
M+0+O9%J_A;Q7HND:W9I/:73V1L[ZQN+GY]L/^"A_@WQX_P 1-0_9S_9__:6_
M:Q\#?"OQ3XC\#>,_BI\"?"_PKB^'3>,O!ES=6/C'P[X!U?XQ_&#X1:G\:KKP
MKJ5E=Z+K%_\  _1?B/H<?B.UO/"]IJMWXDLKW2K?\_O^"?2:7\+_ !5^W+\5
M_%<7CW]GSP?_ ,%8/^"@?Q";]B7P[K?PO^(^C>*O$5Q#\"YK:Z^-VL^#8?#4
M&M_"1OC-J'PT^(GQ;T.?XO6OP]O]4\/:7X>UC5GT[4O%>A6EUPG_  1[_:[^
M G[!O[$/@#]@C]NWX@?#W]BG]I;]CI/'W@/QQX1_:!\4:1\(O#?Q-\/I\1/&
M'B'1/C5\"_&?CN[T+PU\9_ 7C;2]8AU.ZUSP)J6LWECX@EO8-9T_3TO]$FU5
M\L5=V;U5E=WL]]5?9Z?F',]+MJZ=VV]UMHVMUK^7G^_7PA^*/A7XW_"GX:_&
M7P4NKKX.^*W@3PI\1/"JZ_HUWH.O1^'_ !EH=CX@TF+7-"OUCOM$UF&RU"&+
M5-(O46[TV^2>SN%$L+@%?!/B'_@L%^P#X N-'T7QK\3/B'X/UG4_!G@'QS;>
M'Y_V9/VE]8N;+PU\2_ _A[XB>#9+RY\'?"#Q'H%K?7WA+Q1HM_?:-#JTNH^'
M[NZGT+Q!::7X@T[5-*LBER_W7^/^0:?SK[U_\D?J'1112+"BBB@ HHHH _GS
M_P"#H<?\:9?VC/;QW^SD?_-@/AR/ZUH_\&P8_P"-*'[)W)'_ !57[4W3'_1V
M_P <O:N/_P"#I_78=*_X(Z?&2Q>6W23Q+\6OV=M#MTF$ADGEA^+_ (8\0R16
MH1E'VA+30;F=MX9!;P7(V[PK+N_\&NVL65]_P1>_9KL()4:X\/\ C[]I[2-0
M175C%>7/[3/Q7\11QN@^:%FT[7]/G6.7YS'-'*/DEC%;O_=U_P!?7_Z2NISW
M7UEKO16GFIR_1G]!N#ZG]/\ "C'))).>QZ?X?I2UGZK?P:;INHZA<3QVT-A8
M7E[-/*56."*TMY+B2:1G(0)$B&1RY"A5)) !QA;^KOOZG0]$WY/\G_D?P#_\
M&<8Q^UA^WO\ ]D=^&_Z_%'QK7[9?\'%/[$_[;G_!1[X7_ []G+]D_P"!^DZS
MIWPR^+MO\?\ Q-\6O'WQ4^&_@GPC=ZCHWP^\?>"]"^'OAO19=?U3QY>ZW<R^
M,;J_U?4]7\*>'_#=G]FTJWLM9U);W4[C1/PJ_P"#-#Q#9W7[57[9UO<W*G4_
M$?[.WP[\26L<GE0RW-GI_P 2]1&JW(MPP*B"X\4:2LPA1HH'NXXG9&>)6_KJ
M_:H^&?\ P52\5?%V^U;]D?\ :-_9Z^&7P:?P]H<%IX5^)'@]M;\3Q^)H/MO_
M  D.HS7P^%GBW-A>M)9&RC_MJ3REBD!M;4DB3/,L;/+[XBG@<9F$E.G!8? T
MZ52M:I&2=3EK8O!1]G32;G+VUTI1M"=W;W^".&,'Q?F']CXSC#@_@>@\+C,5
M_;7&^8YIEF2N="K04,"L3E'#G%.,^NXGVTGAJ2RU4Y1P^(<\32=.$:OUCX$^
M+WQBUCX,77COQS^RQ\3?!?Q3T>TB@N_@7;^./@!XB\1^)M5CM=,:ZG\#>,K#
MXQ1_#>;P_-=WMW#87?CKQ9X!UMXM(OY;OP_:F72TU/\ (G_@C1\%?V[?V3O$
M7[7_ (/_ &I?V5HO"GAO]K7]M'XW_MG>'/B#\//C/\'OB#H7PSN/C@UOJ6L_
M#?XE:6_BWPSXODO-!E\-Z38Z7KWP\\+^.M-U.^UMS=1:5I]I->Q]T/@E_P %
M[,#'[:'['^.H_P"+<L.O/_1":/\ A27_  7LSG_AM#]C[/K_ ,*Y;/\ ZHFO
M _UDKI3C_JKQ2U.SO]0P7NV=TE_POZJ^NM]D?K?_ ! S(FXM_2.^CG[M]'Q;
MQWNU9W_XTUVT^]^G[B&4$$9QD$9 ((SW![$=J_F#_:O_ .""MO!_P4[_ &4O
M^"BG[&2Z-X3T>U_:K^$7Q2_:_P#@.=1M_#'AG5D\-^*!J&I?'+X=6F;;1CXE
MM(KW6=0\:>"KA4DUR[U35/%'@^6+Q+J?B#1O%?UO_P *1_X+U_\ 1Z'['W_A
MN3_\XFC_ (4C_P %Z_\ H]#]C_W_ .+<GGZ_\6(_EBICQ)B8MN/"_%=I1<9+
MZA@+-/US_P ^BOYA/P+R"=N;Z1GT<7RM25^+>/+IIIII_P#$&UV^9^J_[17B
M3XE>'/@O\0[SX/\ PHUCXT_$FZ\-ZOI7@[X?Z1XI\$^"3JFO:Q8W%CIMUJ_B
MGQ]XD\,:'HGAS3;N>*ZU^^MKK4]>ATV*XET'P]KNH+#83?R_?\$@O@!_P6=_
MX)$?L\>.OV:KW_@G7\)OVI?#_B/XK7_Q?T7QCX,_;C^&?PMO])U+Q-X/\$>$
M]?\ #E]IWC/P7JHUFTM_^$'L=6M-3W://!<7VI63)JT/V.ZA_2K_ (4C_P %
MZ_\ H]#]C[_PW)_^<31_PI'_ (+U_P#1Y_['YZGCX<,>V3P/@0?3'N< <X!N
M'$N(C%P?"G$\E)IMRP."6NB6O^L"22[V>[O?0F?@9D+?M/\ B8[Z.B<(RM;B
MWCMNS5VDGX-ZM\J23M=M:K=?6/[#GB']O3XE_$3]H?XO?MK? [1/V6]$UFT^
M$W@#X#_L^>'?CKH/QYMM(\/^"(O'VN^-_B=K_BCPG9Z;X;7Q9\0O$/CZQT2Y
M2STK2KF+P[\/O#6FW-G<?V9'K6L_HY7PU^QCX(_;Q\&K\0U_;>^,OP@^+L^H
M/X9;X;/\*?#G_"/KH,%M'K/_  EBZX#X%\%&[;4Y;CP^VG$+J0@%E>AGMC*%
MF^Y:]K"8B6+P]/$3PF)P,JG,WA<9"G3Q%&TG'EJ0I8G%P3=N:-L14O&46[-V
M7Y)Q-D=#AO.\=DN&XEX=XOH8*5&-/B+A/%X_'9!F2K8>EB)2R_%9GDO#V-JQ
MP\JTL)7]ME&$Y,5AZU.G[:G&->H4445T'A!1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 C ,,'(Y!X.#P01S]17CT/[//P$MOB._Q
MCMO@E\(;?XO2-=/+\58/AGX*B^)$C7UM/97K/XY31%\3LUW9W5U:7+-JA:XM
MKF>"8O'+(K>Q44??][_S \SL/@O\(=*T'7?"NE_"SX;:9X8\436]SXE\-Z?X
M$\+6>@>(KBT,36L^NZ/;Z5'IVKS6S00-;RZA;W#P-#$8V4QIM9'\%/@]#/X8
MN8?A3\-(;CP0D<?@N>+P%X42;PA'%J$NK1)X7E721)H"Q:I/-J,:Z2UHB7\T
MUZJBYD>4^GT4!9=EIY>=_P SQOQW^SO\ OBEX@T;Q9\3O@C\(?B/XJ\."$>'
M_$WCWX9^"O&/B'0A;O))!_8^M^(M#U+4]-,+S2O%]BNH1&\CM&%+/NZFR^%_
MPWTSPOJ/@?3? '@G3_!6L-=OJ_@ZQ\)>'[3PKJKZAL^WMJ7AZ#3X])OFOC'$
M;MKJTE:X,:><SA5 [NBC^MW;[KV_ ++LCQOQC^SM\ OB)X<\/>#OB!\$/A!X
MZ\'^$2C>%/"?C+X9>"?$_AGPPT2(D3>'="UO0[[3-$,2Q1K'_9EM:A5C0  K
MFNKU+X8_#G6?!$GPRUCP%X*U;X;RZ;!H\OP]U/PIH%]X'ETFU:.2VTN3PG=:
M?+H#Z=;R11R0V)T_[+%)&CQQ(47'<T4??IMJ_P#.P679?<O\CB_ 7PX^'_PK
M\-V7@WX8^!_!_P .?!^FM,^G^$_ ?AC0_!_AFQ>=@TSV6@^';'3=+M7F8!IF
MAM4:4@%R<"NTHHHZWZVM?RO?\P"BBB@ //\ ]:F%#V=AU[Y_SC_]=/HH 9L.
M>';\?\C]<T!3W8MP>N._?ZXXYX] #G+Z* (PA!)WL<X'/;&3QZ9)/KZ=*7:>
M/G;WZ<_X?ACGVXI]% #-A_O-C^GI_G\0:7;_ +3?@<?IBG44!;\"/9_M')Z^
MAZ]1^/U]SFE*9Q\S#Z'ZY]OIQQBGT4 (!@ >@ YZ\4M%% !1110 W;\V[<1G
MJ!C''^?Z#&3EIC)(.]N.G0XX([^Q(SP3QDGG,E% $>PY)WMSCH!V^H//;)SW
MR#2&+.,LQ Z X('&.I&?;.>03G).1+10!'Y>0068CD@$D^HZ]3U/!..F,8%!
M0D8WL,^X/;!Z\]\XR1[<#$E%*VM^_P"@=O+5?E_5[D9CSC+,0,<=LCOCIGN.
M, XXXH6/!!+%B!C)Y/3'7\2?J3S@D5)13 **** "BBB@""ZM;:^M;BRO+>"Z
MM+N"6VNK6YACN+:XMYT:*:">"97BFAEC9DEBE1HY$9D=64D&O9Z98Z= MKIU
MI;:?:))/*EI96\%I;)+=7$EW=21PV\<<:/<W<LMU<,JAI[F62>4O*Y:K]% '
M)?\ " ^",W+?\(?X5S>-,]V?^$<T;==/<BU6X:Y/V+]^TZ65DLS2[S*+.U$A
M86\074L?#VB:7/<W.EZ3I>F7-X5-Y<:=IUE93W>VXNKM1=2VT$3W&+J^O;D>
M<SA;B\NIP!+<2LVS11_P?QU8?U^%ORT,*X\,>'KN>WNKO0]'N;JTF-Q:7$^E
M6$T]I.=035C-:S2V[R6\QU6*+4S+"R.=1BCOBWVI!*;UWI=A?H\=]9VMZDEK
M=6,B7=M!<K)8WOE?;+.03QR"2UNS;P-=6[[H;@PQ&:-_+3;?HH_K]0_K[E;M
MV.0?X?\ @5[N:^?P9X3>]N8UBN+QO#>BM=3QI"UNB3W!LC-*B6[O;JCN5$$C
MQ !"16KJGAW0];"#6='TK5Q$R/$-4TRQU 1-',LZ&/[9!-L*3(DJ%-NR15=-
MKJK+M44??][_ ,Q62TLON7^1FV&D:9I<<D.F6%EIT,MQ-=RPV%I;6<4EU<,'
MGN9([:*)'N)F ::9@99F ,CM@8SM-\'^%=&U;5]?T?PWX?TG7O$#(^NZWIFB
M:98:OK3QL71M7U*TM8;S4F5V=U-[-,59V(.6-='12MT[^;_SN/\ K^NQRK^!
M_!TEU97S^%?#37NFS2W&G7;>']':YT^>=S)+-97#61FM999&,DDL#QR2/\[L
M6+$U[SX=^ ]1TV[T;4?!?A&_T>_2QCOM)O?#.AW6F7J:7N_LQ;NPGL)+6Y73
MM[_85FB<6>]OLPBW-GLJ*?S?3J^FW4++LON7^1!;6T%I#%;6T45O;6\,5O;V
M\$:0P6\$"".&""&)5CBABC 2..-51$5550!4]%% !1110 UEW#&XKSG*]1P1
MQV[]P1WQ3!%M(PS #H!TR<9)'<X& 3DCU/.9:* (_+//SMSTYY ],]2.3U[X
M/84@B +$,068,Q  W,!M!;&"3M"KDDG"*"2%4"6B@"/8<Y+MZ'G'KZ8QC)QZ
M<>BX/+.W;O;ZG!(.<@CC&01GD'GMCBI** (C%DYWOG.<Y&>A'4 'D'![XP!@
M@&E\L$,I.Y6!!4@%2",$%3D$$<$$8-244?\ #@,*=]S9]>,X].GI_,GJ3E/+
MY)WOSZ'!]LD=<=!QT SGO)10!&8P2"68D$$$XX.""1Q@$@]@/3&"05*$@C<P
MS@Y'!&..ON,9^GJ33Z* _K]3G='\*>'O#]YXEU#1=)L=-O\ QEKR^*/%E[:P
M+'=^(_$4>@Z'X6AUG6+GF:^O[?PSX8\.>'K::=V-KHFA:1I=N(K+3K."'?"8
MXW,1C'7'\L#Z<>@Z "GT4>86&%,@#<W'<'&?KZ^AZ>V*0Q(=NX!]C*Z!PK!'
M4$!DR/E89.",$9(7 .*DHH#OY[_U_P ,,"D#[Y/KGG^?3C''KD]2:*?10*R[
M!1110,**** "BBB@#^*/_@MGJFL_M,_MT>/?V2OC9K_B/QA^SE\,+CX#>/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
2**** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>ex5-1_002.jpg
<TEXT>
begin 644 ex5-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !@ X0# 2(  A$! Q$!_\0
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M=3^%5Q\,X+'3[;Q_XMAM-,T7PAIUUHZ:3I\_VVX>ROYK[]8O'_[2?Q6^(_\
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M(],N/!4$D=[JDU[>W1_9.5_]"O*__#9EW_SN#_B(GB+_ -'%\0O_ !/N._\
MZ.3]"_\ A@[]A_C_ (PV_92YZ?\ &.WP@Y^G_%'\]11_PP=^P_G'_#&W[*6?
M3_AG;X0Y]/\ H3_7BOS1_9(_X*#_ !W_ &NO^"<'_!1#X_>(=)\2?L[?'O\
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MQ;T6/X8Z7_P@-SK>H']DY7_T*\K_ /#9EW_SN#_B(GB+_P!'%\0O_$^X[_\
MHY/N3_A@W]B#_HS7]E/_ ,1U^$/_ ,Q]'_#!O[$'_1FO[*?_ (CK\(?_ )CZ
M^MJ*/[)RO_H5Y7_X;,N_^=P?\1$\1?\ HXOB%_XGW'?_ -')\D_\,&_L0?\
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M$5VMXB>(7O6Y?^,_X[UW>O\ QG&FB?<_4T_L'?L/*"S?L;?LHJH&2S?L[?"
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MJST/H7_A@[]A_P#Z,U_92_\ $=?A#_\ ,?2_\,&_L0?]&:_LI_\ B.OPA_\
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M#?V(/^C-?V4__$=?A#_\Q]'_  P;^Q!_T9K^RG_XCK\(?_F/KZVHH_LG*_\
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M!O[$'_1FO[*?_B.OPA_^8^C_ (8-_8@_Z,U_93_\1U^$/_S'U];44?V3E?\
MT*\K_P##9EW_ ,[@_P"(B>(O_1Q?$+_Q/N.__HY/DG_A@W]B#_HS7]E/_P 1
MU^$/_P Q])_PP=^P_P#]&;?LI?\ B.WPA_\ F/J]^UC^U;H/[(?@WP=\0_&?
MPS^)WCKP1XG^*WPM^$NN^)/AR?AE]A^&6H_&+XA^%?A9X*\6_$,_$7XE_#R6
MS\!R>-O&6AZ9K>N>&HO$][X?MIY-4U+2(],AENX_"M2_X*5?#>UU[]K#P?H_
MP;^.GBWQQ^R'\5O@)\'?&7@OP^?@1#K/Q#\6?M+^-M)\"_".X^%-YK_QUT7P
MYJFB:[JNNZ8+K4/&FN^!#I=Z-:\)7L,7Q#\(^,O!?AYK*,L?_,KRO_PVY=_\
M[A/Q%\1%OXB^(7_B?<>?_1P>S_\ #!W[#_\ T9M^RE_XCM\(?_F/H_X8._8?
M_P"C-OV4O_$=OA#_ /,?7RWX[_X*V?"7X6?#_P#:2\>_$[X#_M&> V_91^/?
MPV_9^^,'@W6A^SG<>,=.UGXL>#O!?CKP7\0M&M](_:*U#0M7^$VH:#\0_"5S
M=^+$UZWOM%M+CQ#KVM:#8>%/ /Q"U_PKW_QH_P""CWAGX&^(_B18^)/V;/VD
M-=\"_"7X\_L^_LZ^//C+X9F_9P?X;:#X]_:0B^$K>#;V^3Q%^T3X;\?V7A+P
MU-\<?AI!\0M?OO =JGAY?$4.HV%KKFC6]WJ<#_L?+?\ H597_P"&W+E?[\O7
M=?>+_B(WB)_T<;Q!TW_XS[CS3??_ (SC39[V/9O^&#?V'ST_8U_92/\ W;K\
M(?\ YCZPK_\ 8U_X)]:3J%OI.J_LK_L:Z9JMY:3W]IIFH? WX(66H75C:RQ0
M75[;V5SX8BN9[2VGGAAGN8HFAAEFBCD=7D53YGJO_!2WX:VFN?M9^$=%^#/Q
MT\7^./V0OBK\!/@]XP\%>'F^!$6M?$/Q9^TMXUTGP)\(Y?A1?:_\=M#\-:KH
M^O:QKFF+<ZAXTU[P$=*OCK/A"^@B^(GA'QEX,\/_ $#KO[*GP$^)WQ>M_P!H
M;XI?"?PUXZ^)(^%_A3X9Z#:?%#PUX+\=0?#+P_I'B#Q5XQU:V\&1ZAINMP^&
M=?\ %NL^++6V^(VI^']:N;/Q7!X"^'T)DE@\*V%S.O[)RI/WLKRQ>2RS+F__
M %7-6\^G6P?\1%\17MXB>(3[_P#&?\>)6ZZ_Z\/8X2]_8]_X)Y:=!<W.H?LO
M_L76%M9JCW=Q>_!+X&VL%JDCQQQO<RS^&DC@5Y)8HT:5E#/)&JDLZ@]%_P ,
M'?L/_P#1FW[*7_B.OPA_^8^OY:/A)\"?@"G_  ;4?LW?&34_@A\-K[XC> ?C
M3\'_ !3X>\?Z=\+?#^J?$S1;ZS_X*JZ)H5Q<>%M9TO0YO%[ZO=>%K[5/#4=C
MHT\E[JVE:E<^'DM[NVOY+*;^EB#_ (*%?"3P[XD_:(\*?'KP;\4/V5M7_9H^
M"FG_ +2GCP_&ZW^&^IZ9K'P U"[\9:9+\5/!.L_ WXE?&?2==TO2M>\!^)/#
MVK^%;J]TKXC6FKQZ5''X,N+;Q!X>N=6J63Y6FTLKRMV<E_R+,NZ6UTR[K<E>
M(_B(W;_B(GB$O<C)?\9_QX[\SDK?\EQT4>^OI8] _P"&#?V(/^C-?V4__$=?
MA#_\Q])_PP=^P_\ ]&;?LI?^(Z_"'_YCZQ]._;5\*P?$CX>_";XB?"7XU?!S
MQU\8OAQXW^(_P8T3XAZ'X&FNOBO'\-=(T[Q%X^\!^&H? /Q#\<3Z3\5_"_AS
M5M-\0W'PZ\:P>%==U?19=5OO#"ZZ/!OCV/PM\\_#W_@K+\,/B=X:_9E\:^%O
MV;/VN'\&_MCV6L6G[-?B*_\  WPHLH_B5\1- \->*/&.J_"&70W^-K>*_ 'B
M^'PGX#^(7B:+Q;\4= \$?!6Z\/\ @77]9MOBK-IDWA^[UR?[(RWIE65OTRW+
M?UR_R?W,K_B(WB)_T<7Q"_\ $^X\\O\ JN/-?>NY]/?\,'?L/_\ 1FW[*7_B
M.OPA_P#F/H_X8._8?_Z,V_92_P#$=OA#_P#,?7A.O?\ !4/X+>$?V=/&?[17
MB[X6?M$>'[?X7_M(Z%^R?\6_A%'X!\->+?B_\+?C/XB\<^#_  -I6D^*;7P#
MX\\6?#J^\/7,_P 0? FOV?B_P?\ $;Q1X=U30?&'AQ-&O]1\0ZC#H#6];_X*
M;_!_X?>+_C+\//CQ\-/C3^SG\0?@]\*_#GQOC\(_%BV^#]P?BC\)_%/Q M/A
M+IOC?X:^,_AC\8OB/\,_[)L?BGJWA[P/XM7XA^-OA]>^ ;SQ-X?\0^.;7P[X
M&U.+Q8K_ +'RS_H5Y7O;_D69=Y?]2_S7WKN'_$1O$3_HXWB#_P")]QYMT_YK
MC?1Z>5CVO_A@[]A__HS7]E+_ ,1U^$/_ ,Q]+_PP;^Q!_P!&:_LI_P#B.OPA
M_P#F/K%;]M#0[76O O@/6O@O\;_#_P 9_B9XP\;^&/ /P1U73OAE)XP\5Z%\
M.?"?ACQMXS^+6C>+=(^*.J?!Z\^#6@^'O&WA 7_CN'XF-%;^*O$>E_#&73T^
M*TY\#+YIXP_X*=? ;P)\%O''QE\2>"_CG;R?"G]I?P)^R5\8?A/IWPY@\0?%
MWX4?&;XD^-O O@OP?IWBS0?#_B+4_#=YX8UQ?B=\//%FA>-/"'B[Q1X;\7>%
M/&OA:;P1?^)M<UW3M#G7]D99_P!"O*__  VY=^?]G6_$/^(C>(G_ $<7Q"_\
M3[CS_P"C@]=N?V%_V%K.![F\_8^_9+M+:/8)+BZ_9[^#EO!&9'6- \TOA)(T
MWR.L:;F&YV5%RS &!/V(OV"Y(+FZ3]DC]D)[6R9UO+E/@'\%VM[1HT221;J9
M?"ACMV2.2-W$S(51T8@!@3Q\/Q]^''[46E?M;?LZ?$'X(>,_!/C;X*^"= U'
MXE?![X^Z!\*O$]IK?@CXHZ!XTU'X6?$'2Y_A[X^^,'PW\2^$/%6I?#WQI9Z?
M:WGB"'Q3HFO>"=3C\1^%M#8://J'P#_P1H\8_#CPY_P2:_8<\!Q_LQ_$G4=$
M\4_LS?"Z]\;?\(Y\"=-N_!/CS6M:\+:='KOB/6S"R6/BN37C''/J6MZK:W5U
MJ\2175V[N5"CRC*TFWE>5WTT_LW+7O;ME[[A_P 1%\1;I?\ $1/$)IIN_P#K
M_P >;IVM_P EQ_P>Q^F5M^PY^PC>>;]C_9"_9'N_)=8YOLO[/_P:N/)D9!(L
M<OD^$W\MVC9757PQ0A@"I!JW_P ,&_L/_P#1FO[*7_B.OPA_^8^OP'_X)OWO
MP?\ @5_P1'_8=^)NJ:C^T!\$_#EI^W+%>:U/^R#I_A'P?XE\>^)O$/\ P42^
M*'P?^'?P]^/+W^E)IVI? ;Q+J_B/P=X&^*&EW5_I>I7'AJWTKPYHFKP2165A
M<?LA\7O^"DWP^^$GC_\ :I^'</P%_:;^)&L?L9_#+X>?&GX[ZIX#\&?#G3_#
M6C?"7XB^'/B!XHM/'7A75_BC\6?ALGQ!T_P]IGPQ\9KKFB>"HM;\7WVIZ)?Z
M)X.\.>*M7TW5K/3Z>3Y6I2BLKRM\K:O_ &9EVMG;_H7:7_X EXC^(CC&7_$1
M/$)*2B_^2_X\>\6[?\EOY?F>T?\ #!O[$!Z?L:_LIG_NW7X0_P#S'T?\,&_L
M0?\ 1FO[*?\ XCK\(?\ YCZ\9^/'_!4;]E_X"C4EOM2UKX@W&A?L]:)^U)KV
MF^!+_P"'EEK=C\&/%9U^3P9KFE>'_B7\0/AUKOCKQ+XUT_P=XZU;PQ\.OAUI
MWB[Q_J%EX.U&"3PY:ZQKG@?2O%GUYXW^._PO^'OP6U+]H'Q/XFCM/A9IO@ZP
M\=?\)!#I^IW5SJ>A:Q;6=QX?AT308;5M>U?7_%$NI:7I?ACPS8Z?-X@UW7M5
MTS0=.TVXU:]@LWEY1EBWRO*U?_J69?\ _.X:\1O$1WMXB^(+:WMQ_P =NW_F
M\GE'_#!W[#__ $9M^RE_XCK\(?\ YCZ/^&#OV'_^C-OV4O\ Q';X0_\ S'UQ
M^M_MS:-X(U/7?#_Q4_9\_:0^%'B@>+O@W\/_ (6Z!XM\._"_5(_VB?'OQRD\
M81>%/!?P.\7> OBWXT^'NN^)O#G_  @?BB]^*>F>+?&'@MOA5X9T]?B#XZET
M;X:7FG^,[O'\:?\ !1+X3_#;PC^U[KGQ"^'_ ,:/"7C']B;X76OQP^,'P>N?
M"OA?6?B1JWP8U70_$FN>'_BI\,G\-^-M8\!>/?!6O)X(\>:4FIV'CFVG\.:_
MX&\4Z+XXL_"M]IR17#_L?+/^A5E>NW_"9EWI_P!"[NTO4/\ B(WB)_T<;Q!_
M\3[CSLW_ -%QV3?IJ>D?\,'?L/\ _1FW[*7_ (CM\(?_ )CZ/^&#?V'_ /HS
M7]E+GI_QCK\(>?\ RSZ\8M?^"C>E:I\0-#^%.B?LF?M<:S\1?B#\&IOV@O@C
MX5A\/? C2IOC?\'M,O?#&G>+/%WAO6O$G[0>A^&/AK-X'O\ Q[\/+'Q-X6_:
M-USX(^,OM_CWPSIVA^'M9U*75;+2/J[]G#X_^ _VH_@GX ^//PT378?!WQ"T
MV\O+'3?%.D_V'XI\.ZIHNL:CX9\5>$_%6DK<WUO8>)_!_BS1=<\+^((+'4-2
MTQ=7TB\.EZKJ>G&VU"Y7]D98M\JRM?\ =-RU_EE[&O$7Q$>WB+XA-_\ 9?<>
M6M_XG'G^7<\Y_P"&#?V(/^C-?V4__$=?A#_\Q]'_  P;^Q!_T9K^RG_XCK\(
M?_F/KZVHI?V3E?\ T*\K_P##9EW_ ,[A_P#$1/$7_HXOB%_XGW'?_P!')\D_
M\,&_L0?]&:_LI_\ B.OPA_\ F/H_X8-_8@_Z,U_93_\ $=?A#_\ ,?7UM11_
M9.5_]"O*_P#PV9=_\[@_XB)XB_\ 1Q?$+_Q/N.__ *.3Y)_X8-_8@_Z,U_93
M_P#$=?A#_P#,?1_PP;^Q!_T9K^RG_P"(Z_"'_P"8^OK:BC^R<K_Z%>5_^&S+
MO_G<'_$1/$7_ *.+XA?^)]QW_P#1R?)/_#!O[$'_ $9K^RG_ .(Z_"'_ .8^
MC_A@W]B#_HS7]E/_ ,1U^$/_ ,Q]?6U%']DY7_T*\K_\-F7?_.X/^(B>(O\
MT<7Q"_\ $^X[_P#HY/DG_A@W]B#_ *,U_93_ /$=?A#_ /,?1_PP;^Q!_P!&
M:_LI_P#B.OPA_P#F/KZVHH_LG*_^A7E?_ALR[_YW!_Q$3Q%_Z.+XA?\ B?<=
M_P#T<GR3_P ,&_L0?]&:_LI_^(Z_"'_YCZ/^&#?V(/\ HS7]E/\ \1U^$/\
M\Q]?6U%']DY7_P!"O*__  V9=_\ .X/^(B>(O_1Q?$+_ ,3[CO\ ^CD^2?\
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MJ8[:#[8HH **** "BBB@ HHHH **** "BBB@ HHHH **** /SG^)G[(GQO\
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MA?V,OV]O-?VB/^"CG[+W[+7B2ZT7XPZM\3=)\/>'-7\,Z%\4OBYX>^!_Q?\
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M>_\ $'@J]\%V6MZBSXP_\%)_AA\'_BW\1/A(WP"_;9^*U_\ "N/PS%XU\;?
M;]D[XJ?&+X6Z3K?B;PEIWCM/"LWCWP9IE_I$?B;0_!FO^%/$WB+39V@73-+\
M7>'I1/<2W%W#9?7?@'XMZ?\ %+X(>#?CEX)\*^-[W1_B#\--#^*/@_P9JNE:
M;X3^(FK:3XF\-V_BGPYX?N]#\7ZSH.E^&?%NLV5Y967]D^+]>\/0:+JMVMEX
MEU#0VMKZ2T'=)-[/2^FOKOK\D'NWTU:UTW7IZW[G,_LT_L]^#_V4OV=?A)^S
MG\,'U"Y\+_!WX?Z+X'T34O$DT=QK7B*ZTJS+:CXJ\4W%C#;6T_B#Q=KTM_XE
M\2W&GVEI:2ZQJ^HR:?96ENT-K'^6V@?\$EO%6N?LH_MW?LX_&7QYX UW7?VI
M/VKOCM^VS\$OB=\/-.\<^"_%/[,W[0OQ9\6-\1/ 7B_PIKZZY<>(HO$7P&^(
M%CHFN^$_&OAK4_#6H>*K&/4M UK1-,T?4=2M=3]=TW_@KQ\+A\%/'7[2OB_]
MFC]K;X??L\_"/XM_$?X._&GXO:UX?^ 'C#1OA%KGPB^)NI?"/XD>)/%O@[X.
M_M%?$[XK:EX#\(^-=)OHM9\4^!/ 'C.VLO#T$WC">)/"5K>:U;?J]IFI:=K.
MG:?J^D:A9:MI.JV-IJ6EZKIMU!?:=J6G7T$=S9:A87UK)+;7EE>6TL5S:W5O
M))!<P2)-#(\;!BVW'5Z7=[M;M:O\M?(5HR27\JDDEI922BWIMHM/,_*B]_9#
M_;KU:\_9D^.FH_M/_ <_MG_LV>"/B/\ !O7?B1<? 7Q->_!+]I7X-?&"W^&=
M_P#$;3?B=\)=&^)O@WQ!\.?'5WX]^$/PX^)?A_Q)\+OB';^'M&\2^&M1TP>$
M)?!WBJ?POH^!^VM\!]4^/%Q^PM\&/$'QZTMOVK?"_P"T:_Q-U;Q9X \-Z/X/
MU^7X$:U\./BUX&_:ML-&\'+K'BSQ3\-OA)XG^"GQ"USX+^$/%.HZWXLU+0/B
M)K?P3'B+QQKOCZ6U\4W/WII/[3_PWUS]J3QE^R%86WCE/BOX!^#WACXW>)+G
M4_!&MZ+X&?P7XQ\2WGA70/\ A'?&&LP:?8>-;^?4]+U2*]D\%IK^AZ+<Z??Z
M-K>MZ?XCL+K0T\S\2_%O]ECX9_MO^"OAG>?#.#1?VJ?C[\"O'/C"7XRVOP7B
MTB/6/@I\!=4\/R:QX?\ %G[0M_H^E6WB.S\*ZSXTT>XM?AOH_B;Q7J7@]];T
M[7_$GA_PMI7B3P[JVL";3327=::.Z?W[W^[T!I6>KM=1=VVKIJ^G1[7?GW9]
MF6-C::;I]II^FV5KI]AI\%M9Z?I]C!%:65E8V<:6]I9VEM;I'#;VEK;QI#;V
MT,<<44,:1(D:* /R2^!'_!/_ /:<_8;/B_X:?L,?M*?"+0_V2_$WCCQ#XZ\"
M_LZ?M+_ 7QG\5C^S/=^--;OO$WB_PK\"O'WPU^/'P=O)/A/>^(=7U/5M&^&?
MC30M3N?#EW*[Z=X[9M0U>2^_2KX)_&WX4?M'?"SP;\;?@;XZT+XE_"CX@Z=-
MJ_@SQQX:GEN-%U_3[?4+S2KF>SDGAM[A6M=3T^^T^[@N+>"XM;VTN;:>*.6%
MU'J1.!GKR!VZG@<D@#\2,G@<D RKK3IV?K^EV4TG;I;:VEO+YZ-^:/S-^+?[
M%'QV\2>(/V?_ (]_#O\ :8T^']KOX"^)OBIJS>-_BK\,]0\5_ [Q]X*^.OA'
MPKX5^*GP9'P=\)?$3P7K?PU^&ZS?#WX8^(_AJ?"WQ&U/Q/X7\1?#ZPU[Q[K7
MQ8\1^*OB#K_BWJ?'W[,/[0WQ$\??L'_$+Q?\7/AEXG\1?LJ_'CQ_\</B1>Q?
M#O7?"&G>-V\??!3XS? =?!?PX\/67BWQ#+X.T+PGX3^-^LZGHM[XP\2^/M?U
M34_!_A^#7=5N/[9U;4;303_@H!X'U*V\'>,/"WP:_: \9_ SQY\;= ^ WAG]
MH[PEH?POU+X4WGB[Q#\7(?@5;:]/I4_Q7M?C+9?#6/XIO=>&U^)-W\)(?"6I
MV=G%XO\ #NJ:WX'U[PEXC\0??(Z#Z#_/-/F?EVV^_P! LG\]_.S6OKHE?_AS
M\:KO_@FY\:=6^%/QZ\'W7Q@^&&D>-?'/_!23X=_\%(/A3XAM? /BO7?"OA_Q
M7\-_C7\*?C+IGPI^(GAN?QEX?UCQ#X?U&7X2Z;X<OO%?AGQ/X<U$+XAOM7M]
M#A.C6^E:M[+J'[)'[5'A#]H;Q_\ M!_ /]H?X->"=4_:.\"?"/P[^TYX9\??
M #QEX\\/S^/_ (0:+K'A;1/C#\"H=.^/GA.[\%:S?^#]4L_"VK^#/'EW\0_#
MVH0^%?"&K->PW=AKMKXC_3 G&>#P,Y[?_KH# C//7'2B[_'_ "T]-%H+E22M
M=);:[.[U\F^9_>?"GP9_9H^+'PZ_;2_:=_:4\2>-O!/B/P7^T%\,_P!GKX<V
M7AZUTC5[+QQH#?LY/\5UT/Q%K6KQM;^%M9O?'$?Q>UJ?Q!9:1X?\.V/A^YT3
M38=)&HVU_/\ 8ONRBBAN_P"0TK:+NW\V[O\ $****0PHHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH \)_:>^ GA?\ :C_9W^-?[.WC
M*>>R\/?&CX:>+OAY>ZO:1B34?#D_B31[JPTOQ9HP,D/E:_X0U:2Q\3^'[N.:
M&XL]:TFPNK>>&:&.1?DKP9_P3HT7PS^TG^S[^TEJ7Q/U_7O$'PN^!FH^ _BY
MI T>PT73/VB/C9:^)O%?BWP1^T!XUT_3;@:1IVJ>%/$GQX_:W\60^$+#36T9
M?%_QRTW7=+?2C\.?#]L_W?\ %#XG?#_X,?#SQI\5OBKXPT/P!\./AYX<U3Q=
MXV\:>);V+3M"\->'-%M7O=3U74KR7Y(X;>WC8K$JR3W,QCM;:&:YGABD^/\
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MCRKV4NW;K9=NG7\7KKV0ER+1-+9:/JU9?-J+MZ-J^Y^9W@+_ ()<?M#^"/\
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MQ&_9P_X*A?%2:6:+3OV;OVP]!\5?&'X4_#RPTV/PY-J6F:1X-\6_%O\ 9?\
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M- HHHH **** "BBD!)SQTZ>_\J %HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MU";Q3XJ\+_#]O!WAGX=_$3PGX@TRTD\\^!E[X\\#V5[XMA_95_:#U;Q5=?\
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M ,*G\27UK9W_ (?N-2T'X9^(+KPIZAJ7@#XQZ.W[6EWX$_9O^,/B+X+>!_\
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MQ?IG@:77?A[X?U'3[9;G2/"GCOXE:<MS/;^,[R.WCKY>?ZE-NR:6O57V^_\
MK].8_8U_;'N?C-^P9\._VS/CW8^&_AC+XE\,^-O%_C31/##:QXAT;PE9Z)X^
M\6>'].\.Z(;>/4==\9:O#8Z1INAV?]C:;)JGCKQ,Z+X<\.P7>M:?H,7AWPS_
M &X/VHOBQ^QO^T+^T#X+_9V^'9^,?PL_:$_;&^$NF_"?X@?%&;P1X1\%>'OV
M8?B-\2/ BZA\2?'7@_2/B_/XA\3C_A7Q_M73?AOH^JZ+K_B_6[;1M-\0>'/!
M\-WX\TSY?_8*_89_;*O/V ?V0O!/C3]IGQ/\$O%?PJ^(GQ!^*;?#GQU^RWX
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M UOQ!\//!'ACPU\+AK_8_LX>)+ZY_P""JG[=GC.X^&WQZT/P1\7_ ( _L->
M/AQX\\6?LY?'OP;X#\3^*O@3J'[9FK?%/3XO&GBGX<:1X9TF#P]9_$GP4++4
M]?U72=+\5W>O6UCX/O=?NH[B*(=NG17TUWF_/7W7'[M>HTY:)WWMZKEC?II[
MREWO?TM^NM%%%26%%%% !1110 4444 %%%% !1110!F:WI]SJNC:MI=EK.I>
M'+S4=-OK&T\0:-%I$^KZ%=7=M+!;ZSI4'B'2M=T"?4M,ED2]L8=<T/6='EN8
M(DU/2=1L6GLYOP^_9+\9_M5_M,?"+]JNY\1_M^>/OA;\1_A]^WG^VA^Q[\$O
M$<OPG_9+O_#E[#\#OBQXK^'WPGN_$WA#5/@98WOC;Q->V>A1ZMXOTSPWXF\)
MGQ"+34TT&+PP,7%K^X^IW\.E:=?ZI<QWLMMIMG<W]Q%INFZCK.HR6]G"]Q,E
MAI&D6M]JVJWK11LMIINEV5YJ-].8[6RM;BYEBA?\"O\ @F/^RKX#\8ZU^T+\
M0_BM\%?C'\-_BYX-_P""KO[;'[7'P<\5^/\ X3?%OX17^L> /C!\6?B>GPW\
M1:=-\2/!FAZ)XAT7QK\,/&NNV>K^&DB?Q3X=L=9C;6+'PQK3:=<(UL_ETON[
M?U;;<F2V[OS:6FNMOZ>Q^TGPD\2>*8O WPD\*?&O6/!5I^T/J7PH\/Z]\1/"
M_AS6K&6WO?%>C:3X<T[XG:UX.TY_LFI:CX)TWQKK$=I;:O'IEO;VMOJVAP7T
M5A=:A;VA]>KY.\06?PZ_X;,^&UQ>?LM^*=?^*B_ +XCKH7[8EM\/_!]YX,^'
MW@Q/&7A$:O\  S5OB9/KD/C72/$OC34[FS\5Z'X4M?#MUI-_I^EZ]J%MJ2-%
MKL2_3NL:I#H>DZAK%W%J$]GI.G7NIWD6DZ/JWB#59+;3[66[GCTS0=!L]1US
M6]0DCA=++1]&T^_U;4[EHK+3;.ZO)H8)%_7I_P !#6WDKI>B/R;^(_[27[<G
M[/?QZ_8TO_C%I_P \0_ ?]LG]H6/]FB\^"O@#P'XXM?CM^SQXO\ $_PS^*'Q
M3^'OB.\^,LOQ6\3?#[XVZ5I6E?"_6-.^,L>F_"GX:6/A\-_;7@N]\0Z1IEU<
M7GINA?M6_M&W/_!3NS_9 \<?";X7>"/@5KO[(?QO_:#^'_BW3O'6N^-OC!XO
MUGX4_'GX"_"FVOO%>DP^'O#W@GX:^'-1TOXIZOJNG>%M,U7XHZWK%M+H6K:M
MXF\%:I9:MX(7X\^&/[3_ (J_:'_:N^%'Q>^(G[&W[;=AXOT7QEJ'PZ_97^$G
MQ$_96^+WPF^%O[./A'QRESI'QC_::^.OQO\ &OA&/X>R?&G6_A%I?B&UT:PT
M/4=1TOP9X4U=_@!\.-1U[Q=\7OB%XNU_VOQ3KVI2_P#!9WX/^/H?AI\>I_AW
MX;_8+_:&_9UUGXE0?LY_'J?X;67Q>^(?[37[+/B_PCX;D\>V_P .9?";:7J/
MACX=>,-:G\=1:O)\/M+M-))U3Q392WEC%<W9*Z:5U%ZI]=&NMFTG;_AM9O>S
M3>L[6M]E)[Z:)M?BM=4CZN\0_M">+_'_ .T[J?[+WP#M?#3WGPBT3P5XX_:E
M^*_BJTN=<\/_  QTSQ\M]J'P\^#7A+PWINL:+-XE^.'Q)\.:1JGBVZDO]4A\
M/?!_X?2>&O&_BO3/%$WCWP%X4\1>Y_'[XF1?!?X!_&OXR.+0P_"3X2?$OXFR
M#47*V&SP%X-USQ0XOV$T)%I_Q*B+DBXA*P[V$T94./P!^/W[%.IQ6G_!83P]
MXD_9T^('Q:_:O_:Q^+.J_%_]@#X^^$O VNZA<>&=;UG]F'X-?#/X#OH7[0.A
M2_V7^RYXB_9S^._P^U>[\4:_XP\5?#&>Z\!:=X=\0Z=/XXTJXBT&R_8E_C[X
MO^&46I_"KXI_!']HSXK:E\+/@7\'O%/Q!^.?P_\ @_IOBKX:_%OQ#XPUM?A_
MXYTKX>>'/#?B";QGXF\8>&[FRU3XD>.O 6B> 'N].\!7*G0+/7=5O-%T'59:
M6G;2_GL[@I-WNN]GTWM9^?732QY;^PWXM^/?Q?M9/C1XV_;_ /V.?VO_ (-G
MPWJOAK3+;]C;X.:=X1\"VWQ >X\,ZGJNH>*_BHG[4'[2</B.Z\$Z79WNE:1H
M'AZY\%6JP^,-4UGQ/:ZQ-#X730O5_P!E3X^>-/VKX-2^//AC3-)\,?LG>(%U
M+3/V?YM8TO4Y/B7\=M#TW5C8P?M$S74NHVFE^!_A'XZ:RO[CX+>$QHFM^)/'
M7PZN?#?Q=\0>(_#0\86GPY\._$6C_L=ZE\3/BG_P4=^,7[/'@N__ &6O!_[7
M7[$_A;]F_P +_P!M^!+_ .#E]\3_ -HC3+/]H-+O]IOQ=\+SI&D>./"B>#-&
M^)OP]^'N@^)/&?A[P[\2?%K:!XSEG\*6_A'P_P##SQ3XV\._94_99O?"'BC_
M ().Q? O]G#Q]^S%\3?V8/AW=> _V]_%&I^ M9^'^C>)OAQH7[,%_P##.\^"
M_B[QV]G9^%?VM=5US]H>V^&WC+X;>+/".O\ Q2\-^$-%\ >)?'-CXJ\-2:OH
M^F^+:LM=;[66FFE^GW=7^@F[JR?GN[N]NO2VNC1^J/P4_:"\8_M+?$_QQK_P
MPLM TS]EGX1^.?''PAD^(&KZ9J.I>)OV@_BOX!U/4/!_Q(D^&$D6I:?I?A/X
M0?![XAZ9K'P_OO&FJ67B75_BI\2?"GC/3?#NE^$? G@_2?&OQ5@_;\_: OOV
M;OV>;WQYI'Q?^"WP"UO6/B-\'OAYI7QD_:)LX=3^#'PZC\>?$SPYH7B7Q3XZ
MTRY^(WPBM;ZRTGP9-XCNM.M;GXE^#XKK7(],A.J$LMG=_B/^S-^PCXV^$WP)
M_P"":WP)\!? OQG\,OVZ?V3OVJO M_\ M%_M,6W@SQ+H&@^)?@3X3^(WC[7?
MVC]>UC]I&?3(M#^./PO_ &I_AWJUWI'@SX-6?BWQ?XHTSQ/\4O!%SXN\ > ;
MSX7>+-9^'7[<:G^U!X?UBS\:Z?\ $S]E;]J?1O"F@_'3QU\"OM&M_L[:C\5]
M-\:0^#M$TG5M,^,7AWPC\)+KXJ^*]1^!?Q#_ +6N]&\#>.]3\(V!;5]%UBS\
M6Z1X3C?39=2324M'>.WW==&]7]VG8$VXZZ2W=KVUZ+2^FW>[U=SY=\??M+_'
M/]D[]B?QQ^U5\6_VE/V=OVJ;CQ=XX^!WA_X:_%;X:_#&Y^#'[)?PH^'GQ?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MT+?3.0/IG./\YS4E%&P+3;0**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@!,#.>__ .K_  %+110 UD#%2205.1@XST.#ZC(!QW(&<XI<=\D_Y]!@
M?I2T4!9=A ,$G)Y[9X[?X48]S^A_F":6BA*VBV0604F.O4Y['D?A2T4 )M'O
MVY^F/P[#M1@^I_3_  I:*!67;S^\****!A2$9(//%+10 F ,GUZTM%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>ex5-1_003.jpg
<TEXT>
begin 644 ex5-1_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !2 X0# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% &?%I=C%?SZJEI9KJEU96>G76
MI1VEO'J%SI^G3W]U86,]Z$-U-965QJFHSV=K)*\%K-?WTL"1O=W#2?S@?\'7
MHV_\$?/B&0!_R6[X$8[?\S>P'K_*OZ3Z_FQ_X.O_ /E#W\0^^/C;\"3QUX\7
MD\?E5TOXM+_'^C,JW\.;V?*U=:.VG5:]#]D_V'+I[/\ 82_8]NDM+B^>W_9*
M^ ,ZV5H(C=WC0?"#PE(EK:"XFM[9KJX*^3;K/<01-,\8DFBC+R+YA^R)^W;\
M /VI?C+^TW\(O@W\.OBEX5^(/P!\<VND_M+3>,?AYH_@RPT3XI7FG1>']+T;
M6M7MO$6H'Q?XIO/#'@VUAMM5T*/7M*A\.^'M-ANM:M(GT6UN/6?V#AG]A[]C
M3CE?V5/V>P?_  T_A '!]#M)X] >XK^<W_@G9^TMXF_9^_X*._\ !=RV\/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]Y?^^A_C1O3^\O\ WT/\:_*;_AH?_@JQ_P!(Z_@U_P")C>%__F-H_P"&A_\
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MQ_TCK^#7_B8WA?\ ^8VC_AH?_@JQ_P!(Z_@U_P")C>%__F-H_M["?] >??\
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M]Y?^^A_C1O3^\O\ WT/\:_*;_AH?_@JQ_P!(Z_@U_P")C>%__F-H_P"&A_\
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MQ_TCK^#7_B8WA?\ ^8VC_AH?_@JQ_P!(Z_@U_P")C>%__F-H_M["?] >??\
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M]Y?^^A_C1O3^\O\ WT/\:_*;_AH?_@JQ_P!(Z_@U_P")C>%__F-H_P"&A_\
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MQ_TCK^#7_B8WA?\ ^8VC_AH?_@JQ_P!(Z_@U_P")C>%__F-H_M["?] >??\
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M]Y?^^A_C1O3^\O\ WT/\:_*;_AH?_@JQ_P!(Z_@U_P")C>%__F-H_P"&A_\
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M_M'6&GI>ZUK5U9:=:27E_<6]E9+/<QM<7D\%M 'GEC1O[)*_C _:W^$_PO\
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M:YC^T6%[<VTH:.4BG2<?:4]_CCT5OS"LIJG5NH+W)ZISYO+=\OKIZ'W-^P
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BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>ex5-1_004.jpg
<TEXT>
begin 644 ex5-1_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  ! X0# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
%BB@#_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
